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Chapter 1. Stereoselective preparation o f enantiopure abasic nucleosides
The synthesis of artificial oligonucleotides capable of forming stable complexes with 
divalent Cu2+ ions and, by virtue of that, replacing the hydrogen-bonded natural base 
pairing in DNA has been recently reported. Based on these findings, a strategy for the 
development of novel C-nucleosides analogues bearing functional groups able to 
complex divalent metal ions, therefore avoiding the need of the natural nucleobase for 
the formation of a DNA double helix, has been devised. Here we describe the 
preparation of modified nucleosides, prepared from a cheap and readily available 
starting material (i.e. deoxyribose), which possess additional functional groups for the 
complexation of divalent metal ions. Biological tests to evaluate the ability of forming 
an artificial DNA double helix through the employment of the automated 
oligonucleotide synthesis are also reported.
Chapter 2. Asymmetric Michael addition o f C- and N- nucleophiles to isoxazoles
3-Methyl-4-Nitro-styrylisoxazole has been reported as an excellent Michael acceptor in 
the reaction with enolisable pronucleophiles, allowing the generation of a wide variety 
of Michael adducts. Here we report the development of an enantioselective Michael 
addition reaction between 3-methyl-4-nitro-styrylisoxazole and C- and N-nucleophiles. 
A thorough screen of reaction conditions development, including a screening of chiral 
catalysts, bases and organic solvents under phase-transfer catalysis conditions was 
performed. Next, the phase-transfer catalysed Michael addition of nitromethane to 3- 
methyl-4-nitro-styrylisoxazole has been investigated for the development of the 
enantioselective synthesis of a useful precursor of a commercially available drug.
Chapter 3. }H  NMR titration experiments
Next, an investigation aimed at the identification of the role of the quaternary 
ammonium salt and the hydroxyl group in the cinchona alkaloid-mediated Michael 
addition reaction of nitromethane to 3-methyl-4-nitro-styrylisoxazole has been 
performed. In order to determine whether an efficient catalyst-substrate coordination 
and concomitant activation was taking place during the Michael addition of
Abstract
nitromethane to the substrate, ]H NMR titration experiments have been performed to 
identify the formation of a catalyst-styryilsoxazole complex.
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1.0 Introduction
DNA with its characteristic right handed helix1 structure has become one of the icons of 
modem science. Because of its shape, function and inherent chirality, nucleosides and 
DNAs have served as a template for the design of artificial analogues. Artificial DNAs 
could bear variations either on the sugar or on the base moiety. An example of an 
artificial DNA carrying variation on the sugar-phosphodiester backbone is represented 
by the peptide-nucleic acid (PNA),2 which possesses natural bases, thus the ability to 
interact and recognise natural DNA in antisense and antigene strategies. Alternatively, 
artificial DNAs could possess the D-2-deoxyribose scaffold carrying modifications on 
the type, dimension and shape of the base. These latter have found applications in 
nanotechnology,3 biotechnology4 and chemical biology5'6 applications. Thus, while on 
one side chemists can devote their efforts in designing artificial DNAs possessing 
specific functions (e.g. wires, catalysts), biologists can develop new DNA polymerases 
capable of synthesising artificial DNAs by PCR. The merge of chemical synthesis with 
biology around the artificial DNA platform will deliver to the scientific community a 
new means of preparing useful materials.7
1.1 Structure and properties o f natural DNA
DNA consists of two long polymers formed of units called nucleotides.1 A nucleotide is
constituted by a nucleobase a five-carbon sugar (ribose or 2 -deoxyribose, in the case of
RNA or DNA, respectively), and phosphate groups connected by ester bonds. There are 
four different bases in DNA: adenine (A) and guanine (G) (consisting of a purine-based 
structure), cytosine (C) and thymine (T) (consisting of a pyrimidine-based structure). In 
the case of RNA thymine is replaced by uracil (U).
In the double helix of DNA, the two polymers are used to be antiparallel, which means 
that the direction of the nucleotides in one strand is opposite to the direction of the other 
strand. The two ends of DNA are called the 5 ’ and 3 \  The space between the strands is 
called groove; because the strands are not directly opposite each other, the grooves have 
unequal sizes: the major groove is 22 A wide and the minor groove is 12 A wide.
2
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An important feature of DNA is the “complementary base pairing”, thus each base on 
one strand forms a bond with only one base of the other strand; A only binds T with two 
hydrogen bonds and C only binds G with three hydrogen bonds. The result of this 
complementarity is the formation of the double-helix.
DNA exists in many conformations, including A-DNA, B-DNA and Z-DNA even 
though only B-DNA and Z-DNA have been found in functional organisms.
1) A-DNA (Figure 1, A) is a right-handed double helix with major and minor grooves 
quite similar to the ones in the B-DNA form, but with a more compact helical structure. 
It occurs only in dehydrated samples of DNA, such as those used in crystallographic 
experiments.
2) B-DNA (Figure 1, B) is the most common DNA conformation. It is usually found in 
cells and it is present at the high hydration levels in the living cells.
3) Z-DNA (Figure 1, C) is a left-handed double helical in a zigzag pattern and its 
structure repeats every 2 base pairs. The Z-DNA conformation does not exist as a stable 
double helix.
F igure 1. Tridimensional DNA conformations: A-DNA (A), B-DNA (B), Z-DNA (C)
A B C
1 2 Artificial metal-DNA complexes
The chemical modification of nucleic acids has attracted considerable attention from 
medicinal chemistry and material sciences points of view. It is accepted that the
3
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incorporation of metal complexes into oligonucleotides is a key target for the 
functionalisation of DNA. Since the coordination with a metal-ion is characterised by 
energies in the range of 10-30 kcal/mol, which is in between a covalent bond energy 
(-100 kcal/mol) and a non covalent interaction (1-5 kcal/mol), one metal-base bond 
should compensate for the two (or three) hydrogen bonding interactions present in the 
natural DNA double-helix.
1.2.1 Artificial metal-DNA based on C-nucleosides
One important strategy for the functionalisation of DNA is the replacement of the 
natural bases with artificial nucleosides or nucleoside mimics. However, this approach 
is restricted to molecules with a distinct shape and size that are comparable to the 
natural base pairs, to ensure that the DNA modifications occur specifically and site 
selectively. An interesting approach used for the incorporation of metal complexes into 
oligonucleotides is the direct change of a DNA base into a chelator-containing 
nucleobase. In this strategy, the hydrogen-bond base pairing is replaced by metal- 
mediated base pairing. This represents an important structural requisite for the 
development of new molecular devices based on interacting metal centres. Tor and 
Weizman8 coined the term “ligandosides” for suitable metal ion nucleoside chelators, 
with the following features: a) the most productive geometry for a metal-base pair to 
form the double helix is expected to be square planar, as this will maximize favourable 
nearest-neighbour stacking interactions. The nucleoside mimics should therefore form 
planar complexes with metal ions, and their dimensions should be comparable with 
those of a DNA base pair; the planarity of these artificial DNA base pairs ensures their 
proper intercalation within the DNA base stack, b) the metal-metal distance has to be 
similar to the distance between two adjacent base pairs in natural DNA duplexes (3.4 
A), c) the chelating portion of the nucleoside mimics should have a higher affinity than 
natural DNA bases towards metal ions and, d) the nucleoside mimics should be 
compatible with the standard automated DNA synthesis.
The successful formation of helical DNA-like duplexes is generally confirmed by 
spectroscopic analysis: a) UV/Vis spectra show additional bands as a result of metal 
ions complexation; b) electrospray ionisation mass spectrometry provides the correct 
mass for the intermolecular oligonucleotide complexes, c) circular dichroism spectra
4
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confirm the right-handed helicity of the duplexes.9 In the following section are reported 
examples of metal-mediated base pairs consisting of artificial nucleosides in which 
ligands are introduced for planar complexes.
1.2.1.1 Phenylenediamine, 2-aminophenol and a catechol
A (3-C-nucleoside possessing a phenylenediamine moiety as a chelator for the metal ion, 
forming a 2:1 square-planar complex with a Pd2+ ion in aqueous media, was chosen by 
Shionoya et a l  as a model where the hydrogen bonding interactions are replaced by 
metal coordination in the base pairing.10' 11 In this regard, two types of artificial (3-C- 
nucleoside were designed, possessing a metal-chelating site (2-aminophenol 1.1 and 
catechol 1.2) as the nucleobase moiety. These nucleosides are expected to form metal- 
assisted base pairs in DNA and thereby to create novel structures and functions of 
DNA .12 (Figure 2)
Figure 2. Artificial nucleosides
H ( / \ _
HO
1.1 R' = OH R" = NH2
1.2 R' -  OH R" = OH
The coupling of two complementary single strands of DNA through hydrogen bonding 
to form a double-stranded DNA is called hybridisation. If a double-stranded DNA is 
heated above a certain temperature, the dehybridisation starts and eventually the two 
strands are separated into single strands. This transition temperature is called the 
melting temperature (Tm). To examine the effect of the metal ion on the thermal stability 
of the base pair of O-Bn-2-aminophenol-bearing nucleoside 1.3 in DNA, the melting 
temperature was determined in the presence and in absence of Cu2+ by thermal 
denaturation monitored on UV absorption at 260 nm (Figure 3).
5
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Figure 3. 0-Bn-2-aminophenol-bearing nucleoside 1.3
1.3
In the absence of Cu2+ ion, a 1:1 mixture of oligonucleotides, containing 1.3, 
(dA)iol.3(dA)io and (dT)iol.3(dT)io, melts at 42.5 °C. The dA-dT pair melts at 46.5 °C. 
Therefore, the incorporation of 1.3 base pair destabilises the duplex structure. The 
addition of 1.0 eq. of Cu2+ ion slightly lowered the Tm for the duplex (dA)iol.3(dT)io 
(dT)iol.3(dT)io but the change was not significant.
7.2.7.2
Since its discovery at the end of nineteenth century, the bipyridine ligand has been used 
extensively in the complexation of metal ions.13' 14 It is possible to distinguish the 
symmetrical isomers of bipyridine (2,2’, 3,3’ and 4,4’) from the asymmetrical isomers 
(2,3’, 2,4’ and 3,4’, Figure 3).
Figure 3. Symmetrical and asymmetrical isomers of bipyridine
Symmetric isomers
2,2’
Asymmetric isomers
.N
( 1 ^ 1K J
T V
M l
N U  JN
3,3' 4,4’ 2,3’ 2,4’ 3,4’
The 2,2’-ligandoside 1.413 was incorporated into DNA oligonucleotides using solid- 
phase synthesis (Figure 4).
6
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Figure 4. 2,2’ -bipyridine 1.4
HO'
1.4
Thermal dénaturation experiments were used to compare the relative stability of the 
various duplexes. The melting temperature of the ligandoside-containing DNA was 56.6 
°C, the same as the olinucleotide without, the modified nucleoside. Upon addition of 
Cu2+ the Tm increased to 64 °C. This increase is in agreement with a complex formation.
1.2.1.3 Copper-mediated DNA base pair
In 2000, Romesberg and his research group, developed a base with a pyridine-2,6- 
dicarboxylate nucleobase (Dipic) as a planar tridentate ligand for the metal ion, and a 
pyridine nucleobase (Py) as the complementary single donor ligand (Figure 5) .15
Figure 5. Base pairing between Dipic and Py by complexation to a metal ion
Dipic Py
1.5
The [3 + 1] square planar coordination was chosen over a [2 + 2] coordination geometry 
since the chelating effect of the tridentate ligand should give rise to a higher metal ion 
affinity in comparison to that of the nitrogen atoms of the natural nucleobases. The [3 +
1] coordination scheme also ensures that the metal ion is bound more tightly to one of 
the two unnatural nucleobases. In order to study the effect of the metal ions on the 
stability of the Dipic:Py base pairing, it was introduced in the middle of a 15- 
nucleotides duplex, and the Tm was determined. In the absence of transition metal ions, 
a 1:1 mixture of oligonucleotides (2.0 juM each) containing Dipic and Py showed no
7
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melting transition between 14 and 65 °C, indicating that the two complementary 
oligonucleotides were dissociated. The addition of 1.0 eq. of Cu2+ ions increases the 
melting point to 38.6 °C. Additional Cu2+ ions further increased the stability of the 
structure (39.5 °C with 2.0 eq. of Cu2+, and up to 40.1 when adding 5.0 eq. of Cu2+ 
(Figure 6).
Figure 6. Melting curves of the duplex 15-nucleotides Dipic:Py
TfC>
This metal-dependent stabilisation was not found with other metal ions such as Ni2+, 
Pd2+ and Pt2+. Presumably, the key factor for the stabilisation of the duplex structure is 
the stronger coordination to the pyridine base in the complementary strand in the 
presence of Cu2+. Other melting temperatures of duplexes containing mismatches with 
the natural bases were measured. The duplex containing the Dipic: Py base pair was 
found to be more stable than those mismatched with a natural base (Table 1).
Table 1. Melting temperature of mismatches with Dipic and Py
entry X:Y Tn (°C)
1 Dipic:Py 40.4
2 Dipic:A 36.1
3 Dipic: G 28.6
4 Py:A 28.5
5 Py:G 26.9
8
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In order to improve the affinity of metal-base pairs, different metal-ligand complexes 
were investigated.16 The 2,6-bis(ethylthiomethyl)pyridine (SPy) was found to form 
stable complexes with several transition metals (Figure 7).
Figure 7. Replacement of Dipic nucleobase with SPy
The corresponding phosphoramidite SPy was incorporated in a sequence of 15 
nucleotides and the thermal stability of the duplex was evaluated in the presence of 
different transition metals (Ni2+, Pd2+, Pt2+, Cu2+, Ag+, Au3+) by determining their 
melting temperatures. Only Ag(I) showed a metal-dependent base pairing, and the 
corresponding Tm-values are reported in Table 2.
Table 2. Sequence of 15-mer duplex and dénaturation temperatures
5 ’ -C AC ATT AXTGTTGT A-3 ' 
3 ’-GT GT A AT Y AC A AC AT-5 ’
entry X:Y Tm (° C)
1 SPySPy 42.5a
2 Py:SPy 35.0a
3 dC:dG 41.1
4 dA:dT 39.4
5 SPy.dT 29.4
a T m in  th e  a b se n ce  o f  s i lv e r ( I )  n i t r a te  is  2 3 .4  ° C
In the presence of one equivalent of Ag(I) this self-pair was even more stable than the 
natural dC:dG and dA:dT base pairs (Tm = 42.5, 41.1, and 39.4 °C for dSPy:dSPy, 
dC:dG, and dA:dT, respectively, Table 2, entries 1, 3 and 4 respectively). These data 
suggest that the dSPy:dSPy self-pair exhibits pairing stability and selectivity similar to 
those of the natural base pairs.
9
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In 2005, Carell and co-workers developed a DNA metal-base pair incorporating the 
A^A/',-^Xsalicylidene)ethylenediamine (salen) ligand 1.6 (Figure 8).3,17
Figure 8. Salen ligand
1.2.1.4 Metal-salen base pair
salen-ligand
Based on molecular modelling studies, it was found that two molecules of 1.7, facing 
each other in a duplex structure, could be assembled in the presence of a suitable metal 
ion and ethylenediamine moiety to form a metal-salen complex able to combine a 
covalent cross-link between both DNA single strands. (Figure 9).
F igure 9. Ligand 1.7
HO
1.7
1.7 was treated with 0.5 eq. of ethylenediamine in methanol to afford the salen ligand. 
Treatment of the chelate ligand with one equivalent of [Cu(acac)2] in methanol yielded 
the copper-salen complex (Figure 10).
F igure 10. Assembly of the metal-salen-base-pair complex in the DNA double helix
10
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To determine the thermal stability of DNA duplex a/b containing the ligand 1.7 (Figure
11), melting-point measurements in the absence and presence of diamines and metal 
ions were performed.
Figure 11. Duplex a/b
HO
1.7
a: 5 ,-CACATTA-1.7-TGTTGTA-.T 
b: 3 -GTGTAAT-1.7-ACAACAT-5 ’
The replacement of an A-T base pair with the salicyl aldehyde base pair (1.7/1.7) was 
found to decrease the melting temperature of the duplex a/b by 9.0 °C. The addition of 
an excess of ethylenediamine (en) and one equivalent of Cu2+ induced a shift of the 
melting temperature to 82.4 °C. Intrigued by their own successful results,3,17 Carell and 
co-workers reasoned that this metal-salen base pair complex could allow the 
construction of stable DNA structures containing more transition-metal ions.18 
Therefore duplex la /b  was prepared containing two isolated salen ligands separated by 
three W atson-Crick base pairs, and duplex 2a/b, which contains two adjacent salen 
ligands. (Figure 12).
Figure 12. Modified oligonucleotides
la : 5 ’-CGGA-1.7-GAC-1.7-AGCG-J ’ 
lb : 3 ’-GCCT-1.7-CTG-1.7-TCGC-5 ’
2a: 5'-CAC ATT-1.71.7-TG TTG TA-3’ 
2 b :3 ,-GTGTAA1.71.7ACAACAT-5,
Two complementary single strands were put together, followed by addition of 
ethylenediamine and the metal salt. A melting-point study of duplex la /b  in the absence 
and presence of ethylenediamine and 2.0 eq. of Cu2+ was performed (Figure 13).
11
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Figure 13. Comparison of the melting curves recorded for duplex la /b
r rc
In the absence of ethylenediamine or metal ions, the Tm of la /b  duplex was found to be
34.2 °C. The addition of ethylenediamine raised the melting temperature to 41.6 °C. The 
addition of a second equivalent of Cu2+ led to a melting point at Tm = 92.1 °C, which 
indicates the formation of DNA duplex species containing two Cu2+ ions.
1.2.2 Artificial metal-DNA based on N-nucleosides
1.2.2.1 Hydroxypyridone nucleobase
Shionoya and co-workers reported the synthesis of a hydroxypyridone nucleobase (1.8), 
which meets all the criteria for a ligandoside. It was chosen as a flat bidentate ligand 
that forms, after deprotonation, a stable and neutral square-planar complex with a 
divalent Cu2+ ion (1.8-Cu2+-1.8), able to replace hydrogen-bonded natural base pairs 
(Figure 14).19-21
Figure 14. Square-planar complex 1.8-Cu2+-1.8
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UV-absorption showed that an increase in Cu2+ concentration resulted in a gradual 
decrease of the absorbance at 282 nm, while a new peak at 303 nm appeared. This 
simultaneous change indicated the deprotonation of phenolic hydroxy groups of 
hydroxypyridone ligands upon Cu2+ complexation (Figure 15).
Figure 15. UV absorption changes of 1.8 at various concentrations of CUSO4 at 25 °C
W a v e le n g th  / n m
The pair was then introduced in a 15-nucleotide DNA duplex and the melting 
temperature in the absence or presence of Cu2+was measured (Figure 16).
F igure 16. 15-nucleotide DNA duplex a/b
a: 5 ’-CACATTA-1.8-TGTTGTA-3’ 
b: 3 ’-GTGTAAT-1.8-ACAACAT-5’
In the absence of Cu2+ ions, the duplex showed a melting temperature of 37.0 °C 
(Figure 17, a), whereas a natural-type duplex, melted at 44.2 °C (Figure 17, b). The 
addition of equimolar Cu2+ ions to the duplex led to base pairing with higher thermal 
stability, characterised by a Tm of 50 °C (Figure 17, c).
F igure 17. Melting curves of the duplex a/b
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A complex comprising 1-deazaadenine (1.9), 1-methylthyminate, and one Ag+ ion was 
synthesised (Figure 18).22
Figure 1 8 .1-deazaadenine (1.9a) and 1-methylthyminate (1.9b)
’P - * *  » yFTNn^ N  ^ n.K x /  O R'
1.9 Thymine (dT)
The Ag+ ion was chosen as it prefers to have a linear coordination geometry forming 
stable complexes with nitrogen donor ligands. Initial experiments using an equimolar 
mixture of the oligonucleotides d(A1.9A1.9A1.9A1.9A) and d(Tg) showed that, in the 
absence of the Ag+ ion, no melting was observed. Upon addition of Ag+ ions, however, 
distinct melting curves were obtained. The appearance of the melting curves changed 
until one equivalent of Ag+ ion was present (Figure 19).
Figure 19. Melting curves of d(A1.9A1.9A 1.9A 1.9A)*d(T9) in the presence of various 
equivalents of AgNCb
1.2.2.2 Silver-mediated DNA base pair
10 15 20 25 30 35 40
77 °C
The melting point of this system was very low, therefore the characterisation was very 
difficult. It was therefore analysed the more stable duplex formed from d(1.9 i9A) and 
d(T2o). Upon addition of increasing amounts of A gN 03, distinct melting curves were 
observed as shown in Figure 20. The melting temperature increased until one equivalent 
of Ag+ ion was present. Under these conditions, Tm reached a value of 51.2 °C,
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corresponding to an increase of more than 36 °C  An excess of Ag+ ion did not lead to 
any further stabilisation. Clearly, the duplex reaches its maximum stability at 1:1 ratio.
F igure 20. Melting behaviour of d(1.9 i9A) d(T2o) in the absence (— ) and presence of 
different amounts of AgNC>3 (------) 0.75 equiv; (••••) 1 equiv).
1DÛ
Î SO
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To gain insight into the conformation of the duplex d(1.9 i9A)*d(T2o), circular dichroism 
(CD) spectroscopic measurements were performed (Figure 21).
F igure 21. CD spectra of d(1.9igA) ■ d(T2o) in the absence (— ) arid presence of 1.0 eq. 
of AgNC>3 (••••)
-tiM------,—.—,—.—,----- ,—.—,—.—,
2 0 0  2 2 0  M  S 5  2BD  3 C 0  3 5 0
A /tw  — »■
The addition of the first equivalent of A gN 03 led to small but significant changes in the 
CD spectrum (••••). Furthermore, a broad band appeared at 299 nm. This change 
indicated a structural change inside the duplex, such as the replacement of a proton by 
an Ag+ ion. In conclusion, specific binding of one Ag+ ion per base pair led to the 
formation of d(1.9 i9A)'d(T2o)*Ag+, accompanied by an increase of the melting 
temperature of more than 36 °C.
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1.2.2.3 A purine-like nickel-mediated DNA base pair
Switzer and co-workers reported the synthesis of P u rp, a base formally derived from 
adenine by replacing the 6-amino group with a pyridyl group (Figure 22).23
Figure 22. Adenine and P u rp
Purp Adenine (dA)
The resulting base pair (Purp N iP u r p, Figure 23) was found to have a greater stability 
(Tm = 46.1 °C) when compared to a G-C base pair (Tm = 40.1 °C).
F igure 23. P u rp metal base pair
Purp-Ni2+-Purp
= Ni2+
Complementary dodecamer DNA strands were prepared to test the stability of the 
complexes. Melting temperatures in the presence of several divalent ions, were 
measured (Table 3)
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Table 3. DNA-duplex melting temperatures in the presence and absence of divalent 
ions
5 '-CTTTCT-X-TCCCT-3 ’
3 -G AA AG A-Y - AGGG A-5 ’
entry X:Y m etal r m (°c )a
1 P u rp:Purp NiCl2 46.1
2 P u rp:Purp N i(N 03)2 46.6
3 P u rp:Purp CoCl2 38.8
4 P u rp:Purp CuCl2 31.4
5 P u rp:Purp A gN 03 30.5
6 P u rp:Purp - 28.5
7 T :Purp N1CI2 27.1
8 C :Purp NiGl2 26.6
9 A :Purp NiCl2 27.0
10 G :Purp NiCl2 29.1
a Samples contained 2.5 |iM of each strand and 5 |iM of divalent ions
According to the results in Table 3, only the addition of Ni2+ gave Tm values for the 
duplex that differed significantly from the metal-free control experiment (Table 3, 
entries 1 and 2). The P u rp*Purp duplex is highly destabilised in the absence of Ni2+ 
(Table 3, entry 6). In the absence of a geometric preference of the metal ion, the most 
productive geometry for a metal-base pair to form the double helix is expected to be 
square planar because this will maximize favourable nearest-neighbour stacking 
interactions. Ni2+ and Co2+ stabilise the P u rp2-bearing helix, whereas the Cu2+, Ag+, and 
Pd2+ ions are not able to do that. In Figure 24 the square-planar geometry of the duplex 
P u rpNi2+P u rp is depicted.
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Figure 24. Stereoview of the structure P u rpNi2+P u rp
Purp-Ni2+-Purp
oThis structure bears a N 9-N 9 ’ (purine numbering) distance of 9.54 A, which nearly
oreplicates the N 9-N I purine-pyrimidine distance of 9.05 A that occurs in natural B- 
DNA helices for both G-C and A-T base pairs. This suggests Purp-Ni2+* Purp is a good 
dimensional mimic of natural base pairs.
1.2.2.4 A pyrimidine-like nickel-mediated DNA base-pair
Pyrp is formally derived from the natural nucleobase cytosine by replacement of its 4-
amino group with a pyridine ring (Figure 25) 
F igure 25. Cytosine and Pyrp
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Pyr
NH2 
N
■|A>
H
Cytosine
The resulting base pair (Pyrp Ni*Pyrp) was found to be highly stable (Figure 26).
F igure 26. Pyr metal base-pair
Ni2+
Pyrp-Ni2+-Pyrp
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The complementary dodecamer DNA strands were prepared to test the stability of the 
complexes (Table 4).
Table 4. DNA-duplex melting temperatures in the presence and absence of divalent 
ions
5 '-CTTTCT-X-TCCCT-3 ’
3 ’-G A A AG A-Y - AGGG A-5 ’
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entry X:Y m etal Tm (°CY
1 P yrp:Pyrp Ni2+ 41.2
2 Pyrp:Pyrp - 24.7
3 T:Pyrp Ni2+ 19.5
4 C:Pyrp Ni2+ 19.3
5 A:Pyrp Ni2+ 19.7
6 G:Pyrp Ni2+ 22.9
a Samples contained 2.5 \iM of each strand and 5 (iM of divalent ions
The employment of Ni2+ as a divalent metal ion resulted in a dramatic increase in Tm of 
16.5 °C relative to the metal free duplex (Table 4, entries 1-2). The stability of the four
• P 2+natural bases against Pyr in the presence of Ni was measured and these data indicated 
instability of the complex Pyrp'Ni2+ natural nucleobase (Table 4, entries 3-6).
1 7.3 DNA-based catalysis
1.3.1 Reactions DNA-based catalysis
The development of catalytic asymmetric reactions is a crucial target in modern organic 
chemistry. Several metal-catalysed enantioselective reactions have been investigated so 
far. The search for more efficient methods, from both economic and environmental 
points of view is still a great challenge. The double-helical structure of DNA with the 
complementary hydrogen bonding interactions is an extraordinary store for the genetic 
information. However the interest in DNA has been now expanded from biology to
19
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several fields and it would appear reasonable to use the double helix of DNA as a chiral 
environment in which the reactions can take place.
Deoxyribozymes (or catalytic DNA) are DNA molecules with catalytic ability. The first
25deoxyribozyme was discovered in 1994 by Joyce and co-workers.
1.3.1.1 DNA-mediated catalytic enantioselective Diels-Alder reaction
The first example of asymmetric DNA-mediated catalysis was reported by Feringa and
Of*Roelfes in 2005. The design involved the assembly of a DNA-mediated catalyst from 
a natural DNA duplex, usually salmon testes DNA (st-DNA), and a copper complex of 
a non-chiral ligand to bind the DNA in a non covalent manner. Specifically it was used 
in copper(n)-catalysed Diels-Alder reaction between a cyclopentadiene and an 
azachalcone. This catalytic system included a copper complex with a non chiral-ligand, 
incorporating a metal binding site, a spacer and a covalently attached intercalator such 
as 9-aminoacridine (Scheme 1).
Scheme 1. Schematic representation of the asymmetric Diels-Alder reaction catalysed 
by copper complexes of achiral ligand in the presence of DNA
O
achiral ligand
As a result, the active Cu(II) centre is brought into close proximity of the chiral 
environment, allowing the transfer of chirality from the DNA to the reaction product.
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The reaction was carried out in water and the Diels-Alder adduct was observed as a 
mixture of endo (major) and exo (minor) isomers. The Cu(II) centre acts as a Lewis acid 
and the mechanism of the catalytic reaction involves the activation of the dienophile by 
reversible coordination to the ketone oxygen atom and the pyridyl nitrogen atom. This 
is followed by the Diels-Alder reaction. The product was finally dissociated from the 
Lewis acid, and the catalyst was regenerated for another catalytic cycle. The proposed 
catalytic cycle for the copper-catalysed Diels-Alder reaction is shown in Scheme 2 .27
Scheme 2. Proposed catalytic cycle for the copper-catalysed Diels-Alder reaction of 
1.11 with 1.10
The DNA-catalysts investigated in this study were bound to a series of Cu(II) 
complexes based on achiral poly aromatic bidentate ligands.
Two general series of ligands were investigated; in the first one the DNA binding 
moiety was linked to the metal binding domain via a short spacer. In the second class of 
ligands the metal binding and the DNA binding domain were integrated into one moiety 
so that no spacer was needed (Figure 27).28
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Figure 27. Ligands used in DNA-mediated asymmetric catalysis
1.13, n = 2 R =
1.14, n = 3 R =
Class 1
1.15, n = 2R =
1.16, n = 3R =
N-
NH R
r ~ ( ~ }  j m—y
OMe
sOMe
Kinetic studies were carried out to determine the effect of the DNA on the reaction rate. 
The equilibrium constants for the binding of the azachalcone (dienophile) to Cu(II) (Ka), 
the rate of the reaction of cyclopentadiene with the Cu(II)-bound azachalcone (Kcat), and 
the dissociation constant for the release of the product from the copper complex (Æd) 
determine the overall rate of the reaction. The result of the kinetic studies revealed that 
the binding of the Lewis acid (Cu2+) to the azachalcone occurs with equal efficiency in 
the absence or presence of DNA in the presence of ligands of class 1.
The results of the kinetic studies using ligands of second generation were absolutely in 
contrast to those obtained with the first generation; in the case of 1.21-Cu, the presence 
of DNA resulted in a rate acceleration with a factor of 58 suggesting that the catalysts, 
depending on the type of ligand, interact differently with DNA and proving the presence 
of different mechanisms.27
The mechanism of the chirality transfer from the DNA to the catalysed reaction is still 
not fully understood. Two different mechanisms can be considered for chirality 
transfer: the first mechanism can be explained by direct transfer of chirality, in which
the chiral environment of DNA controls the face-selectivity of the copper-bound 
dienophile that is attacked by the diene. For this mechanism, it is necessary that the 
reaction proceeds very close to the DNA, possibly inside the groove. This mechanism 
involves the catalysts from class 2, since with the Cu2+ is located very close to the DNA.
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The second mechanism involves a two step chirality transfer. The DNA first introduces 
a chiral conformation on the catalyst, which is then converted into enantioselectivity in 
the reaction. Since the chirality of DNA is transferred by the metal complex, the 
enantioselectivity in this proposed mechanism is less dependent on the distance between 
the catalytic metal centre and DNA.
It was found that the R substituent and the spacer length of the ligand are crucial for 
both the observed enantioselectivity. As shown in Table 5, an analysis of ligands 
indicated the influence of the R group and especially the necessity to include an 
aromatic group. This suggests the involvement of %-n interaction between the 
substituent and the dienophile (Table 5).26
Table 5. Results of the catalytic Diels-Alder reaction with 1.13-1.16 ligands
entry ligand dienophile endolexo endo (% ee) exo (% ee)
1 1.13 1.12a 96:4 -48 -37
2 1.14 1.12a 98.2 49 18
3 1.14 1.12c 98:2 48 24
4 1.15 1.12a 98:2 -37 -78
5 1.15 1.12b 88:12 -47 -78
6 1.15 1.12c 91:9 -53 -90
7 1.16 1.12a 98:2 -37 -7
The reaction resulted in the formation of the Diels-Alder product with an endolcxo ratio 
of 98:2 and 49% ee for the endo isomer (Table 5, entry 2). An opposite result was 
obtained with a spacer length of n=2 which afforded a value similar to entry 2 (48% ee) 
of the opposite enantiomer (Table 5, entry 1). It was then observed that an extension of 
the spacer in the ligand resulted in a decrease of the enantioselectivity and for n=5 no 
significant enantiomeric excess was observed.
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Another investigation was carried out on the type of substrate. For example the pyridine 
moiety of the dienophile was modified introducing a methyl group onto the pyridyl ring 
and varying its position (Figure 28).
Figure 28. Azachalcone 1.22
O
1.22
Interestingly, the employment of the ligand 1.16 in the reaction of 1.22 resulted in the 
formation of the opposite enantiomer to that afforded using 1.13 as a substrate. This 
behaviour was explained on the basis that the azachalcone substrate can adopt either a 
cisoid or transoid conformation (Figure 29).
F igure 29. Cisoid and transoid conformations of the azachalcone
n . p N
cisoid transoid
In the case of 1.22, the dienophile is forced to react in the cisoid conformation because 
the transoid form is unfavoured for steric reasons.29 This is likely to be the reason why 
with 1.22 the same enantiomer is obtained in excess with all ligands.
1.3.1.2 DNA-mediated catalytic enantioselective Friedel-Crafts alkylation
The Friedel-Crafts reaction is one of the most used Lewis acid catalysed reactions for 
the formation of C-C bonds. Even though this reaction is associated with anhydrous 
conditions, some examples of Friedel-Crafts alkylation in water, catalysed by achiral 
Lewis acids have been reported.30'31 In 2009, Feringa and co-workers reported the first
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catalytic asymmetric Friedel-Crafts alkylation reaction with olefins mediated by a 
DNA-mediated catalyst using water as the solvent. As previously described for the 
Cu(Il)-catalysed Diels-Alder reaction, even in this case the catalytically active species 
is generated by a noncovalent bond of a transition-metal complex to the DNA, which 
leads to an efficient chirality transfer from the DNA double helix to the catalysed 
reaction. The Friedel-Crafts alkylation reaction of indoles in water has been investigated 
by Feringa by using a,p-unsaturated 2-acyl imidazoles, which were able to bind to the 
Cu(II) ions in a bidentate manner. The DNA-based catalyst was developed by 
incorporating a Cu(II) complex within salmon testes DNA (st-DNA) and the best results 
were achieved using 1.21 as ligand in the copper(II) complexes (Scheme 3).
Scheme 3. Cu-1.21/st-DNA catalysed Friedel-Crafts alkylation
,Cu2+/ \
78% yield 
83 % ee
The reaction between the imidazole 1.23 and the indole 1.24 afforded the adduct 1.25 in 
78% yield and 83% ee.
1.3.1.3 DNA-mediated catalytic enantioselective Michael addition reaction
Encouraged by these results, Feringa and co-workers decided to extend the DNA- 
mediated catalysis concept by applying it to the catalytic asymmetric Michael reaction 
in water.33 The reaction was performed between a a,(3-unsaturated 2-acylimidazoles 
(1.23, 1.26-1.30), capable of binding Cu(II) ions in a bidentate manner in aqueous 
conditions and nucleophile (dimethyl malonate or nitromethane). The reaction, carried 
out in presence of achiral ligands (1.19-1.21) and salmon testes DNA (st-DNA), was 
performed at 5 °C and at pH = 6.5
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Table 6. Results of Michael addition reactions catalysed by DNA/[Cu(1.19- 
1.21)(N03)2]
-N pCM_ Achiral ligand NuH
Cu2+, DNA
cN .0-K -T
\  R
1.23 R = Me
1.26 R = Ph
1.27 R = p-MeOPh
1.28 R = p-CIPh
1.29 R = o-BrPh
1.30 R = 2-furanyl
Achiral ligands
r ^ T  N
r ^ N f ^ N  11
1.19 1.20 1.21
entry ligand3 substra te13 CH 2(C 0 2M e)2 
conversion (% ) ee (% )
CH3NO2 
conversion (% ) ee (% )
1 - 1.26 26 <2 0 n.d.
2 1.19 1.26 4 56 - -
3 1.20 1.26 90 80 - -
4 1.21 1.26 quant. 91 91 85
5 1.21 1.27 94 86 89 82
6 1.21 1.28 75 90 72 85
7 1.21 1.29 quant. 99 70 94
8 1.21 1.30 96 86 quant. 87
9 1.21 1.23 92 58 95 62
a concentration of [Cu(1.21)(N0 3)2] 0.3 mM b 3.3 eq.
In the absence, of a ligand (in presence only of Cu(H) complex and DNA), low
conversion and no enantioselectivity was observed (Table 6 , entry 1). Low reactivity 
and low ee were observed when the ligand 1.19 was used (Table 6 , entry 2). In contrast, 
high reactivity and high ee (up to 80%) were achieved using 1.20 as ligand and 
dimethyl malonate as nucleophile (Table 6 , entry 3). Nevertheless, the best result was 
obtained in presence 1.21 which led to full conversion and 91% ee (Table 6 , entry 4), 
Reducing the amount of [Cu(1.21)(N03)2] up to 0.15 mM, with the same amount of 
DNA, resulted in the same level of conversion, however, reduced conversion was
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observed in  presence o f  0.05 m M  o f  [C u (1 .2 1 ) (N 0 3 )2], and in  both cases the ee 
rem ained the same show ing  that decreasing the D N A /[C u (1 .2 1 ) (N 0 3 )2] ra tio  d id  not 
a ffect the enan tiose lec tiv ity .
1.3.1.4 DNA-mediated catalytic enantio selective carbon-fluorine bond form ation
F luo rina tion  is one o f  the m ost im portan t too ls ava ilab le  to  the synthetic chem ists fo r  
the im provem ent o f  the b io lo g ica l properties o f  drug candidates, as m any 
pharm aceutical products conta in  flu o r in e  atoms. Several m ethodolog ies fo r  chem ica l 
enantioselective flu o r in a tio n  have been reported .34'37 O ’Hagan et a l  iso la ted a bacteria l 
f lu o rin a tin g  enzym e ‘fluo rinase ’ fro m  Streptomyces cattleya  w h ich  catalyses the 
flu o rin a tio n  o f  S -adenosyl-L-m eth ion ine. to  J ’- f lu o ro -J ’-deoxyadenosine .38 As part o f  
th is process Shibata and co-w orkers reported the f irs t  exam ple o f  D N A -m ed ia ted  
enantioselective e le c tro p h ilic  f lu o r in a tio n .39 A  ca ta ly tic  set in c lu d in g  D N A , an ach ira l 
ligand  and C u (II)  proved to be able to  fo rm  a ch ira l C -F  bond at the quaternary carbon 
centre in  p -ke to  esters. The flu o r in a tio n  was perfo rm ed under the typ ica l cond itions 
p rev ious ly  used b y  Shibata and co -w orkers34,40'41 in  com b ina tion  w ith  the D N A  
catalysis p ro toco l developed by F e ringa ’ s research group (Scheme 4 ) .26,42 Indanone 
carboxylate deriva tives 1 .3 1 a -f were fluo rina ted  in  w ater in  the presence o f  salmon 
testes D N A  (s t-D N A ) and an ach ira l coppe r(II) com plex. The copper com plex was 
prepared before use fro m  C u (N 0 3 )2-3H 2 0  w ith  nonch ira l b identa te ligands, in  a 1.1:1 
r a t io 42-43
Scheme 4. D N A -m ed ia ted  enantioselective C -F  bond fo rm a tio n
O
fluorinating
reagent COoR
1.31a R = Me, R’ = H 
1.31b R = Bn, R' = H 
1.31c R = Et, R' = H 
1.31d R = /-Pr, R' = H 
1.31e R -  f-Bu, R' = H 
1.31 f R = Me, R' = Br
1.32a-f
up to 74% ee
= achiral ligand
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D iffe re n t ach ira l ligands and flu o r in a tin g  reagents were investiga ted (Tab le  7). 
T a b le  7. S tructures o f  flu o r in a tin g  reagents and nonch ira l ligands
Q Achiral ligand P
Fluorinating reagent .FG02R _________________
R1 Cu2+, DNA, H20  R
c o 2r
e n try  su b s tra te  a c h ira l l ig a n d  f lu o r in a t in g  re a g e n t y ie ld  (%>) ee (% )
1 1.31a 1.19 N F S I n.d 0
2 . 1.31a 1-19 M E C -0 2 n .r -
3 1.31a 1.19 S e lec tfluo r n.d 15
4 1.31b 1.21 S e lec tfluo r 35 24
5 1.31c 1.21 S e lectfluor 72 54
6 1.31d 1.21 S e lec tfluo r 96 70
7 1.31e 1.21 S e lec tfluo r 75 74
8 1 .3 1 f 1.21 S e lec tfluo r 33 22
fhe flu o rin a tio n reaction  o f  1.31a carried ou t in presence o f  N-
f luo robenzenesu lfon im ide  (N F S I) and M E C -0 2  as flu o r in a tin g  reagents a ffo rded  
d iscourag ing results (Tab le  7, entries 1 and 2). The h ighest enan tiose lec tiv ity  was 
obta ined in  the flu o r in a tio n  o f  fe r/-b u ty l indanone carboxy la te  (1.31e) in  presence o f  st- 
D N A  and [C u (1 .2 1 )(N 0 3)2] (74%  ee, Tab le  7, entry 1).
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T o  investigate the m echanism  fo r  the ch ira l induc tion , the o r ig in  o f  the D N A  was 
changed: s t-D N A  was replaced b y  c a lf thym us D N A . Increasing the size o f  the 
substituent fro m  M e  to E t, i-P r and ¿-Bu o f  1.31 resulted in  an increase o f  
stereoselectiv ity. A ssum ing  that the geom etry o f  the C u (II)  connection to the ligand  and 
substrate adopted a tw is ted  square p lanar in  the trans ition  state, a hypo the tica l schem atic 
representation fo r  the fo rm a tio n  o f  0R)-1.31e is shown be low . The o r ig in  o f  the m a jo r 
enantiom er resulted fro m  the attack re-face to  the in term ediate ; therefore, the 
enan tiose lectiv ity  was h ig h ly  dependent upon the size o f  the ester substituent (F igure  
30).
F ig u re  30. Schem atic representation o f  in te rca la tion  o r groove b in d in g  o f  the 
[C u (1 .2 1 )(N 0 3)2 ]-1 .31e  com p lex  to D N A  fo r  p roduc ing  (/?)-1.32e
1.3.1.5 DNA-mediated hydrolytic kinetic resolution o f  epoxides
The h y d ro ly tic  k in e tic  reso lu tion  (H K R ) catalysed by  ch ira l (salen)Co11 com plexes is a 
p o w e rfu l m ethod fo r  the preparation o f  enantiopure te rm ina l epoxides .44 The a ttractive  
features o f  the H K R  inc lude  h ig h  se lec tiv ity  factors across a w ide  range o f  te rm ina l 
epoxides, h igh  enan tiose lec tiv ity  (>99%  ee) and product y ie lds approaching to the 
theore tica l ones.45
In trig u e d  by  results in  the H K R  o f  epoxides in  aqueous env ironm en t,46 Feringa and co­
w orkers reported the f irs t  exam ple o f  D N A -m ed ia ted  k in e tic  reso lu tion , a h y d ro ly tic  
k in e tic  reso lu tion  o f  epoxides (Scheme 5 ) .47
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Schem e 5. Schem atic representation o f  the D N A -m e d ia te d  h y d ro ly tic  k in e tic  reso lu tion  
o f  2 -pyridy lox irane s  1.33a-e
O 1.33a R = H 
1.33b R = Ph (trans)
R 1.33c R = Ph (c/s)
1.33d R = 4-MeO-C6H4 
1.33e R = Me {trans)
1.33a-e
HO OH
"  'R
O
Achiral ligands
r ^ N r ^ Nii
>
1.20 1.21
1.34a-e
In  order to f in d  the m ost suitab le  m e ta l-ion  fo r  the D N A -m ed ia ted  H K R  o f  2- 
p y rid y lo x ira n e  1.33a, the substrate ( in it ia l concentra tion  3.0 m M ) was added to  a 
so lu tion  o f  s t-D N A , 1.20 (0.39 m M ) and a range o f  m etal ions (0.30 m M ). H y d ro ly t ic  
conversions o f  epoxide 1.33a were determ ined a fte r 72 hours and i t  was concluded that 
o n ly  C u2+ and N i2+ s ig n ifica n tly  increased the rate o f  the h yd ro lys is  o f  1.33a. H ow ever 
the ee o f  recovered epoxide 1.33a was in s ig n ifica n t.
The conversions, ee and se le c tiv ity  factors fo r  the H K R  o f  substrates 1.33a-e are shown 
in  Table 8 .
T a b le  8 . Conversions, ees and se le c tiv ity  factors fo r  the k in e tic  reso lu tion  o f  substrates 
1 .33a -ea
1.33a-e
Achiral ligand
Cu2+, DNA, H20
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e n try su b s tra te lig a n d co n ve rs io n  (% ) ee ( % ) b 5
1 1.33a 1.21 42 10 1.5
2 1.33b 1.21 85 61 2.0
3 1.33c 1.20 57 <5 n.d.
4 1.33c 1.21 31 4 1.2
5 1.33e 1 .20 55 11 1.3
6
a o » m
1.33e
^,„2+_____ j  b" _
1.21 49 <5 n.d.
a 0.3 mM Cu2+ was used. b ee of the recovered epoxide
A s a resu lt o f  th is p re lim in a ry  screening using 1.21 as the ligand, 2 -p y rid y lo x ira n e  
1.33a a fforded 10% ee a fte r 42%  conversion (Tab le  8 , en try 1). The e ffec t o f  13- 
substituents on the oxirane  r in g  was also studied. 1 .33b was tested as a substrate in  the 
D N A -m ed ia ted  H K R . A fte r  5 h  w ith  1.21 as ligand, the reaction proceeded to  85% 
conversion and 61% ee (Tab le  8 , en try  2). The em ploym ent o f  the ris - iso m e r 1.33c 
instead o f  the irans-isom er 1.33b resulted in  a considerable decrease in  se lec tiv ity , 
whereas the rate o f  h yd ro lys is  was approx im ate ly  the same (Tab le  8 , entries 3 and 4).
1.3A .6  D NA-based asymmetric catalysis with the employment o f  G-quadruplex
D N A  structure is no t lim ite d  to  duplexes since several o ther com plexes are know n  (e.g. 
G -quadruplexes). G -quadrup lexes are nucle ic  acid sequences w ith  a h igh  guanine 
percentage capable o f  fo rm in g  a four-stranded structure. These consist o f  a square 
arrangement o f  guanines, stab ilised by  hydrogen bond ing  interactions. T hey are also 
usua lly  stab ilised b y  the presence o f  m onova len t cations, such as potassium , in  the 
centre o f  the structure. In trig u e d  b y  the p revious results reported in  the lite ra tu re  by  
Feringa and co -w o rke rs ,26 27,32 33 M oses et a l  described the f irs t  construc tion  o f  a G- 
quadrup lex ch ira l ca ta lys t.48 T h e ir  in it ia l experim ents in vo lve d  the use o f  C u2+ in  
presence o f  ach ira l ligands 1.19, 1.20 and 1.21 in  con junc tion  w ith  tw o  d iffe re n t G - 
quadrup lex, h-T e l and c -k it  con ta in ing  a large excess o f  1.10 (Tab le  9).
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O
Table 9. Diels-Alder reactions between 1.10 and l . l l a
h-Tel: 5 ’-A G G G T T A G G G T T A G G G T T A G G G -3  ’ 
e -k it: 5  ’-A G G G A G G G C G C T G G G A G G A G G G -3 '
e n try lig a n d cha lcone G -q u a d ru p le x endoiexo endo (%  ee) exo (%  ee)
1 1.19 l . l l a ¿ -Te l 96:4 -24 -51
2 1.19 1 .11c c -k it 92:8 -4 18
3 1.20 l . l l a ¿ -Te l 92:8 -7 -18
4 1.20 1 .11c c -k it 94:6 3 34
5 1.21 l . l l a h-T e l 95:5 -34 -46
6 1.21 1 .11c c -k it 79:21 3 11
a DNA (0.3 eq.), ligand-Cu (0.24 eq.), 1.10 (90 eq.).
Tab le  9 shows that the endo d iastereoisom er was fo rm ed as m a jo r product. In  the 
presence o f  A -Tel and ligand  1.21, the D ie ls -A ld e r reaction  between 1.10 and l . l l a  
a ffo rded good ee in  bo th  the diastereoisom ers (Tab le  9, en try  5). W hen ligands 1.19, 
1 .20  and 1.21  were used w ith  c -k it, the results were unsatis facto ry fo r  bo th  endo and 
exo products (Tab le  9, entries 2, 4 and 6 ). The best resu lt was a fforded w hen ligand  1.19 
was em ployed in  presence o f  chalcone l . l l a  and h-T e l resu lting  in  51%  ee fo r  the exo 
product (Tab le  9, en try  1).
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Rom esberg15 and S h ionoya19"21 reported the synthesis o f  a r t if ic ia l o ligonucleo tides able 
to  fo rm  stable com plexes w ith  a d iva len t C u2+ ion  w h ich  cou ld  replace hydrogen- 
bonded natural base p a ir in g  in  D N A  (see sections 1.2.1.3 and 1.2.2.1). Based on these 
find ings , w e started an investiga tion  aim ed at the id e n tif ic a tio n  o f  nucleoside analogues, 
w ith o u t the need fo r  the nucleobase po rtion , w ith  the a b ility  o f  inse rting  in to  D N A  
strands lik e  natural nucleosides and also, at the same tim e, to fo rm  stable com plexes 
w ith  d iva len t m etal ions (such as C u2+) fo r  the fo rm a tion  o f  an a rt if ic ia l D N A  duplex.
In  th is regard, we set up a program  aim ed to  test w hether sm alle r ligands, such p- 
diam ines, (3-am inoalcohols, (3-diols o r hyd roxam ic  acids, cou ld  be used in  place o f  the 
hyd roxypy rido ne  m o ie ty  developed by  Shionoya et al. T h is  a lte ra tion  w o u ld  be 
advantageous fo r the fo llo w in g  reasons: 1) C-nucleosides bearing  a b identate acyc lic  
ligand  such as diam ines, am inoa lcoho ls o r hyd roxam ic  acids cou ld  be used to com plex 
several m etals o ther than C u2+, in c lu d in g  Fe2+, Z n 2+, Pd2+, P t2+ o r sem iconductors such 
as T i4+; 2) considering the large b in d in g  constant d isp layed b y  am inoa lcoho ls, d iam ines 
and-hydroxam ic acids fo r  trans ition  m etals, i t  is l ik e ly  that the m etal duplexes obtained 
w i l l  d isp lay  a h igh  therm a l s tab ility .
In trigued  by  Rom esberg and S h ionoya5 s results we designed and prepared nove l C- 
nucleosides analogues able to m im ic  the natura l a b ility  o f  the D N A  pairs to fo rm  the 
D N A  he lix . W e focused on testing our m onom ers a b ility  to  act as a natura l nucleobases 
rep lac ing the hydrogen-bonded natural base pairs; fo r  th is purpose these nove l 
analogues were incorporated in to  o ligonuc leo tides duplexes using the so lid  phase 
synthesis and phosphoram id ite  m ediated chem istry  on nucleoside 3 ’-( 2 - 
cyanoe th y ld iisop ropy lphosphoram id ite ) b u ild in g  b locks.
Furtherm ore  we evaluated the ir a b ility  to incorporate d iva len t m etals fo rm in g  square 
p lanar com plexes by synthesising C-nucleosides o f  the deoxyribose series w ith  specific  
fu n c tio n a l groups on the anom eric pos ition  (e.g. d io l and am inoa lcoho l, F igu re  31).
1.4 Results and discussion
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F ig u re  31. O ur proposed square p lanar com p lex
R = O, N
Since m ost na tu ra lly  occu rring  C -g lycosides possess an anom eric p -con fïgu ra tion , we 
focused our a ttention on the synthesis o f  P -C  nucleosides series.
A s described in  Section 1.4.1, to  insert a nucleoside m onom er in to  a D N A  strand, the 
tw o  pro tecting  groups in  3 ’ and 5* (phosphoroam idate and d im e th o x y tr it il,  D M T , 
respective ly) are required.
A  general re trosynthetic  analysis fo r  the preparation o f  a nucleoside fro m  a cheap and 
read ily  ava ilab le  starting  m ateria l (2 -deoxyribose), possessing the tw o  required 
p ro tecting  groups and a d io l m o ie ty  fo r  the com p lexa tion  w ith  the m eta l-ion , is depicted 
in  Scheme 6 . F ina l target 1.39p was prepared b y  debenzyla tion  fo llo w e d  by  p ro tection  
o f  positions 3 ’ and 5 ’ o f  m onom er 1.38P w h ich  was y ie lded  b y  pro tecting  the d io l 
1.37P obtained by  treatm ent o f  the alkene 1.36p w ith  OSO4. 1.36P was prepared 
starting fro m  1.35 w h ich  was undergone to  G rignard  reaction  fo llo w e d  by r in g  c los ing  
in  presence o f  TsC l.
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Scheme 6. Retrosynthetic analysis for DMTr-phosphoramidate
OAc OAc . ° H
^  B n O ^ } ^ O A c  = = >  B n O ^ G ^ OH 
BnC? BnO'
1.38(3 1.370
BnO \ __/
BnÓ
1.35
The synthesis o f  com pound 1.35 started fro m  the co m m e rc ia lly  ava ilab le  2 -deoxy-D - 
ribose was repeated accord ing to  a procedure reported fro m  our labora to ry  (Scheme 
7 ) .49
Schem e 7. S tereospecific synthesis o f  1.42a and 1.42b
BnCI (14.0 eq.)
/ ^ / V O H  AcCI (6.5 mol%) 0 .  0 CH3 KOH (9.0 eq.) ^ / V o C H 3
HC/ \  f  --------------------- ► HCÌ \  T  -------------------------“  OBn^ \  f
. . ;— ' c h 3o h  ; — ' t h f  ;— '
HO" r.t., 1 h H(5 reflux, 24 h OBn'
2-deoxy-D-ribose 1-41
>99% yield 85% yield
OH OH
' \  OH
AcOH/HoO 8:2 Rn<Y / B r M q ^ ^  (2.0 eq.) BnO't g
49 BC, 48 h BnO THF
r.t., 46 h
1.35
83% yield
2-D eoxy-D -ribose was treated w ith  A c C l to a ffo rd  1.40 w h ich  was subsequently 
subjected to  benzy la tion  reaction.
Due to  the huge am ount o f  B nC I (14.0 eq) and K O H  (9.0 eq.) required fo r  the fo rm a tion  
o f  1.41, the p u rif ica tio n  was perform ed e xp lo itin g  the azeotropic m ix tu re  o f  w ater and
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the B n O H  fo rm ed  d u ring  the reaction, resu lting  in  a s ig n ifica n t reduction  o f  crude 
vo lum e and therefore an easier p u rifica tio n . 1.41 was then deprotected on the anom eric 
pos ition  in  presence o f  acetic acid and w ater to a ffo rd  1.35 in  83%  y ie ld .
1.35 was reacted w ith  e thyny lm agnesium  b rom ide  and the resu lting  d iastereoisom eric 
d io ls  1.42a and 1.42b were subsequently separated by  co lum n  chrom atography. D io ls  
1.42b was reacted w ith  p -to luene su lfony l ch lo ride  and K O H  to  ob ta in  1.43p (Scheme 
8).
Scheme 8 . Synthesis o f  1.43P
OH OH
BnO
BnO
p-TsCI (1.1 eq.) 
KOH (2.6 eq.)
acetone 
r.t. 52 h
BnO'
1.42b
1.43p was subjected to ca ta ly tic  hydrogenation  to  a ffo rd  1.36p (Tab le  9).
The stereochem istry at the anom eric pos ition  o f  1 .36p was p rev ious ly  detected b y  N O E  
experim ents and reported in  lite ra tu re .49 The ca ta ly tic  hydrogenation  cond itions required 
to obta in  1.36p were determ ined by  va ria tion  o f  parameters described in  Tab le  10.
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Table 10. Catalytic hydrogenation of 1.43ß
BnO
H2
Pd/BaS04
BnO
poisoning, solvent
BnO
BnO
1.43ß 1.36p
e n try 1.43ß P d /B a S 0 4 p o is o n in g
agen t
so lven t y ie ld  (% )
1 0.56 m m o l 12 m g qu ino lin e toluene
a
2 0.39 m m o l 7 m g P y/qu ino lin e toluene 13b
3 0.56 m m o l 12 m g P y/qu ino line to luene
C
4 0.36 m m o l 5 m g Py benzene
_d
5 0.36 m m o l 5 m g Py benzene e
6 0.36 m m o l 8 m g Py benzene 72f
a Carried out with 1.5 eq. o f quinoline, r.t., 1 hour. b Carried out with 0.7 eq. of quinoline and 3.2 eq. of 
Pyridine, r.t., 72 hours. c Carried out with 0.9 eq. of quinoline and 3.1 eq. of Pyridine, r.t., 50 hours. d 
Carried out with 3.2 eq. of Pyridine, r.t., 50 hours.e Carried out with 3.2 eq. of Pyridine, 35 °C, 50 hours.f 
Carried out with 13.7 eq. of Pyridine, r.t., 3 hours.
W hen the reaction was perfo rm ed  in  to luene w ith  qu ino lin e  as po ison ing  agent no 
product fo rm a tio n  was detected and sta rting  m ate ria l was recovered unreacted (Tab le  
10, en try  1). Several attempts were made ca rry ing  ou t th is  reaction in  presence o f  
q u ino lin e  and p y rid in e  in  to luene (Tab le  10, entries 2 and 3) bu t these d id  not resu lt in  
p roduct fo rm a tion . To our de ligh t, the p roduct 1.36(3 was f in a lly  obta ined in  72%  y ie ld  
when 13.7 eq. o f  p y r id in e  were em ployed (Tab le  10, entry 6 ).
In  order to reduce the num ber o f  synthetic steps, a faster and m ore e ff ic ie n t pathw ay 
was devised. 1.35 was treated w ith  an excess o f  the co m m e rc ia lly  ava ilab le  
v iny lm agnes ium  b rom ide  at room  tem perature and, a fte r 24 hours, the fo rm a tio n  o f  the 
p roduct as a d iastereo isom eric m ix tu re  w ith  an ove ra ll y ie ld  o f  1 .44a /b  o f  91%  was 
observed (Scheme 9).
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Scheme 9. Synthesis of 1.44a/b by addition of vinylmagnesium bromide to 1.35
BnO'
,o. oh <^ MgBr1MinTHF(3-0eci) ^  PH° H
BnCf THF, r.t., 24 h Bnc5
1.35 1.44a/b
91% yield
mixture of two 
diastereoisomers 
(dr 60:40)
Treatm ent o f  the d iastereoisom eric m ix tu re  1.44a/b  w ith  /? -to luenesu lfonyl ch lo ride  and 
K O H  resulted in  the fo rm a tio n  o f  1 .3 6 a  and 1.36p (dr 1:1.5) w h ich  were successfu lly 
separated b y  co lum n chrom atography (Scheme 10).
Schem e 10. Synthesis o f  1 .36 a /p  b y  add ition  o f  /? -to luenesu lfonyl ch lo ride  to 1.44a/b
OH OH
BnO %
BnO
p-TsCI (1.1 eq.) 
5MKOH (2.5 eq.)
35 °C, 52 h
BnO
1.44a/b
BnO
1.360
36% yield
+ B n O ^ ^ ^ ' " ^  
BnOC
1.36a
23% yield
The N M R  spectroscopy data o f  1.36p (and therefore the stereochem istry at the 
anom eric pos ition ) were consistent w ith  those already reported in  lite ra tu re .50 The 
ove ra ll lo w  y ie ld  was due to the fo rm a tio n  o f  m any u n id e n tifie d  side-product.
The next step in vo lve d  the d ih yd ro xy la tio n  o f  1.36P to d io l 1.37p. The firs t series o f  
experim ent was perfo rm ed w ith  Encapsulated Os cata lyst (O sE nC at™  40) in  presence 
o f  N M O  (O sEnCat is less hazardous than 0 s 0 451). H ow ever, even w ith  OsEnCat 
load ing  was raised to 15 m o l% , no product was observed and we were o n ly  able to 
recover the unreacted starting  m ateria l (Tab le  11).
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B n6 
1.36p
Table 11. Dihydroxylation of 1.36P by using OsEnCat™
e n try O sE n C a t y ie ld  (% )
1 5 m o l% -
2 10 m o l% -
3 15 m o l% -
4 15 m o l% a
a Carried out at 40 °C.
OsEnCat™ n  ? H
NMO (1.5 eq.) Bn0^ _ > ^ \ ^ O H
acetone/H20 10:1 Bn0c
1.370
H ow ever, w hen the conven tiona l d ih yd ro xy la tio n  m ethod in v o lv in g  OSO4 (10 m o l% ) 
was carried out, the reaction a ffo rded  1.37P in  quan tita tive  y ie ld  (Scheme 8 ).
Scheme 11. D ih y d ro x y la tio n  o f  1.36P by  using OSO4
0s04(10 mol%) n ? H
NMO (1-5eq.) B n O ^ T / ^ OH
THF/H20 1:1 Bndf
r.t., 1 h
1.36p 1.37p
99% yield
mixture of two 
diastereoisomers 
(dr 80:20)
The d io l 1 .37p was obta ined as an inseparable m ix tu re  o f  tw o  diastereoisom ers w ith  a 
ra tio  o f  80:20, even w hen the reaction was carried out at -78 °C. In  order to increase the
d iastereoisom eric ra tio  in  fa vo u r o f  one diastereoisom er, the Sharpless asym m etric
d ih yd ro xy la tio n  was attempted. The experim ent was perfo rm ed in  presence o f  
cinchona a lka lo id  lig a n d  h yd roqu in id ine  1 ,4 -ph tha laz ined iy l d ie ther (D H Q D )2P H A L  
(10 m o l% ), N M O  (2.2 eq.) and OSO4 (10 m o l% ). U n fo rtu n a te ly  the reaction d id  not 
resu lt in  any im provem en t in  the reaction dr  (Scheme 12).
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Scheme 12. Sharpiess asymmetric dihydroxylation of 1.360
BnO
,cx
0 s0 4 (10 mol%) 
NMO (2.2 eq.)
\  (DHQD)2PHAL (10 mol%)
------------------------------  BnO
THF/H20  1:1 
r.t., 12 h 1
OH
OH
BnO" BnO'
1.360 1.370
79% yield
mixture of two 
diastereoisomers 
(dr 80:20)
As m entioned above, the purpose o f  ou r p ro jec t was to  test the a b ility  o f  our m onom er 
to  act as natural nucleobase rep lac ing  hydrogen-bonded natural base pairs. T h is  nove l 
analogue w i l l  be incorpora ted in to  o ligonucleo tides duplexes using the so lid  phase 
synthesis and phosphoram id ite  chem istry.
The o ligonuc leo tide  synthesis is a stepwise add ition  o f  nucleotide  residues (m onom ers)
automated process that a llow s the in tro d u c tio n  o f  selected residues fo r  the fo rm a tio n  o f  
a w ide  va rie ty  o f  o ligonucleo tides. I t  consists o f  fo u r d iffe re n t chem ica l reactions that 
are re iterated u n t il com p le tion  o f  the strand (Scheme 13):
1) D eb lock ing  (o r d e tr ity la tio n ) w h ich  a llow s the chem oselective rem ova l o f  the 4 ,4 ’ - 
d im e th o x y tr ity l p ro tec ting  group (D M T ) .57
2 ) C oup ling  o f  the deprotected residue w ith  another nucleoside
3) Capping, w h ic h  prevents the excess o f  deprotected nucleosides fro m  inserting  in  the 
g ro w in g  chain.
4) O x ida tion , w h ich  brings the phosphorus atom  to the same state o f  o x id a tio n  present 
in  the natural D N A .
1.4.1 Oligonucleotide synthesis
to  a g row ing  cha in .53'54 A s in  the case o f  the D N A  in  the l iv in g  cells, the add ition  o f  the 
nucleotides takes place on the 5 ’-te rm inus o f  the g ro w in g  o ligonu c leo tide .55'56 T h is  is an
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Scheme 13. Oligonucleotide synthesis
The autom ated o ligonu c leo tide  synthesis starts fro m  the co m m e rc ia lly  ava ilab le  so lid - 
supported C PG -resin  (C on tro lled  Pore G lass-rcsin) w h ich  undergoes deprotecuon 
(D eb lock ing ) to  fo rm  the free h yd ro x y l group. The coup ling  w ith  a protected nucleoside 
fo rm s a d im er (C o u p lin g ) w h ich  is fo llo w e d  b y  capping o f  the excess C P G -res in -O H
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(C apping). Subsequently the o x id a tio n  reaction leads to  the fo rm a tio n  o f  the d im er 
(O x ida tion ). The d im e r fo rm ed  needs to  be deprotected (D e b lo ck in g ) and then coupled 
w ith  another protected nucleoside repeating the cyc le  (Scheme 13).
1.4.1.1 Deblocking
The com m erc ia lly  ava ilab le  f irs t  m onom er 1.45, w h ich  is  attached to the so lid  support 
C PG -resin  is at f irs t  inac tive  as the active site (5*) is protected (Scheme 14).
Schem e 14. D e b lock ing
DMTO V BaSe 3% DCA or TCA ^ / - / V B a s e
CH2CI2 q
DMT
1.45 1.46
= CPG-resine (Controlled Pore Glass-resine)
The 5 '-O -p o s itio n  o f  1.45 is usua lly  protected by  the ac id -lab ile  D M T  group, w h ich  was 
in troduced 1962 b y  K horana and co -w o rke rs .57 The D M T  group is rem oved w ith  an 
acid ic  so lu tion , such as 3%  d ich lo roace tic  acid (D C A ) o r trich lo roace tic  acid (T C A ) in  
C H 2C I2, resu lting  in  a free 5* h y d ro x y l group on the f irs t  nucleobase 1.46.
1.4.1.2 Coupling
The fo llo w in g  m onom er (1.47) cannot be coupled u n t il i t  has been activated. Th is  is 
achieved b y  adding te trazo le to  1.47. Tetrazo le  (pK& =  4.89 in  w ater) cleaves o f f  a 
d iisop ropy lam ine  m o ie ty  on the phosphorus linkage  (a). The free 5 ’-h y d ro x y l group o f  
1.46 and the n e w ly  activated phosphorus couples the tw o  bases together to  a ffo rd  1.48 
(b ). The phosphoram id ite  coup ling  is h ig h ly  sensitive to the presence o f  w ater and is 
com m on ly  carried out in  anhydrous ace ton itrile  (Scheme 15).
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Scheme 15. Coupling
o
0DMT-
NC— o ^ n-
Mimick
1.47
H
N„ >  
N-N
Mimick Base
HO
1.47 1.46
1.48
a
1 .4 .1 3 Capping
A fte r  com p le tion  o f  the coup ling  reaction, a ,small percentage o f  the so lid  support-bound 
5 ’-O H  groups (0.1 to  1%) rem ain  unreacted and need to  be perm anently  b locked fro m  
fu rth e r chain e longa tion  (to  prevent the fo rm a tio n  o f  o ligonuc leo tides w ith  an in te rna l 
base de le tion  com m on ly  re ferred to  as shortm ers). Th is  is done b y  acety la tion  o f  the 
unreacted 5 ’-h yd ro xy  group using a m ix tu re  o f  acetic anhydride and 1- 
m e thy lim idazo le  as a cata lyst (Scheme 16).
Schem e 16. C apping
o
Ac O'
Base
1.46 1.49
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A s the n e w ly  fo rm ed  tricoo rd ina ted  phosph ite trieste r 1.48 is not in  the same ox ida tion  
state as the natural D N A  phosphodiester linkage, i t  has lim ite d  s ta b ility  under the 
cond itions o f  o ligonu c leo tide  synthesis. The treatm ent o f  the support-bound m ateria l 
w ith  iod ine  and w ater in  the presence o f  a w eak base (pyrid ine , lu tid in e  
o r c o llid in e ) ox id ises the phosph ite triester in to  a tetracoord inated phosphate triester, a 
protected precursor o f  the na tu ra lly  occu rring  phosphate d iester in tem uc leos id ic  linkage  
(Scheme 17).
Schem e 17. O x ida tion
1.4.1.4 Oxidation
U pon  com p le tion  o f  the synthesis, the fu l ly  protected, so lid  support-bound 
o ligonuc leo tide  1.50 is subjected to  depro tection  using trich lo roace tic  (T C A ) o r 
d ich lo roace tic  acid (D C A , Scheme 18) and the cyc le  is repeated u n t il chain e longa tion 
is com plete (Scheme 13).
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Scheme 18. Deprotection
TCA or DCA
1.50 1.51
A fte r  a ll the nucleobases have been added and the o ligonuc leo tide  chain is ready, th is t 
m ust be cleaved fro m  the so lid  support and deprotected before  i t  can be e ffe c tive ly  
used. Th is  is done b y  incuba ting  the chain in  am m onia  o r K O H  at h igh  tem perature fo r  
17 hours (Scheme 19).
Schem e 19. C leavage fro m  the so lid  support and cleavage o f  the cyanoethyl m o ie ty
NH3 aq. or KOH 0.4 M 
CH30H:H20, 17 h
HO 
1.52
In  order to evaluate ou r m onom er a b ility  as a natura l nucleoside m im ic , i t  was necessary 
to f in d  a p ro tec ting  group fo r  the d io l m o ie ty  stable bo th  in  the ac id ic  and basic 
cond itions used in  the o ligonuc leo tide  synthesis, bu t easily  rem ovable  at the end o f  the 
process.
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As a tem porary  p ro tec ting  group fo r  1.37p, we in it ia l ly  evaluated 
[( tr iis o p ro p y ls ily l)o x y ]m e th y l ch lo ride  (TO M -C 1, Tab le  12).
T a b le  12. P ro tection  o f  1.37P using TO M -C 1
TOM-CI
1 .3 7p 1 .5 30
e n t r y T O M -C I b a s e s o l v e n t t e m p e r a t u r e y i e l d
( % )
1 2.4 eq. D IP E A 1,2 -d ich loroethane 70 °C —>r.t. a
2 2 .0  eq. D IP E A 1,2 -d ich loroethane 70 °C —»r.t. _b
3 2 .0  eq. D IP E A 1,2 -d ich loroethane r.t. -
4 4.0 eq. D IP E A 1,2 -d ich loroethane 0 °C —>120 °C -
5 4.0  eq. D IP E A 1,2 -d ich loroethane r.t. c
6 4.0 eq. - T H F 0 ° C c
7 4.0 eq. N a H C 0 3 C H 2C12 r.t. _d
8 4.0 eq. N a H C 0 3 C H 2C12 50 °C _d
9 10.0  eq. N aH  95 %
---------K— 1 . .
C H 3C N 0 °C —H\t. -
a Carried out with r-BuSnCl2 2.4 eq. b Carried out with r-BuSnCU 2.0 eq.c Carried out with~DMAP 4.0 eq. 
d Schotten-Baumann conditions: CH2Cl2/NaHC03 1:1, r.t.
D espite  the e ffic ie n cy  o f  the reported procedure ,58 we were no t able to  p ro tect 1.37P and 
we recovered the unreacted starting  m ateria l.
Even w hen the T O M -C I was em ployed together w ith  a n u c le o p h ilic  ca ta lyst (D M A P ) 
the reaction fo llo w e d  the same pathw ay, and no desired p roduct was obta ined (Tab le  12, 
entries 5 and 6 ).
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A n  add itiona l experim ent in vo lve d  the fo rm a tion  o f  an acetonide w h ich  is one o f  the 
most com m on pro tecting  group fo r  1,2-d io ls. The reaction  was carried out b y  using 
TsO H  H 20  in  acetone at room  tem perature a ffo rd in g  the desired p roduct as a m ix tu re  o f  
tw o  diastereoisomers in  77%  y ie ld  (dr 75:25). (Scheme 20).
Scheme 20. P ro tection  o f  1 .370 th rough the fo rm a tio n  o f  acetonide
The ease and the success o f  the reaction insp ired  us to  use the acetonide as p ro tecting  
group in  the o ligonuc leo tide  synthesis (see section 1.4.1).
groups, used bo th  in  so lid  and hom ogeneous phase synthesis. A n  a lte rnative  fu n c tio n a l 
group was found  in  the acety l group, since i t  is reported to be stable in  the reaction 
cond itions required fo r  the o ligonucleo tides synthesis (see section 1.4.1).
Scheme 21. P ro tection  o f  1 .370 w ith  the em p loym ent o f  acetyl group
BnO BnO'
1 .3 70
1.540
77% yield
mixture of two 
diastereoisomers 
(dr 75:25)
In  add ition , we considered the re a c tiv ity  and s ta b ility  o f  a w ide  range o f  p ro tec ting
BnC>
1.370
Py (10.7 eq.) 
CH2CI2l r.t. BnO"
1.380
80% yieldmixture of two 
diastereoisomers
mixture of two 
diastereoisomers 
(dr 67:33)
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1.370 was reacted w ith  18.3 eq. o f  AC2O in  Py in  presence o f  N,N- 
d im e th y la m in o p yrid in e  (D M A P  5 m o l% ) y ie ld in g  1.380 as m ix tu re  o f  tw o  
diastereoisom ers (dr 75:25 where 1.38|3-a is the m a jo r diastereoisom ers and 1.38|3-b is 
the m in o r d iastereoisom er), w h ich  were easily  separated b y  co lum n  chrom atography.
In  order to assign the stereochem istry o f  the C -6  bond on both  the diastereoisom ers o f  
1.38(3 (F igure  32), N O E  experim ents were perform ed.
F ig u re  32. General structure o f  a protected d io l
OR
U n fo rtu n a te ly  i t  was not possib le  to  determ ine the con figu ra tio n  o f  the C -6  centre b y  !H  
N M R  experim ents. T h is  was l ik e ly  to be due to  a fast ro ta tion  o f  the C 1-C 6 bond.
The em ploym ent o f  a b u lk y  p ro tec ting  group fo r  the d io l m o ie ty  was then decided. W e 
reasoned that a group characterised b y  a m arked steric hindrance cou ld  be use fu l to 
im pede the C 1-C 6 bond ro ta tion , therefore a llo w  us to determ ine the absolute 
con figu ra tio n  o f  C 1-C 6 by  ]H  N M R  N O E  analysis. 9-anthra ldehyde d im e th y l acetal 
1.55 was chosen as a p ro tecting  group (F igu re  33).
F ig u re  33. A n th ra ldehyde d im e th y l acetal
MeO^ X>Me
1.55
The em ploym ent o f  9-anthra ldehyde d im e th y l acetal has been successfu lly  reported in  
the p ro tec tion  o f  d io l m oieties w ith  the fo rm a tio n  o f  c rys ta lline  structures .59 The 
p o s s ib ility  o f  p e rfo rm ing  X -R a y  crys ta llog raph ic  analysis was considered a va lid  
a lte rna tive  to  the lH  N M R  N O E  analysis fo r  the dete rm ina tion  o f  the absolute 
con figu ra tio n  o f  C 1-C 6. 1.55 was synthesised accord ing to  the procedure reported in  
lite ra tu re .59 The acetylated m a jo r d iastereoisom er 1.38(3 was deprotected b y  means o f
48
35%  N H 3 at 45 °C , 24 h and the resu lting  free d io l was reacted w ith  1.55 by  
transacétalisation in  M e C N  catalysed by  p-T S A  to a ffo rd  1.56P as m ix tu re  o f  tw o  
diastereoisomers (dr 78 :22) (Scheme 22).
Schem e 22. P ro tection  o f  1.37P b y  means o f  9 -anthra ldehyde d im e th y l acetal 1.55
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OH 1.55(1.25 eq.)
p-TSA (2 mol%)
BnO
CH3CN 
r.t., 12 h
1.370 1.56P
18% yield
One diastereoisomer
mixture of two 
diastereoisomers
The tw o  diastereoisom ers were easily separated by  co lum n  chrom atography, but 
un fo rtuna te ly  no crysta ls were obta ined as a ye llo w  o il was recovered.
The absolute co n figu ra tio n  o f  C 6 -0  bond fo r  bo th  the diastereoisomers o f  1.56P by ]H 
N M R  N O E  analysis is s t i l l  under investiga tion  b y  D r. John O ’ B rien  fro m  the C hem is try  
D epartm ent o f  T r in ity  C o llege  o f  D u b lin .
1.4.2 Stability test o f  the diol protecting groups
W ith  the acetonide 1.54P in  our hands (a m ix tu re  o f  diastereoisom ers), we reproduced 
in  ou r labora to ry  the same cond itions o f  the solid-phase o ligonuc leo tide  (see section 
1.4.1). Tests were perfo rm ed on a 7 jumol scale in  N M R  test tubes in  C D 3C N  (0.75 m L ) 
to  easily m o n ito r the s ta b ility  o f  1.54p every 30 m inutes fo r  3 hours then every 2 hours 
fo r  a to ta l o f  24 hours. These reactions were decided in  order to  investiga te  the s ta b ility  
o f  the m onom er under the autom atised co nd ition  app lied  by  o lig o  synthesizer. The firs t 
experim ent was carried out in  presence o f  3%  T F A  and i t  was m on ito red  b y  N M R  
spectroscopy. U n fo rtuna te ly , 1.54P resulted unstable under ac id ic  cond itions, and 1.37p 
was detected b y  ]H  N M R  analysis a fte r o n ly  30 m inutes (Scheme 23).
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o 4 ^  OH
« n y i  3%tf< .
CD3CN
BnOs 30 minutes, r.t. Bn0
1 .5 40  1 .370
The same reaction  cond itions were then app lied  to  1 .38p to  test the s ta b ility  o f  the
protected d io l in  the ac id ic  environm ent. W e were de ligh ted to observe that the acetyl
pro tecting  groups were s u ffic ie n tly  stable to su rv ive  in  aqueous T F A  fo r  24 hours
(Scheme 24).
Scheme 24. T reatm ent o f  1.38p w ith  3%  T F A
Scheme 23. Hydrolysis of 1.54p under acidic conditions
OAc OAc
3% TFA ^  /O.
BnO' \  /  "— OAc ----------------   BnO/ ^ '  r \ ^ - O A c
r.t., 24 h .
BnO" Bn(i
1.38)3 1.38(3
W ith  th is exce llen t resu lt in  ou r hands, we were ready to investigate the s ta b ility  o f
1.38p under a ll the cond itions present in  the o ligonuc leo tide  synthesis. In  th is  regard,
1.38P was treated w ith  0.45 M  te trazo le in  C D 3C N  and we were de ligh ted  to observe
that the p ro tecting  groups were stable under these cond itions  fo r  24 hours (Scheme 25).
Schem e 25. T reatm ent o f  1.38P w ith  0.45 M  tetrazo le in  C D 3C N
n  P ^c 0.45 M tetrazole n  ? ^ c
B n 0 " ^ O ^ ° Ac inCD3CN ■ B n O ^ Q ^ - O A c
BnO" r t ’ 24 h BnO"
1.380 1.380
The th ird  step in vo lve d  the capping reaction  cond itions  o f  the unreacted 5 '-O H  groups 
(w h ich  needs to  be perm anently  protected). The ace ty la tion  o f  unreacted 5 ’-h yd ro xy  
groups was perfo rm ed b y  using a m ix tu re  o f  acetic anhydride in  T H F  (1 :9 ) in  presence 
o f  1 -m e thy lim idazo le  in  p y rid in e  (9 :1) as a cata lyst (Scheme 26).
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Scheme 26. Treatment of 1.380 with methylimidazole/Py
,0  JpAC THF/Ac20  9:1 0  OAc
BnO \__ ! n—OAc----------------------- ------- „  BnO^ ' OAc
BnCi methylimidazole/Py 9:1 BnCÎ
r.t.
1.380 1.380
A  successful resu lt was achieved since o n ly  starting  m ate ria l 1.380 was detected b y  !H  
N M R  analysis.
O x id a tio n  o f  phosphate triester in to  a te tracoord inated phosphate trieste r was 
reproduced trea ting  our m onom er 1.380 w ith  0.02 M  I 2 in  T H F /P y /t^ O  (89.6 /10 /0 .4 ) 
(Scheme 27).
Schem e 27. T reatm ent o f  1.380 w ith  0.02 M I 2 in  C D 3C N
OAc 0.02 M \2 OAc
1.380 1.380
T o  our de ligh t 1.380 proved to be stable even under these cond itions fo r  24 hours. The 
last step in vo lve d  the depro tection  o f  acety l groups by  treatm ent w ith  35%  N H 3 (60 °C, 
20 h). The !H  N M R  spectrum  showed the desired deprotected target (Scheme 28).
Schem e 28. H yd ro lys is  o f  acetyl groups using 35% N H 3
OAc OH
A .  J f  _ . 35% NH3 ^  JX
BnO' \  /  ^ - 0 A c ----------------- ^  B n o '^ ^  r ^ X ^ O H
60^,1611
BnO BnO
1.380 1.370
W e were de ligh ted to  observe these successful results fo r  each test carried  out, so we 
concluded that the acety l is the cheapest, the s im plest and the m ost suitab le group fo r  
ou r purpose.
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N o w  we were ready to  ca rry  out the debenzyla tion  o f  1 .38p-a. Despite the w ide  am ount 
o f  s tra igh tfo rw ard  procedures reported in  lite ra tu re , the developm ent o f  debenzyla tion  
reaction on our m onom er represented a challenge (Table 13).
T a b le  13. Screening o f  reaction  cond itions fo r  debenzyla tion  o f  1.38P-a
1.4.3 Synthesis of nucleoside possessing the acetate protecting group
OAc Pd/C OAc
,0 ,  J  h2 _
BnO' \  /  T ^ V -O A c
solvent,
BnC) temperature HC)
1.38p-a 1.57p-a
e n try
P d /C
1 0 %
h y d ro g e n
source
so lven t te m p e ra tu re y ie ld  (% )a
1 - h 2 M e O H r.t. _b
2 0.1  eq. h 2 M e O H /H C O O H  9:1 r.t. -
3 1.3 eq. h 2 M e O H /H C O O H  9:1 r.t. c
4 1.1 eq. h 2 E tO H /H C O O H  9:1 r.t. -
5 0.2  eq. h 2 E tO H /H C O O H  9:1 40 °C d
6 0 .2  eq. h 2 T H F /H C O O H  9:1 60 °C _d
7 0 .2  eq. h 2 M e O H /H C O O H  9:1 40 °C _d
8 0.3 eq. H C O O H M e O H /H C O O H  8:2 r.t _d
9 0.3 eq. H C O O H E tO A c /H C O O H  8:2 r.t d
10 0.3 eq. H C O O H M e O H /H C O O H  85:15 55 °C e
12 - - C H 2C12 -78 °C 70f
13 0.4 eq. N a H 2P 0 2g M e 0 H /H 20  2:1 70 °C n.d.
14
a x t _ .
2 .0  eq. h 2
_ _____ - .  b •
M e O H /H C O O H  9:1 r.t. 92
Pd(OH)2/C 20% 0.1 eq. c Carried out in a Parr hydrogenator at 750 psi (51 atm.). d Carried out in 
sonication conditions. e Carried out under microwave irradiation at 40W for 40 minutes. f Reaction was 
performed by means of BC13 1M in CH2C12 (2.2 eq.). g NaH2P02 1.5 eq.
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A t firs t, we investigated the m ost com m on procedure reported in  lite ra tu re  in v o lv in g  
Pd/C  10% o r P d (O H )2/C  (10 m o l% ) and H 2. H ow ever w e were o n ly  able to recover 
starting m ateria l (Tab le  13, entry 2). Even w hen the reaction was perform ed in  Parr 
hydrogenator, son ication  cond itions o r m icrow ave  irrad ia tion , we were able to  recover 
o n ly  the unreacted sta rting  m ateria l (Tab le  13, entries 1, 3, 5-10). A n  encouraging resu lt 
was obta ined by  using fresh ly  opened B C I3 in  C H 2C12 (1 M ), b u t due to the in s ta b ility  o f  
boron tr ich lo rid e  so lu tion  the reaction was no t genera lly  reproducib le  (Tab le  13, en try 
12). A  transfer hydrogenation  was proposed to  occur via isom erisa tion  o f  the 
phosphory l (N a O )H 2PO to  the hyd rox ide  (N a O )(H O )P H  fo rm  fo llo w e d  by  d issoc ia tion  
o f  the P -H  bond .60 W e were de ligh ted to observe the p roduct fo rm a tion  o f  1.57p-a. 
H ow ever, due to h igh  p o la r ity  o f  the debenzylated com pound a p rob lem  occurred 
because o f  the sim ultaneous presence o f  bo th  ino rgan ic  salts and 1 .570-a in  aqueous 
laye r a fte r w o rk  up. W e decided to attem pt a fu rth e r reaction  w ith  the em ploym ent o f  an 
excess o f  Pd/C  (2.0 eq.), H 2 and 10% o f  H C O O H  in  M e O H  and w e were de ligh ted  to 
observe the fu l l  convers ion o f  1 .38p-a  in  h ig h  y ie ld  (92% , Tab le  13, entry 14).
A s p rev ious ly  described, the 5 ’-0 -p o s itio n s  o f  the phosphoam id ite  b u ild in g  b locks are 
usua lly  protected b y  the 4 ,4 ’ -d im e th o x y tr ity l group (D M T ) required fo r the so lid  phase 
synthesis (Scheme 29).58
Schem e 29. P ro tection  o f  5 ’-<9-position o f  1 .57p-a  w ith  the em ploym ent o f  D M T-C 1
,0
OAc OAc
HO OAc
HO
DMT-CI (1.3 eq.
Py 
r.t. 16 h
DMT-0 -OAc
1.570-a
HO
1.58p-a
60% yield
The reaction was carried  out under argon atmosphere b y  using 4 ,4 '-d im e th o x y tr ity l 
ch lo ride  in  d ry  py rid ine . W e noticed that, to ensure the p roduct fo rm a tion  in  h igh  y ie ld , 
a d ry  m ed ium  and the com plete exc lus ion  o f  traces o f  acid were cruc ia l. In  th is  regard, 
before  the use, C D C I3 was filte re d  th rough a short p lug  o f  basic a lum ina  to rem ove any 
traces o f  acid.
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The reaction  proceeded sm ooth ly  a ffo rd in g  1.58P-a ty p ic a lly  in  16 hours in  60%  y ie ld . 
The last synthetic step requ ired  the p ro tec tion  o f  the 5 '-O -p o s itio n  o f  1 .58p-a  us ing  2-
58cyanoethyl N ,7V -d iisopropylch lorophosphoram id ite  1.59 (Scheme 30).
Schem e 30. P ro tection  o f  3 '-O p o s it io n  o f  1 .58p-a  w ith  the em ploym ent o f  1.59
,0.
OAc
DMT-0 OAc
HO
1.580-a
OAc
1 ■'
X
^,CN
1.59
95% yield
The 5 ’-D M T -p ro te c te d  in term edia te  1 .58p-a  was converted in to  the correspond ing 
phosphoram id ite  b u ild in g  b lo c k  1 .39p-a  in  95%  y ie ld . The reaction  proceeded sm oo th ly  
and, as in  the previous p ro tec tion  w ith  D M T-C 1, even in  th is  case the absence o f  any 
acid and the anhydrous env ironm en t were c ruc ia l fo r  the success o f  the reaction.
G iven  the success o f  the synthesis to a ffo rd  the fin a l target 1.39P-a starting fro m  the 
m a jo r d iastereoisom er o f  1.38P (1 .38p-a), we decided to ob ta in  the fin a l target even 
em p loy ing  the m in o r diastereoisom ers o f  1 .38p (1 .38P-b). The last three synthetic steps 
to prepare the fin a l m onom er were perfo rm ed under the same op tim ised  cond itions 
described in  Tab le  12 (en try  14), Schemes 29 and 30. T o  our de ligh t the synthesis was 
successful a lthough w ith  lo w e r ove ra ll y ie ld  (Scheme 31).
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Scheme 31. Synthesis o f  f in a l target sta rting  fro m  the m in o r diastereoisom ers o f  
1.380 (1 .38p -b )
,C ? A° Pd/C (2.0 eq.)
BnO ’ / ' n - ' O A c  H2 H o ' x  f ^ - O A c  DMT-CI (1.3 eq.)
BnO' MeOH/HCOOH 9:1 HO' Py
r.t., 16 h r.t. 16 h
1.38p-b 1.57p-b
minor diastereoisomer 43% yieJd
(from the minor 
diastereoisomer of 1.380,
1.380-b)
OAc OAc
^  A  DlpEA (2-5 eq.) ^  J
D M T - O '^ ^ T N - 'O A c  1.59 (2.2 eq.) D M T - 0 '^ ~ ^ _ / X - ''OAc
HO' CH2CI2 I O'
r.t., 16 h
1.58(3-b 1.39p-b
43% yield 41% yield
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In trig u e d  b y  the successful synthesis o f  the protected d io l 1 .39p, we were encouraged to 
investigate a lte rnative  m oieties capable o f  com p lex ing  m eta l-ions to fo rm  other 
unnatura l C -nucleosides. A  ve ry  a ttractive a lte rnative  was represented by  the 
am inoa lcoho l group. A  re trosyn the tic  analysis is shown in  Scheme 32.
Schem e 32. R etrosynthetic  analysis fo r  D M T r-phospho ram ida te  1.64
1.4.4 Synthesis of nucleoside possessing an aminoalcohol moiety
o
/ ^ t/°v-OCH3
= >  B n O \__j H = >  B n O i \ J  = >  B n C i \ J  
BnO' BnO" BnOs
1.61 1.60 1.41
A cco rd ing  to the procedure reported in  lite ra tu re ,61 1.41 was subjected to  treatm ent w ith  
tr im e th y ls ily l cyanide (T M S C N ) and B F 3 E t20  to a ffo rd  1 .60 a /p  as a m ix tu re  o f  tw o  
diastereoisom ers w h ich  were separated by  co lum n  chrom atography. The 
stereochem istry at the anom eric pos ition  o f  1.60 was assigned b y  N O E  experim ents and 
i t  was consistent w ith  the data reported in  lite ra tu re .61
1 .60a  was reacted w ith  d iiso b u ty la lu m in iu m  hyd ride  to y ie ld  the aldehyde 1 .61a  w h ich , 
after treatm ent w ith  D IB A L -H , led  the n itro  a lcoho l m o ie ty  (1 .65a ). T h is  was reduced 
to 1 .62a  b y  using H C O O N H 4 in  a transfer hydrogenation  process assisted by  
m icrow ave  irrad ia tion .
Here w i l l  be described in  de ta il the preparation o f  1 .6 0 a /p  (Scheme 33), whereas the 
synthesis o f  1.41 sta rting  fro m  2-deoxy-D -ribose was repeated accord ing to  a procedure 
reported in  Scheme 7 49
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Scheme 33. Synthesis of 1.60a/p
TMSCN (1.4 eq.)
// - ^ ° V - O C H 3 BF3 Et20  (3.6 eq.)
BnO \  /  --------------------------- BnO \  /  + BnO \  /
CH2CI2, 0 °C, 2 h
BnO BnO BnO
1.41 1.600 1.60a
41 % yield 49% yield
The reaction was carried  out in  d ry  C H 2C12 in  presence o f  T M S C N  (1.4 eq.) and 
BFa E t20  (3.6 eq.) at 0 °C. A fte r  2 hours the reaction a ffo rded the desired 1 .56 a /p  as a 
m ix tu re  o f  tw o  diastereoisom ers (dr 4 .4 :5 .6 a /P ) w h ich  were separated b y  co lum n 
chrom atography in  ove ra ll y ie ld  o f  90% .
The next step in vo lve d  the reduction  o f  the m a jo r d iastereoisom er 1 .60a  in to  the 
aldehyde 1 .6 1 a  b y  using d iiso b u ty la lu m in iu m  hyd ride  1M  in  toluene (D IB A L ) .  The 
o p tim um  cond itions were found  w ith  the em ploym ent o f  D IB A L -H  1.2 eq. at -78 °C  
a ffo rd in g  1 .6 1 a  in  37%  y ie ld  (Tab le  14).
T a b ie  14. R eduction  o f  1 .6 0 a  in to  the aldehyde 1 .61a
0
Sn0 ' ^ ) ' ' ° N DIBAL-H|l-2 ” > \
„  toluene
BnO BnO
1.60a 1.61a
e n t r y D IB A L - H t e m p e r a t u r e y i e l d  ( % ) a
1 1.0  eq. 0 ° C -
2 1.2 eq. o°c -
3 1.2 eq. -78 °C 37
3 Isolated yields after column chromatography.
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The treatm ent o f  1 .6 0 a  w ith  D IB A L -H  1M  in  to luene (1.0 and 1.2 eq.) at 0 °C  resulted 
in  degradation o f  the p roduct (Tab le  14, entries 1 and 2) whereas w hen the temperature 
was low ered  to -78 °C , 1 .61a  was y ie lded  in  37% , p ro v in g  the im portance o f  the 
reaction tem perature in  th is procedure. In  the next step 1 .6 1 a  was successfu lly  
converted in to  the n itroa lcoho l 1 .6 5 a  b y  H e n ry  reaction w ith  the em p loym ent o f  
n itrom ethane (Scheme 34).
Scheme 34. Synthesis o f  1 .6 1 a  b y  H enry  reaction
q  CH3NO2 (15 eq.) q u
n  JJ Et3N(20mol%) .(
B n O ^ O  H -------- ^ ^ N° 2
BnO' r.t., 20 h BnO'
1.61a 1.65a
68% yield
mixture of two 
diastereoisomers (dr 70:30)
1 .61a  was treated w ith  C H 3N O 2 (15.0 eq.) in  presence o f  trie thy lam ine  (20  m o l% ). The 
reaction proceeded in  20 hours at room  tem perature a ffo rd in g  1 .65a  as a m ix tu re  o f  
tw o  diastereoisomers in  to ta l y ie ld  o f  6 8 %. (dr 70:30)
The reduction  o f  1 .6 5 a  to the am inoa lcoho l 1 .6 2 a  was perfo rm ed by  using H C O O N H 4 
in  a transfer hydrogenation  process (Tab le  15).
T a b le  15. R eduction  o f  1 .6 5 a  to  1 .62a
Q ? H HCOONH4 (10 eq.) „  ° H
Bn0 ^ Q " " ^ N 0 2 Pd/C 10% (1.0 eq.) Bn0^ )  ' " V N H 2
BnC) CH3OH, 15 min BnO'
MW
1-65“ 1.62a
e n try te m p e ra tu re y ie ld  ( % ) a
1 r.t. -
2 0 ° C -
3 40 °C 64b,c
a Isolated yields after column chromatography. 
b Carried out under microwave irradiation for 15 minutes.
Dr 70:30
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W hen the reduction  was perform ed at room  tem perature o r 0 °C , no p roduct fo rm a tio n  
was observed (Tab le  15, entries 1 and 2) as o n ly  unreacted starting  m ateria l was 
recovered. W hereas, w hen 1 .65a  was subjected to  m icrow ave  irrad ia tion , the reaction 
proceeded in  15 m inutes at 40  °C  and 1 .62a  was obta ined in  64%  y ie ld .
The isola ted 1.60P was subjected to the same reaction  cond itions to  obta in  aldehyde 
1 .6 i p  and n itro a lco h o l m oieties 1.65p resu lting  in  61%  and 54%  yie lds, respective ly  
(Scheme 35).
Schem e 35. Synthesis o f  1.61 p and 1.65p starting  f ro m l.6 0 p
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o  CH3N02 (15 eq.) OH
BnO' A V CN DIBAL-H(1'2eq ) B n O ^  ^  <2° m °'%) B n O ^  > ^ N O :
d toluene _ ^  CH2CI2 Rnri'
Bn°  r.t. Bn0  r.t., 20 h Bn°
1.600 1.61 p 1.650
61% yield 54% yield
mixture of two 
diastereoisomers 
(dr 70:30)
Since we proved the e ffic ie n cy  even o f  the am ino a lcoho l route, th is  cou ld  be 
considered a va lid  a lte rna tive  to the d io l one fo r  the fo rm a tio n  o f  m eta l com plexes. W e 
focused our a ttention  to the d io l pa thw ay firs t, how ever the am ino a lcoho l m o ie ty  cou ld  
be considered in  case o f  unsatis facto ry b io lo g ica l results in v o lv in g  the d io l m oie ty.
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Th is  w o rk  was carried ou t by  D r. M a ria  M o cc ia  at R C S I and IB B -C N R  (Naples) 
laboratories.
G iven  the success o f  the synthesis to a ffo rd  the fin a l target 1 .390-a, we were ready to  
investigate the a b ility  o f  our m onom er to  act as a natural nucleoside m im ic .
F irs t, we decided to  p e rfo rm  the p re lim in a ry  m anual o ligonuc leo tide  syntheses using the 
phosphoram id ite  m ethod. The syntheses were perfo rm ed on a 1 jumol scale using the 
co m m erc ia lly  ava ilab le CPG co lum n  purchased fro m  A p p lie d  B iosystem  and a ll the 
reagents were loaded using tw o  syringes attached to  bo th  sides o f  the co lum n  (F igure  
34).
F ig u re  34. Apparatus fo r  m anual D N A  Solid-Phase Synthesis: C P G -co lum n 
(C on tro lled  Pore G lass-co lum n)
1.5 Preliminary biological tests and results
T w o  D N A  sequences, d (5 ’-D M T 1 .3 9 p -a T -3 )  1.70 and d (5 '-T 1 .3 9 p -a T -5 ')  1.75 were 
prepared accord ing to the o ligonu c leo tide  synthesis processes as described in  section
1.4.1 (Scheme 36 and Scheme 37).
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Scheme 36. Synthesis of d(5’-DM T139$-aT-3’) 1.70
0
1.66
Deblocking
ho^ t v
o 0
OAc
1.67
Coupling
1.39{5-a
OAc OAc
1) Capping
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Scheme 37. Synthesis of d(5'-T1.39p-aT-:T) 1.75
DMT-0'/>^ _ ^ Ny ' NH 
d f °
1.66
o
3% TCA .
-------------------- HO' \ _ r  Y m
c h 2c i2 o- 0
OAc
DMT
Deblocking
1.67
Coupling
1.39p-a
OAc
1) Coupling
3) Oxidaxion
4) Deblocking
D M T - 0 ^ ° ^ - Ny , NH
o ' 0  OAc 
X>
NC.
OAc
1) Capping
2) Oxidaxion
3) Deblocking
J o
‘O' O y m
o
HO Y NH
?.o
NC^ 0 ' K 0
OAc
NC. P>
'c r vo
OAc
y m
0
1.73 1.74 56%
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The reagents were passed backwards and fo rw ards  th rough the co lum n  (using the 
syringes) fo r  the requ ired tim e  depending on the synthesis step (coup ling , capping, 
o x ida tion  and deb lock ing).
U pon com p le tion  o f  the synthesis, the excess reagents were rem oved fro m  the co lum n 
and the resin was washed several tim es w ith  C H 3C N  and C H 2C I2.
Once the sequences 1.70 (E xact mass =  783.2536) and 1.75 (E xact mass =  784.1616) 
were prepared, these were analysed b y  Mass spectrom etry (M A L D I)  w h ich  con firm ed  
the id e n tity  o f  both products (F igures 35 and 36). Thus, 1 .39p-a was successfu lly 
incorporated in  the short sequence (1-71) w ith  an e ffic ie n cy  o f  70%  and was also able to  
incorporate at its  5 ’ a thym ine  nucleoside w ith  an e ffic ie n c y  o f  56% .
F ig u re  35. M A L D I  analysis fo r  1.70
M M  D N A  3 vr<100Q-TOF 2011DB10MF002 25B (4.905) AM (Cen,4, 80-00, Ht,8600.0,1568.66,0.70); Sm (SG, 1x5.00); St) (15,10.00 ); Cm (40:285) « 783.2491 ' .
i ji !I-I
705.0902'; 740.0372
¡785.2527. ‘
I
845.1711
¡847.1705;
B 15.0875
i t
1.1651 950.2253;'
700 ... 720- 740 760* -780
84a.17548SVj1.497 916'15S1| 935.2011 $862.1666
W . i .  . r  .  . , : j i ,  . | j . .884.1535 H ,  J93'721“ S - |  -,
000 820 ' 840 ' 860 8B0- "  900' " 920 940 660' ‘ 930 *
10-Aug-2011I 
TOF MS LD- 
2.0fie3
992.2256’
! 993.2284' .
k 1037:4315 '1054,1534
fÌ-Ì”wXj., A"".*,'.:
lo b o V  102D ' 1040 1 1060 1080 . " -1100
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Figure 36. MALDI analysis for 1,75
1'
847.0891.
.¡MM D N A 2‘
¡Q-TOF 2011Q810MF001.W 7 (3.339; AM (Cen,4, 80.00, Ht,8600.0,1568.66,0.70); Sm (SG, ,1x5.00); Sb (15,10.00 ); Cm (2:201).
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The successful coup ling  o f  1.39p-a in  the D N A  strand was then also con firm ed  by  
means o f  U V -spectroscopy w ith  the absorbance at A™ax=498 nm  in  correspondence o f  
the release o f  the dark orange 4 ,4 '-d im e th o xy tr ity l ca tion  1.76 (F igu re  37).
F ig u re  37. 4 ,4 '-d im e th o xy tr ity l ca tion  1.76
64
Chapter 1
Prom pted by  these successful results, we em barked on the investiga tion  aimed to 
evaluate the s ta b ility  o f  a 1 .39p-a /1 .39p-a  base p a ir w hen in troduced  in  the m idd le  o f  a 
15 -o ligonucleo tide  dup lex  (F igure  38).
F ig u re  38. 15 -o ligonuc leo tide  dup lex
d(5  ’-C A C A T T A A T G T T G T A -J ') A
d (3 ’-G T G T A A T T A C A A C A T -5  ') B
d (5 '-C A C A T T A 1 .3 9 p -a T G T T G T A -3  ’) C  
d (3 ,-G T G T A A T 1 .3 9 p -a A C A A C A T -5  ’) D
A l l  sequences were assembled using an autom atic D N A  synthesiser (A B I 3400, A p p lie d  
B iosystem ) w ith  the standard 1 (jm o l-sca le  p ro toco l and phosphoroam id ite  chem istry , 
except fo r  the 1.39p-a u n it w h ich  was in troduced w ith  m anual s ingle inse rtion  using the 
aforem entioned procedure.
A l l  the sequences (A -D ) were deprotected and detached fro m  so lid  support, p u rifie d  by  
reversed phase io n  pa iring  H P L C  (A = H 2 0  0.1 M /T E A A  pH = 7 ; B = C H 3C N ) and 
successively characterised by  M A L D I-T O F  analysis w h ich  con firm ed  the ir identities.
A l l  the o ligom ers A -D  were quan tifie d  b y  U V  spectroscopy, m easuring the 260 nm  
absorbance at 85 °C , and ca lcu la ting  the ove ra ll e x tin c tio n  co e ffic ie n t feeo) as the sum 
o f  the 8260 o f  the D N A  d iffe re n t bases.
P re lim ina ry  t itra tio n  experim ents were also carried out to  establish the exact 
s to ich iom e try  o f  the com p lex  between 1 .39p-a /1 .39p-a  base pa ir and C u2+ ions in  a 
dup lex (C /D ), us ing U V-spectroscopy.
The experim ent was perfo rm ed  b y  record ing  the U V  spectrum  between 220 and 320 nm  
o f  the dup lex C /D  [ l p M  -2 5 m M  N aM ops] at 20 °C  (fo lded ) and 80 °C (un fo lded ) in  
correspondence o f  the a dd ition  o f  0.1 eq. po rtions o f  C u2+ (F igure  39).
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F ig u re  39. U V  absorption change o f  1 .39p-a /1 .39p-a  at various concentrations o f  C u2+ 
at 80 °C: b lue in  absence o f  C u2+; red 0.5 p M  Cu2+; green 1 p M  C u2+; red 1.5 p M  C u2+
Wavelength [nm]
In  Table 16 are reported the absorbance values correspond ing to each add ition  o f  C u2+ 
and the absorption data at 260 nm  were p lo tted  as a fu n c tio n  o f  the concentra tion  o f  
C u2+ show ing the titra tio n  curve reported in  F igu re  39.
T a b le  16. Absorbance values corresponding to each add ition  o f  C u2+
C u ** A b s ( 2 b 0 n m ] 0 .3 5
Ü .0 0 O J - W J 0 .5 4 5
0 . 1 0 0 . 3 4 b
O .M
Ü .4 0 0 . 3 2 0 7
0 . 5 0 0 , 3 2 4 3 f  L \3 5 5
n . f i o n . 1 7 4 4
• «  0 . Î 3
U . / 0 U . i l b . a
o . s o 0 ,3  2 b 2 0 .5 2 5
0 . 9 0 0 .3 2 £ > 8 no'
1 . 0 0 0 . 3 2 7
0 .3 1 5
1 .5 0 0 3 2 0 2 <
2 .CIO 0 . U 9 S
0,00.
T T
♦ o
0 .5 0 1.00 [C u * * ] 1 ,5 0 2.00 2 ,5 0
A s shown in  F igure  39 and Tab le  16, fro m  these p re lim in a ry  experim ents we were no t 
able to observe a s ig n ifica tive  change in  the dup lex  con fo rm a tion  in  correspondence to 
add ition  o f  C u2+.
0 a-
M e ltin g  temperatures, in  absence and in  presence o f  Cu ions, were also measured by  
U V -m o n ito re d  therm a l denatura tion experim ents (F igu re  40).
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F ig u re  40. M e lt in g  curves o f  the dup lex 15-nucleotides 1 .39p-a /1 .39p-a : 2jaM , 2 5 m M  
N aC l, lO m M  phosphate b u ffe r pH =7. B lue  in  absence o f  C u2+; green 1 juM  C u2+; red 2 
H M  C u2+
Temperature [C]
In  absence o f  C u2+ ions the dup lex 1 .39p-a /1 .39p-a  showed a Tm o f  24 °C  whereas a 
natu ra l-type  dup lex  (F igure  38, A /B )  in  w h ich  the 1 .39p-a /1 .39p-a  base p a ir is replaced 
by  A T  base pa ir, m elted at 44.2 °C  (Section 1.2.2.1, F igu re  17). Thus, the presence o f  
1 .39p-a in  the m idd le  o f  D N A  natura l sequence perturbed the ove ra ll fo rm a tio n  o f  the 
dup lex, resu lting  in  a decrease o f  the m e lting  tem perature o f  20.2 °C.
A s shown in  F igure  40, m e ltin g  experim ents fo r  dup lex  1.39p-a /1 .39p-a  were carried 
out in  presence o f  d iffe re n t concentration o f  C u2+ and decreases o f  the m e lting  
temperatures (Tm <20 °C ) fo r  bo th  the add ition  o f  1 juM  and 2 j jM  o f  C u2+ were 
observed.
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In  conclusion , the design and deve lopm ent o f  a new class o f  m o d ifie d  unnatura l C- 
nucleosides fo r  the synthesis o f  a r t if ic ia l D N A  through m etal com p lexa tion  has been 
perform ed. T w o  d iffe re n t fu n c tio n a l groups have been insta lled  on the m o d ifie d  
nucleoside (d io l 1.39p and am inoa lcoho l 1 .65a). In  order to  synthesise nucleoside 
analogues able to m im ic  the natural a b ility  o f  the D N A  pairs to fo rm  the D N A  h e lix  by  
com p lexa tion  w ith  m eta l ions, we needed to f in d  a suitable p ro tecting  group fo r  the 
o ligonuc leo tide  synthesis. The s ta b ility  o f  the ace ty l group as p ro tec ting  group fo r  the 
d io l m o ie ty  was tested by  reproducing  in  ou r labora to ry  the reaction cond itions used in  
the o ligonuc leo tide  synthesis. W e were de ligh ted  to observe the com plete s ta b ility  in  
each test reaction carried out. Th is  led  us to  conclude that the acetyl group was the m ost 
suitable (and cheapest) p ro tecting  group fo r  our purpose. The p re lim in a ry  evaluation o f  
the p o ss ib ility  o f  inse rting  the m onom er 1.39(3 in to  a D N A  strand proved successful, as 
tw o  short m o d ifie d  D N A  sequences com pris ing  bo th  natural nucleobases and our 
unnatura l base were synthesised. T itra tio n  experim ents were perform ed to  determ ine 
whether these tw o  m o d ifie d  D N A  strands were able to com plex a copper ion  (CUSO4). 
D N A  M e ltin g  experim ents were carried ou t in  the presence o f  d iffe re n t concentration o f  
C u2+, how ever a decrease o f  the m e ltin g  tem perature (therefore no com p lexa tion ) was 
observed. Thus, the presence o f  1.39p inserted in  the m idd le  (or at the end) o f  D N A  
natural sequence perturbed the fo rm a tio n  o f  the dup lex. Even though we m a in ly  focused 
to  the d io l m o ie ty  ra ther than to the am inoa lcoho l 1 .65a, i t  w i l l  be d e fin ite ly  w o rth  to 
protect 1 .6 5 a  w ith  the acetyl group, the D M T -C 1  and phosphoram idate in  order to insert 
th is new m o d ifie d  m onom er in  a D N A  strand to evaluate the a b ility  o f  the am inoa lcoho l 
m o ie ty  to com plex a m etal ion . G iven  the success o f  the synthesis o f  f in a l target 
1.39p and the in term ediate 1 .65a , a fu rth e r a lte rnative  route cou ld  be seen in  the 
d iam ines o r hyd roxam ic  acid m oieties w h ich  cou ld  be in troduced in  the m idd le  o r at the 
end o f  a D N A  strand. Once in troduced in  a D N A  strand, in  order to evaluate w hether 
our unnatura l nucleosides (d io l, am inoa lcoho l, d iam ines o r hyd roxam ic  acids) are able 
to  com plex m eta l ions, a va rie ty  o f  d iffe re n t m eta l ions (Fe2+, Z n 2+, Pd2+, Pt2+ or 
sem iconductors such as T i4+) cou ld  be em ployed in  a screening study, w h ich  should 
then consider also the e ffec t o f  d iffe re n t reaction  cond itions such as pH .
1.6 Conclusions
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C h a p te r  2
A s y m m e tr ic  M ic h a e l  A d d it io n  o f  C - A n d  N - N u c le o p h ile s  to  I so x a z o le s
)
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2.0 In t ro d u c t io n
2.1 Introduction to organocatalysis and phase-transfer catalysis
The term  “ organocata lysis ” 62 describes the acceleration o f  a chem ical reaction in  the 
presence o f  substo ich iom e tric  amounts o f  sm a ll m eta l-free organic m olecu les .63"66 The 
rap id  rise o f  organocata lysis has been made possib le  b y  a com b ina tion  o f  in te resting  
features :67 organocatalyst s tructura l tem plates are usua lly  ava ilab le  in  enan tiom erica lly  
pure fo rm  d ire c tly  fro m  nature (e.g., am inoacids, carbohydrates) and therefore qu ite
¿TO
inexpensive. They are genera lly  stable, n on -tox ic  and env ironm en ta lly  fr ie n d ly . T h e ir 
lo w e r o x o p h ilic ity  ( i f  com pared to  several m eta l ions) avoids the need fo r  u ltra -d ry  
solvents and exc lus ion  o f  oxygen and m o is tu re .67 Nevertheless, one o f  the m ost 
im portan t achievements fo r  the f ie ld  has been the conceptua lisa tion  o f  organocatalysis 
no t o n ly  as a term , bu t also, in  the w ords o f  Prof. D a v id  M a c M illa n , “ as an econom ic, 
environm enta l and sc ie n tific  bene fit fo r  the co m m u n ity ” .62 The id e n tif ica tio n  o f  a 
generic activa tion  m ode fo r  the desired trans fo rm ation  a llow s the cata lyst design and 
developm ent process to  be a re la tive ly  s tra igh tfo rw ard  task.
Phase-transfer cata lysis is a branch o f  organocatalysis w h ich  o ffe rs  add itiona l 
advantages in  terms o f  econom ic and env ironm en ta l benefits. Th is  is equa lly  true 
leading w ith  deve lopm ent o f  asym m etric  processes as w e ll as racem ic ones where 
hydrox ides cou ld  replace a lk y l l ith iu m  bases. The te rm  “ phase transfer cata lysis”  (PTC ) 
was in troduced b y  Starks in  1971 to exp la in  the ro le  o f  quaternary am m on ium  or 
phosphonium  salts in  reactions between substances situated in  d iffe re n t im m isc ib le  
phases.69 Several reports o f  asym m etric  phase-transfer catalysed reactions have been 
published in  the last decade.70'76
G enera lly, reactions between tw o  substances p laced in  d iffe re n t phases are 
unsuccessful. F o r instance, as Sparks reported, the heterogeneous m ix tu re  between 1- 
brom ooctane and aqueous sod ium  cyanide a fforded, a fte r tw o  weeks at 100 °C, o n ly  the 
hyd ro lys is  o f  N a C N  to sod ium  form ate. Starks described phase-transfer cata lysis as a 
so lu tion  fo r  the heterogeneity p rob lem  in  reaction  environm ents. Phase-transfer 
cata lysis is based on the use o f  sm a ll quantities o f  a substance w h ich  transfers one 
reactant th rough the in te rface  so that the reaction  can take place. The phase-transfer 
ca ta lyst is no t depleted and i t  is able to p e rfo rm  the transport repeatedly (F igure  1).
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RBr + QCN ----------RCN + QBr (Organic phase)
QBr
N aB r-+  QCN -   - NaCN + QBr (Aqueous phase)
Phase-transfer cata lysis reactions are carried  ou t in  typ ica l cond itions in v o lv in g  b i-  o r 
t r i-  phasic systems, ty p ic a lly  aqueous/apolar solvents. M ild  experim enta l cond itions and 
inexpensive reagents ( fo r  exam ple ino rgan ic  bases such as K 2C O 3, N aO H  and K 3PO 4) 
used in  phase-transfer catalysis, make these reactions appealing fro m  both  an indus tria l 
and an academic research p o in t o f  v iew .
A  com m on class o f  enantiopure phase-transfer cata lyst is represented b y  the quaternary 
am m onium  salts derived fro m  cinchona a lka lo ids. Even though the steric and e lectron ic 
cata lyst properties and th e ir  im p lica tions  on the reaction  enan tiose lec tiv ity  can not be 
generalised, X -ra y  crys ta llog raph ic  studies perfo rm ed on cinchona a lka lo ids deriva tives 
have a llow ed an in  depth know ledge o f  the cata lyst fa m ily .77 W h ile  the ro le  o f  the 
secondary a lcoho l on C -9 p os ition  cou ld  not be generalised, i t  has been established that 
the ro le  o f  the substituent on the quaternary am m on ium  has a central ro le  in  the 
enan tiose lec tiv ity .78"79
These find ings  have triggered the in terest o f  m any research groups, resu lting  in  the 
preparation o f  new cinchona a lka lo ids derived catalysts, ty p ic a lly  N -benzy l and N - 
an tracenylm ethyl deriva tives. W e g ive  an account here o f  ch ira l quaternary am m onium  
salts em ployed under phase-transfer cata lysis cond itions described in  the lite ra tu re  
together w ith  m ost im portan t applications.
2.2 Alkylation o f  a-amino acids
2.2.1 Cinchona alkaloids derivatives
In  1989, O 'D o n n e ll and co-w orkers reported the use o f  N -benzy l c in ch o n in iu m  brom ide  
as a ch ira l phase-transfer cata lyst in  the asym m etric  a lk y la tio n  o f  g ly c in e .80 A  
p re lim in a ry  experim ent was perform ed in  the same cond itions  used p re v io u s ly  fo r  the 
a lk y la tio n  o f  indanone .81'82 A  protected g lyc ine  de riva tive  (2.2, Scheme 1) was reacted
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Figure 1. PTC interfacial mechanism
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in  presence o f  a lly l b rom ide , N -benzy l cinchona cata lyst and N a O H  in  to luene bu t the 
results were d iscourag ing. H ow ever, changing the so lven t to C H 2C I2 and ra is ing  the 
concentra tion  o f  the a lk y la tin g  agent (5.0 eq.) resulted in  a m oderate 6 6 % product ee. 
Ten years la ter C orey et a / .83 and L yg o  and et a / . ,84'85 independently  developed a new 
class o f  cinchona a lka lo id -de rive d  catalysts bearing an N -an th raceny lm e thy l m o ie ty  
(2.1, F igu re  2). C o rey  e t a l  started an in ves tiga tio n  on sca ffo ld  2.1 as part o f  a study 
a im ed at de te rm in ing  the e ffec t o f  c inchon id ine  on the enan tiose lec tiv ity  d isp layed in  
the d ih yd ro xy la tio n  o f  o le fin s .86'91
F ig u re  2. 0 -a lly l-N -(9 -a n th ra ce n y lm e th y l)c in ch o n id in iu m  brom ide
2.1
C orey and co -w orkers evaluated cata lyst 2.1 in  the p ro m o tio n  o f  the asym m etric 
a lky la tio n  o f  tert-b u ty l g lyc ina te . (Scheme l ) .83,92 W hen 2.1 was em ployed as cata lyst 
and CSOH H 2O  was used as base in  C H 2C I2, good to  exce llen t ee were obta ined 
(Scheme 1).
Schem e 1. Enantiose lective  a lky la tio n  under phase-transfer cata lysis cond itions
2.2
RX (5.0 eq.)
2.1 (10 mol%) 
Cs0HH20
CH2CI2 
-78 °C
up to 90% yield 
up to 99% ee
In  2001, L y g o  and co -w orkers84 reported the investiga tion  o f  a range o f  quaternary 
am m on ium  salts bearing a general core structure 2.4 in  the asym m etric a lk y la tio n  o f  
g lyc ine  im in e  esters (F igu re  3 ) / 3’*5’92- '05
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F ig u re  3. General core structure o f  quaternary am m onium  salts
R-|0
N X
2.4
The firs t series o f  quaternary am m on ium  salts investigated (2.6a-e) was characterised 
by  d iffe re n t R 2 substituents. In  order to  com pare the new  catalysts to N -benzy l 
c inchon id ine  b rom ide  and TV-benzyl c inchon ine  brom ide, the salts 2 .6 a-e were prepared 
fro m  the corresponding qu inuc lid ines  via a lk y la tio n  o f  2.5 w ith  benzy l b rom ide  (Tab le  
1).
T a b le  1. V a ria tio n  o f  R 2
PhCHoBr
Rc
N' 'NT Br
¿H toluene, reflux OH + L
Ph
2.5 2.6a-e
e n try p ro d u c t r 2 y ie ld  (% )
1 2 .6 a cyc lo h e xy l 77
2 2 .6 b C H 3O C H 2- 100
3 2 .6 c Ph 78
4 2 .6 d n a p h th - l-y l 89
5 2 .6 e q u in o lin -4  y l 76
The resu lting  salts 2 .6a-e were then em ployed as phase-transfer catalysts in  the 
a lky la tio n  o f  2 .2  w ith  benzy l b rom ide, reaction  that was a lready reported w ith  good to  
exce llen t levels o f  enen tiose lec tiv ity  (Tab le  2 ).80,83,106-107 S ince 2.7 was found  to  be 
sensitive to the co lum n chrom atography, i t  was hydro lysed  to phenyla lan ine te rf-b u ty l 
ester 2 .8  before the p u rifica tio n .
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2.6a-e (10 mol%) ..
50% aq. KOH Vv V
PhCH2Br
Table 2. Asymmetric alkylation of 2.2 catalysed by 2.6a-e
CH2CI2 
25 °C, 24 h
15% aq. citric acid, 
THF
HpN O'Buw
2.2 2.7
Ph
2:8
e n try ca ta ly s t y ie ld  (% ) a (% ) b
1 2 .6 a 64 23
2 - 2 .6 b 66 10
3 2 .6 c 52 48
4 2 .6 d 76 36
5
a j ___  ^ 0 b .
2 .6 e 76 56
I t  was found  that the salts 2.6a-e were good prom oters o f  the a lky la tio n  o f  2.2 w ith in  24 
hours at room  temperature, and in  a ll cases the (/?)-isom er o f  the im in e  2.7 was form ed. 
The h ighest enan tiose lec tiv ity  o f  2.7 (56% ) and y ie ld  o f  2.8 (76% ) were observed w hen 
2.6e was em ployed as cata lyst (Tab le  2, en try  5).
F rom  th is  study i t  was clear tha t a p lanar substituent in  p os ition  R 2 (2.6c-e) is favoured
i
to  a ffo rd  good levels o f  y ie ld  and ee. Subsequently, a va rie ty  o f  R 3-substituents were 
inserted via quatern isa tion o f  the q u in u c lid in e  r in g  (us ing a general pheny l group as R 2 
substituent, Tab le  3).
T a b le  3. V a ria tio n  o f  R 3
Ph
OH
2.9
r 3c h 2x
toluene, reflux
Ph
N X
0 H  \  H 3
2.10a-i
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e n try  p ro d u c t c a ta ly s t R 3 X  y ie ld  (% )
2 PhY  If  x
OH k
3
4
5 '•
6
7
8
9
Ph
N X
OH 4
2 .10a H I 79
2 .10b n -p ro p y l I 27
2 .10c cyc lo h e xy l B r 30
2 .10d 4 -n itrophe ny l B r 69
2 .10e 4-m ethxypheny l C l 69
2 .10 f n a p h th - l-y l C l 60
2 .10g naphth-2 -y l B r 95
2 .10h antracen-9-yl C l 51
2 -10 i Ph B r 75
The resu lting  salts 2 .10a -i were evaluated under op tim ised  cond itions in  the reaction o f  
2.2 w ith  a lly l b rom ide  (Tab le  4).
T a b le  4. A sym m etric  a lky la tio n  o f  2.2 catalysed b y  2.10a-e
2.10a-i (10 mol%) , ,
50% aq. KOH t
PhCH2Br OlBu 15% aq. citric acid,
i2^>2 
25 °C, 24 hCHpClp / ~ \  THF \  OPh
2.2 2.7 2.8
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e n try  c a ta ly s t y ie ld  (% ) a ee ( % )b
1 2 .10a 67 8
2 2 .10b 76 2
3 2 .10c 56 4
4 2 .10d 66 38
5 2 .10e 59 38
6 2 .1 0 f 67 52
7 2 .10g 67 40
8 2 .10h 57 75
9 2 .10 i 73 2
Yield refers to 2.8. ee refers to 2.7.
A  range o f  deriva tives w ith  the in tro d u c tio n  o f  R \-substituents (2.11a-e) was prepared 
via a lky la tio n  o f  the oxygen atom  (using general R 2 and R 3 substituents, Table 5 ) .106
T a b le  5. V a ria tio n  o f  R i
Phy ^ j  b_ _ R , x , c h 2c i2 t p ^  x
OH + I  50%aq, NaOH 0 R,+ L
Ph 1 Ph
2.6c 2.11a-e
e n try p ro d u c t R i X y ie ld  (% )
1 2 .11a c h 3 I 92
2 2 .11b n -B u ty l I 76
3 2 .11c P hC H 2 B r 83
4 2 .11d C H 3O C H 2 B r 82
5 2 .11e P hC H 2O C H 2 B r 94
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The resu lting  salts 2.11a-e were evaluated under op tim ised  cond itions in  the reaction  o f  
2 .2  w ith  benzy l b rom ide  (Tab le  6 ).
T a b le  6. A sym m etric  a lk y la tio n  o f  2.2 catalysed by  2.11a-e
2 .11a-e (10 mol%) 
50% aq. KOH 
PhCH2Br
CH2CI2 
25 °C, 24 h
O'Bu ac*' c‘tr‘c ac'c1,
b THF
HoN OlBu
o
2.2 2.7
Ph
2.8
e n try ca ta ly s t y ie ld  ( % )a ee (% ) b
1 2.11a 59 36
2 2.11b 57 50
3 2 .11c 64 48
4 2 .11d 60 26
5 2 .11e 50 30
A t  th is  stage the authors prepared cata lyst 2.12 possessing the three op tim ised  m oieties, 
hop ing  that the e ffec t o f  the substituents were synerg istic  in  the a lky la tio n  reaction 
(Scheme 2).
Schem e 2. Synthesis o f  2.12
2.13
I t  was found  that in  presence o f  2.12, the a lk y la tio n  o f  2.2 a ffo rded 2.7 in  85% ee and
2.8 in  75%  y ie ld  (Scheme 3).
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Scheme 3. Asymmetric alkylation of 2.2 catalysed by 2.12
2.12 (10 mol%) 
50% aq. KOH 
PhCH2Br
CH2CI2 
25 °C, 24 h
2.2
THF
85% ee
H2N O'Bu 
f t
2.8
75% yield
The h igher levels o f  enena tiose lectiv ity  prom pted L y g o  and co-w orkers to  investigate 
the natural a lka lo ids as d irec t cata lyst precursors. Thus, 2.14 was reacted w ith  
c inchon ine  2.15 and c inchon id ine  2.16 to a ffo rd  quaternary am m onium  salts 2.17 and 
2.18 respective ly (Scheme 4).
Schem e 4. Synthesis o f  2 .17 and 2.18
2.17 and 2.18 were em ployed as catalysts in  the a lky la tio n  reaction o f  2.2 (Scheme 5).
Scheme 5. A sym m etric  a lky la tio n  o f  2.2 catalysed b y  2.17 o r 2.18
Î  / /
(fl)-2.7 
86% ee
2.17 (10 mol%) 
50% aq. KOH 
PhCH2Br
CH2CI2 
25 °C, 24 h
2.2
2.18 (10 mol%) 
50% aq. KOH 
PhCH2Br
CH2CI2 
25 °C, 24 h
(S)-2.7 
91% ee
A s shown in  Scheme 5, the em p loym ent o f  the c ichon ine  derived 2.17 led to  the 
fo rm a tio n  o f  (R)-2.1 whereas the c inchon id ine  derived  2.18 led  to  (S)-2.7 w ith  h igh  
leve ls o f  enan tiose lec tiv ity  in  bo th  cases. Im m ed ia te ly  fo llo w in g  th is  w o rk , L y g o  and
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co-w orkers carried  out a solvent screening fo r  the a lky la tio n  o f  2.2 (Tab le  7) and 
to luene was found  to be the op tim a l solvent, chosen fo r  the lo w e r v o la tile  nature i f  
com pared to  d ich lorom ethane, ie r i-b u ty l m e thy l ether and d ie th y l ether. W ith  optim ised  
reaction cond itions in  th e ir hands, L yg o  and co-w orkers investiga ted the va ria tion  in  the 
nature o f  the e lectroph ile  (Tab le  7).
T a b le  7. V a ria tio n  in  the nature o f  the e lectroph ile
Catalyst (10 mol%) N .
50% aq. KOH > / /
PhCH2X
toluene 
25 °C, 24 h
H2N OlBu 
Qtßu 15% aq. citric acid, d
THF O
Ph
2.2 2.7 2.8
e n try X ca ta ly s t y ie ld  ( % )a ee ( % ) b
1 Cl 2.18 0 -
2 B r 2.17 63 89 (R)
3 B r 2.18 68 9 l ( S )
4
___ - - -  ^~ k
I 2.18 77 89 CS)
Yield refers to 2.8. ee refers to 2.7
In  presence o f  bo th  benzy l b rom ide  and benzy l iod ide , 2.2 was successfu lly a lky la ted  
(Tab le  7, entries 2-4). Fu rthe r experim ents were carried  ou t in  order to  analyse a series 
o f  a lk y l halides w ith  d iffe re n t structures and re a c tiv ity  us ing  2.17 and 2.18 as phase- 
transfer catalysts (Tab le  8 ).84
T a b le  8. V a ria tio n  o f  the e lectroph ile
catalyst (10 mol%) 
50% aq. KOH 
RX
toluene 
25 °C, 24 h
H2N OlBu 
15% aq. citric acid * ^ ^
THF 0
2.2 2.19a-c 2.20a-c
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e n try R X ca ta lys t p ro d u c t y ie ld  ( % )a ee (% )
1 C H 2= C H C H 2B r 2.17 (/?)-2.19a 62 88
2 2.18 (S)-2.19a 76 88
3 C H 2= C (C H 3)C H 2B r 2.18 (S )-2.19b 61 84
4 C H 3I 2.17 Cft)-2.19c 40 86
5 2.18 (5)-2 .19c 41 89
Yield refers to 2.20.
N ext, 2.21 was prepared and evaluated in  the standard a lk y la tio n  reaction (Scheme 6 ). 
Schem e 6. A sym m etric  a lky la tio n  o f  2.2 catalysed b y  2.21
15% aq. citric acid
2.21 (10 mol%) 
50% aq. KOH
CH2CI2 
25 °C, 24 h
THF
2.2 2.7
94% ee
H2N OlBu 
Ph
2.8
2.7 was y ie lded  in  94%  ee w h ich  represents a m arked increase in  ste reose lectiv ity  over 
the previous cata lyst 2.18 (Tab le  7, en try  3). T h is  demonstrated the exce llen t a b ility  o f  
cinchona-derived  quaternary am m on ium  salts as prom oters o f  the phase-transfer 
catalysed asym m etric  a lky la tio n  o f  a -a m in o  acid deriva tives.
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2.2.2 C2-symmetric chiral quaternary ammonium salts
In  1999 M a ruoka  and co-w orkers reported the em p loym ent o f  a b inaphthyl-based 
structure as a ch ira l cata lyst in  the enantiose lective a lk y la tio n  o f  2.2  w ith  benzyl
102-103,108-111brom ide  (Scheme 7).
Schem e 7. A sym m etric  a lky la tio n  o f  2 .2 catalysed b y  2.23c
2.23c (1 mol%) 
50% aq. KOH 
PhCH2Br
toluene
95% yield 
96% ee
The quaternary am m on ium  salts o f  type 2.22 were prepared fro m  com m erc ia lly  
ava ilab le  (S V b inaph to l in  a s ix  step synthesis .102 H ow eve r w hen 1 m o l%  o f  2.22a was 
em ployed in  presence o f  benzy l b rom ide  (1.2 eq.) and 50%  aqueous K O H /to luene  at 0 
°C  fo r  6  hours, lo w  y ie lds and ee were obta ined (34%  and 2 1 %, respective ly). Changing 
the a ry l group o f  the cata lyst to a naphthyl m o ie ty  (2 .22b) resulted in  a s lig h t increase in  
enantiom eric  excess (29% ). These results prom pted M aruoka  and co-w orkers to  design 
a m ore r ig id  structure, such as a ch ira l sp iro  am m on ium  salt 2 .23a w h ich , under the 
same reaction cond itions, fu rn ished  2.7 in  73%  y ie ld  and 19% ee.102 The use o f  2.23c 
increased the y ie ld  (95% ) and product enan tiose lec tiv ity  (9 6 % ).102 W hen m e thy l iod ide  
was em ployed as the a lk y la tin g  agent in  the presence o f  2.23c, the corresponding 
p roduct was obta ined in  90% ee . 102 Furthe r experim ents carried out by  M a ru o ka  and co­
w orkers in vo lve d  the a lk y la tio n  o f  2.2 w ith  benzy l b rom ide  in  the presence o f  2 .23d
81
Chapter 2
(0.05 m o l% ) and 18-crow n-6  2.24 (0.05 m o l% ). The reaction  a ffo rded  (S)-2.7 in  90%  
y ie ld  and 98%  ee (Scheme 8 ).
Schem e 8 . A sym m etric  a lky la tio n  o f  2 .2 catalysed by  2 .23d in  presence o f  18-crow n-6
2.23d (0.05 mol%) =  
2.24 (0.05 mol%) /
50% aq. KOH ^  4
PhCH2B r
toluene 
0 °C, 3 h
N O'Bu
2.2 (Si-2.7
The increased levels o f  enan tiose lec tiv ity  were exp la ined b y  the a b ility  o f  the crow n 
ether 2.24 to extract K O H  in to  the to luene phase accelerating the o therw ise s low
112
deprotonation process (Scheme 9).
Schem e 9. Proposed m echanism  o f  the phase-transfer system in  presence o f  2.24
Ph
c )o o 
,0.
2.24
toluene phase
s O A O A A A A A A A A A A A A A T V A A ^ a n A ^ A ^ r t A ^ n A n ^ A A A A A A A / I ^ A A A A A / W W W W W W W W V W V V V W V A A A A A A /
KOH aq. phase
O
O O
O O
2.24
KOH
?
O. Ì .0.
..J
o ' : "o
Ó,
-HoO 2.2
‘O
C ^  jo : o OH'
vwwwwww
/O'. i ^0,
IK*,' . I OH‘
O '' ! O
The r ig id  con fo rm a tion  o f  2.23a-e represents an im portan t feature fo r  the achievem ent 
o f  h ig h  enan tiose lectiv ity . H ow eve r i t  imposes lim ita tio n s  on the cata lyst design due to
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the requ irem ent o f  tw o  d iffe re n t ch ira l b inaph thy l m oieties. F o r th is  reason, M aruoka  
and co-w orkers developed tw o  new  C 2-sym m etric  ch ira l quaternary am m onium  salts
(2.25 and 2.26) w h ich  incorpora te  an ach ira l a rom atic  subun it (Tab le  9). 
T a b le  9. A sym m etric  a lk y la tio n  o f  2.2 catalysed by  2.25 o r 2.26
113-114
2.25 or 2.26 (1 mol%) . .
50% aq. KOH v  / /
RX >=N 0 ‘Bu
toluene / — \0 °c \  // R °
e n try R X ca ta lys t p ro d u c t y ie ld  (% ) e e (% )
1 P hC H 2B r 2.25a ( R y u 62 64
2 P hC H 2B r 2.25b (/?)-2.7 85 87
3 P hC H 2B r 2.26 (R)-2.7 87 83
4 P hC H 2B r 2.25c (R )-2J 95 92
5 P hC H 2B r 2 .25d (R)-2.7 81 95
C ata lyst 2 .25a was evaluated in  the benzy la tion  o f  2.2, resu lting  in  the fo rm a tio n  o f  (R)- 
2.7 in  62%  y ie ld  and 64%  ee (Tab le  9, en try  1). Based on th is result, ca ta lyst 2 .25b was 
then evaluated, and bo th  y ie ld  and enan tiose lec tiv ity  im proved  to  85% and 87%, 
respective ly  (Tab le  9, en try  2). The same reaction, catalysed b y  2.26 a ffo rded  (R)-2.7 in  
87% y ie ld  and 83% ee (Tab le  9, en try  3). Even w hen 2.25c and 2 .25d  were em ployed in  
the presence o f  d iffe re n t a lk y l halides, the reaction  a ffo rded  the desired adduct w ith  ee 
values h ighe r than 90%  (Tab le  9, entries 4-5 ).
83
Chapter 2
In  2004, M aruoka  and co -w orkers designed and reported nove l ch ira l phase-transfer 
catalysts based on p o ly  am ine structure. T h e ir e ffic ie n cy  was evaluated in  the benchm ark 
reaction w ith  benzy l b rom ide  (Tab le  10) .115
T a b le  10. A sym m etric  a lk y la tio n  o f  2.2 cata lysed.by 2.27a o r 2 .27b
e n try  c a ta ly s t y ie ld  (% ) ee (% )
1 2.27a 76 63 (S)
2 2.27b  65 95 (R)
The in troduc tion  o f  3 ,4 ,5 -tr iflu o ro p h e n y l m o ie ty  at 3 ,3 ’ -pos ition  (2 .27b) resulted in  an 
exce llen t asym m etric in d u c tio n  (Tab le  10, en try  2). T w o  d iffe re n t C2-sym m etric  phase- 
transfer catalysts were synthesised and evaluated (Tab le  11).
T a b le  11. A sym m etric  a lk y la tio n  o f  2.2 catalysed b y  2.28a or 2 .28b
2.28 (1 mol%) 
50% aq. KOH 
PhCH2Br
toluene 
0 °C
2.2 (S)-2.7
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e n try ca ta ly s t y ie ld  (% ) ee (% )
2.28a
2.28b
94
96
65 (S) 
94 (S)
The em ploym ent o f  ca ta lyst 2 .28b  resulted in  the fo rm a tio n  o f  (S)-2.7 in  exce llen t y ie ld  
and ee (Tab le  11, en try  2). F in a lly , cata lyst 2.29 was prepared (Table 12) and exh ib ited  
a h igh  ca ta ly tic  perform ance, be ing capable o f  p ro m o tin g  the asym m etric a lky la tio n  o f
2.2 w ith  benzy l b rom ide  in  exce llen t ee (up to 97%  at 0.1-0.01 m o l%  load ing ) . 116
T a b le  12. A sym m etric  a lk y la tio n  o f  2.2 catalysed b y  2.29
2.2
2.29 (0.01-1 mol%) 
50% aq. KOH 
PhCH2Br
toluene 
25 °C
= N  0*Bu
e n try lo a d in g  (% ) y ie ld  (% ) ee (% )
1 1 97 97 ÇR)
2 0.1 96 97 (R)
3 0.01 95 96 (R)
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2.2.3 Other chiral phase-transfer catalyst fo r  the alkylation o f  glycine Shiff 
base
In  the past decade tartra te-derived am m on ium  salts cata lysts117' 123 (F igure  4) and other 
cata lysts122,124"129 have been em ployed in  the p ro m o tio n  o f  the asym m etric a lky la tio n  o f122,124-129
2.2. I t  was found  that the change o f  the counterion  had a s ig n ifica n t e ffec t on the 
reaction stereochem ical outcom e.
Shibasaki and co-w orkers reported that the a lk y la tio n  o f  2.2 in  presence o f  2 .30b 
a fforded the desired 2.7 w ith  a h ighe r enantiom eric  excess com pared to  the cata lyst 
w h ich  bears an iod ine  counterion  (2 .30a ).118,123
F ig u re  4. Tartra te -derived  am m on ium  salts catalysts
Me / — 4-MeO-C6H4
determ ine w hether the counterion  had an im po rtan t o r o n ly  m arg ina l e ffec t on the
by L y g o 79’85’93-94’96-97’126 were evaluated in  the a lky la tio n  o f  2.2  w ith  benzyl b rom ide  
(Table 13).
T a b le  13. A sym m etric  a lky la tio n  o f  2 .2 catalysed b y  2.1 o r 2.18
Me/ 4-MeO-C6H4
2.30a (X = I) 
2.30b (X = BF4)
The counterion e ffec t was also investiga ted b y  N ajera  and co-w orkers. 1 18,123,130-132
enantiose lectiv ity , the tw o  catalysts 2.1 developed b y  C orey83,92,100 and 2.18 developed
m ;o
catalyst 
PhCH2Br 
OlBu conditions
O
Oteu
2.2 (S)-2.7
8 6
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2.1 2.18
e n try  c a ta ly s t c o n d it io n s 3 y ie ld  (% )  ee (% )
1 2.1 B 86 93
2 2.1 B b 93 95
3 2.18 A 70 91
4 2.18 B 50 91
5 2.18 B b 73 90
a Conditions A: 10 mol% cat., 50% aq. KOH, toluene, 25 °C; Conditions B: 5 mol% cat., 50% aq. KOH, 
toluene/CHCl3 7:3, 25 °C. bThe reaction was performed at 0 °C.
The highest p roduct ee (93% ) was achieved using 2.1 a cata lyst under cond itions B 
(Table 13, en try  1) and th is  value was fu rth e rly  increased p e rfo rm ing  the reaction at 0 
°C  (Table 13, entry 2). The use o f  the m ix tu re  to luene /C H C l3 was found to  be 
p a rticu la rly  e ffic ie n t, a ffo rd in g  the h ighest enan tiose lec tiv ity  using c in ch o n id in iu m  salts 
as cata lysts .133 Once the reaction cond itions were op tim ised  (cond ition  B at 0 °C ), the 
next step became the investiga tion  o f  the in fluence  o f  the cata lyst counterion  on the 
ove ra ll enantiose lectiv ity . F o r th is  purpose a c inchon ine -derived  series was also tested 
(Tab le  14).
T a b le  14. A sym m etric  a lky la tio n  o f  2.2 catalysed by  2.1, 2.18, 2.31 and 2.17
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e n try ca ta ly s t p ro d u c t y ie ld  (% ) ee (% )
1 2.1 (S)-2.7 93 95
2 2 .1a (S>2.7 83 96
3 2 .1b ( s y i . i 84 96
4 2.18 (S)-2.7 73 90
5 2.18a ( s y u 80 94
6 2.18b ( s y u 60 95
7 2.31a (R ) -2.7 86 92
8 2.31b (/?)-2.7 75 92
9 2.31b ( R ) - U 73 95
10 2.17 ( R y u 94 93
11 2.17a ( R ) - U 94 98
12 2.17b ( R y u 93 94
A l l  the experim ents perform ed resulted in  exce llen t levels o f  enan tiose lec tiv ity  (>90%  
ee). The h ighest enan tiose lec tiv ity  was obta ined w hen 2.17a was em ployed as cata lyst 
(Tab le  14, en try  11).
8 8
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2 . 2 . 4 A p p l i c a t i o n  t o  t h e  a s y m m e t r i c  s y n t h e s i s  o f  ( X - a m i n o  a c i d s
The asymmetric phase-transfer alkylation of 2.2 has been largely exploited for its 
aplication in the synthesis of amino acid derivatives and natural products. The most 
significant examples are depicted in Figure 5 108-109’134' 137
Figure 5. Amino acid derivatives
f-BuO
BocHISL XCV-Bu
V
Br
CCV-Bu
\
Ac
2.32
Imperiali
83% yield 
96% ee
2.33
Lygo
75% yield 
94% ee
2.34
Maruoka
94% yield 
99% ee
Oh2n,_XOf-Bu
OH
,vC02f-Bu
NH
Ph
C=N
Ph
18
Oi-Bu
X x ,OMe
2.35
Maruoka
2.40a R = OH 94% yield, 98% ee 
2.40b R = H 94% yield, 98% ee
2.36
Maruoka
82% yield, 98% ee
2.37
Lemaire
90% yield, 96% ee
2.3 Asymmetric synthesis of a, a-dialkyl- a-amino acids
a,a-Dialkyl-a-amino acids138"141 have been found to be powerful enzyme inhibitors, 
therefore their enantioselective synthesis has been intensively investigated. 142 In this 
regard, phase-transfer catalysis has represented an important approach in the 
development of methods for their preparation. For example, aldimine derivative 2.38 
(easily prepared from glycine) has been employed as substrate for the preparation of 
a,a-dialkyl-a-amino acids by sequential adition of diferent alkylating agents in the 
presence of catalyst (S,S)-2.23e (Scheme 10) . 103
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Scheme 10. Preparation of a,a-dialkyl-a-amino acids 2.40a-b by sequential adition of 
diferent alkylating agents
Cl.
-Of-Bu
1) (S,5)-2.23e (1 mol%)^  H2N ^ X
Of-Bu
O
2.39
Method A 
or
Method B 
Cs0H H20, toluene
2) Hydrolysis
r
-c Ph 2.40-
Method A:
2.40a (fl) 80% yield, 98% ee
Method B:
2.40b (S) 74% yield, 92% ee
Method A: 1- Allyl bromide 
2- Benzyl bromide
Method B: 1- Benzyl bromide 
2- Allyl bromide
Interestingly, the order of adition of the alkylating agents was found to be crucial for 
the absolute configuration of 2.40. When alyl bromide was employed as the first 
electrophile (Method A), the Æ-enantiomer was obtained. In contrast when benzyl 
bromide was used as the first (Method B), the S-enantiomer of 2.40 was recovered. This 
method was aplied to the asymmetric alkylation of a diversity of aldimines 2.41 a-d 
(Figure 6 ) .103
Figure 6 . Aldimines range
\= N  Of-Bu
R O
2.41a R = PhCH2 2.41b R = Me 
2.41c R = /-Bu 2.41 d R = Ph
143A procedure for the synthesis of a-alkyl serine derivatives was reported by Jew et ai 
The asymmetric alkylation of phenyl oxazoline derivatives 2.42 in the presence of 
catalyst 2.23e resulted in the formation of 2.43 in 98% yield and >99% ee (Scheme 11).
Scheme 11. Preparation of 2.43 catalysed by 2.23e
O'
2.42
C02f-Bu 1) (S,S)-2.23e (2.5 mol%) 
RX 
KOH
_____ toluene, 0 °C
2) 6N HCI, EtOH, reflux
H2N
HO
^COOH
>
2.43 R = PhCH2Br 
98% yield, >99% ee
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A variety of asymmetric methodologies for the alkylation of p-keto esters under phase- 
transfer conditions have been developed in the last decade. Dehmlow and co-workers 
reported the benzylation of P-keto ester 2.44 in presence of catalyst 2.45, which 
aforded 2.46 in excelent yield and moderate ee (Scheme 12) . 144
Scheme 12. Preparation of 2.46 catalysed by 2.45
2 . 4  A l k y l a t i o n  o f  p - k e t o  e s t e r s
Maruoka reported the employment of 2.23f in the reaction of 2.47 with a variety of 
alkylating agents, obtaining excelent levels of enantioselectivity of 2.48a’, 2.48a” , 
2.48b (Scheme 13).145'146
Scheme 13. Preparation of 2.48a\ 2.48a” , 2.48b catalysed by 2.23f
2.23f (5 mol%) 
O RBr
xx^ccy-Bu CsOHH2Q
toluene 
-50 °C
2.47 (n = 1)
2.47a (n = 2)
O
2t-
— 0 R wn
Bu
2 48a (n = 1) 2-48a' R = PhCH2 94% yield, 97% ee
2.48b (n = 2) 2.48a" R = PhCH=CHCH2 80% yield, 92% ee 
2.48b R = PhCH2 88% yield, 92% ee
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In 1975 Wynberg and Helder reported an example of asymmetric Michael adition of 
nucleophiles to enones with the employment of cinchona-alkaloids catalysts. They 
demonstrated that the quinine-catalysed adition of several Michael donors to methyl 
vinyl ketone 2.50 aforded opticaly active products proceding asymetricaly. 147' 148 
Later, Hermann and Wynberg reported the adition of 2-carboxymethoxy indanone 2.49 
to 2.50 with the employment of I mol% of quinine (2.52) or quinidine (2.53) resulted in 
the formation of the Michael aduct 2.51 (Table 15).147,149
Table 15. Preparation of 2.51 catalysed by 2.52 or 2.53
o
2 . 5  P h a s e - t r a n s f e r  c a t a l y s i s :  a s y m m e t r i c  M i c h a e l  a d d i t i o n  r e a c t i o n
entry catalyst product yield (% ) ee (% )
1 2.52 (S)-2.51 99 76
2 2.52 (S)-2.51 98 60
3 2.53 (Æ)-2.51 quant. 69
Another interesting example is the one involving indanone (2.54) in the reaction with 
2.50 in the presence of cinchona-derived 2.55 and 2.56. This resulted in the formation 
of 2.57 in high yields and ee (Scheme 14).150
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Scheme 14. P re p a ra tio n  o f  2.57 c a ta ly se d  b y  2.55 or 2.56
2.57: 95% yield, 80% ee 
2.57: 93% yield, 52% ee
The high enantioselective Michael adition of 2-carboxycyclopentanones to enones or 
enals has been reported by Maruoka with the employment of 2.23f as a catalyst 
(Scheme 15).145
Scheme 15. Preparation of 2.60 catalysed by 2.23f
0
2.58 R = 9-fluorenyl
Corey and co-workers employed the quaternary ammonium salt 2.21 in the Michael 
adition of acetophenone 2.62 to 4-methoxychalcone 2.61. This resulted in the
formation of the Michael aduct 2.63 in 72% yield and 80% ee (Scheme 16)151
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Scheme 16. P re p a ratio n  o f  2.63 c a ta ly se d  b y  2.21
H.CO 2.61
The asymmetric adition of nitroalkanes to 4-nitro-5-styrylisoxazoles with the 
employment of cinchona-d&nved catalysts was developed by Adamo and co-workers
t ^ 7(Scheme 17) afording excelent levels of enantioselectivity.
Scheme 17. Asymmetric adition of nitroalkanes to 4-nitro-5-styrylisoxazoles
80% yield 
97% ee
2.6 Aldol reaction
A highly enantioselective aldol reaction involving 2.2 with a range of aliphatic 
aldehydes under phase-transfer conditions employing N-spiro chiral quaternary 
ammonium salt 2.23g, has been reported for the synthesis of opticaly active anti-P- 
hydroxy-a-amino esters 2.67a-e (Table 16).153-154
Table 16. Preparation of 2.67a-e catalysed by 2.23g
o
1) ecl‘
2.23g (2 mol%) 
1% NaOH aq. 
NH4CI {10 mol%) 
toluene, 0 °C
2) 1N HCI
PH
R— ( OlBu
HoN O
2.2 2.67a-e
9 4
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CF3
, R ’
U 1 \ ¡1 fS CF3
Q
N+ T II /=- 1
s Br 
R ' M l
" c f 3FgC
2.23g
entry R product yield (%) ee (%)
1 Ph(CH2)2 2.67a 82 98
2 CH3(CH2)4 2.67b 79 97
3 /-Pr3SiOCH2 2.67c 73 98
4 ch3 2.67d 54 99
5 Cy 2.67e 53 98
2.7 Mannich reaction
Over the last decade, several highly enantioselective Mannich and aza-Mannich 
reactions with the employment of a-amido sulfones catalysed by N-benzyl quininium 
chloride 2.68 have been reported in literature (Figure 7) .155
Figure 7. N-benzyl quininium chloride
For example, Rici and co-workers reported the Mannich reaction of a-amido sulfones 
2.69a-d with £/s’-(4-methoxyphenyl) malonate 2.70 under phase-transfer conditions 
catalysed by 2.72 (Table 17).156
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Table 17. S y n th e s is  o f  2.71a-d c a ta ly se d  b y  2.72
NHCbz
R^SOjp-Tol
O
( T " O A r
2.72 (1 mol%) 
K2C03
toluene 
-20 °C, 48 h
2.69a-d
(Ar = 4-MeO-C6H4) 
2.70
entry R product yield (%) ee (%)
1 Ph 2.71a 81 98
2 p-MeO-CétLi 2.71b 85 98
3 ch3 2.71c 93 86
4 c-Hex 2.71d 80 80
This protocol resulted in the formation of 2.71a-d in as high as 93% product ee.
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2.8 Results and discussion
3-methyl-4-nitro-5-styrylisoxazole (2.64) has demonstrated an excelent ability as 
Michael aceptor in the reaction with enolisable pronucleophiles (e.g. acetylacetone, 
ethyl acetoacetate and acetone) 157"160 and thiols, 161 alowing the generation of a variety 
of Michael aducts (Scheme 18).
Scheme 18. General reactivity of 2.64: 1,4 conjugate adition
nucleophile
base
solvent
The use of 2.64 as Michael aceptor is not limited to the aforementioned
pronucleophiles, since also iV-nucleophiles have been found to be amenable substrates
1 f\0for the nucleophilic aditions to 2.64 by previous members of the group. For
i zqexample, l/-benzotriazole 2.73 has been found to be an excelent nucleophile, 
posesing interesting biological properties (benzotriazole containing molecules have
been demonstrated to display antiemetic and gastroprokinetic features, 
19).162
164 Scheme
Scheme 19. Synthesis of 2.74 and 2.75 using 2.73 as nucleophile
2.73 (5.0 eq.) 
DMAP (5.0 eq.)
CH3CN #  r.t., 24 h
2.64 2.74 (73% yield)
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As shown in Scheme 19, the reaction between styrylisoxazole 2.64 and benzotriazole 
2.76 aforded the desired product as a mixture of two diastereoisomer (dr 9:1). 
Unfortunately, when diferent N-nucleophiles such as imidazole, piperidine, 1,2,3,4- 
tetrahydroquinoline and 2-methylindoline were employed, no Michael adition product 
was observed, except in the case of indoline 2.76 which aforded Michael aduct 2.77 in 
89% yield in presence of DMAP in CH2CI2162 (Scheme 20).
Scheme 20. Synthesis of 2.77 using 2.76 as nucleophile
2.64 2.77 (89% yield)
The organocatalytic version of the aza-Michael reaction has been widely explored, even 
though it was only 2006 when MacMillan reported the first organocatalysed aza- 
Michael reaction using TV-silyloxycarbamates as nucleophiles in the adition to a,p- 
unsaturated aldehydes. 165 Over the past. 5 years several examples of aza-Michael 
reaction, using N-heterocycles, 163,166 hydrazones, 167 amino benzaldehydes168 and 0- 
benzylhydroxylamine169 as nucleophiles have been reported.
In 2009 our group reported the enantioselective adition of nitroalkanes to 4-nitro-5-
* I S')styrylisoxazoles in combination with cinchona-alkaloid derived catalysts which 
aforded high levels of enantioselectivity. Inspired by these findings we started an 
investigation aimed at identifying a protocol for the adition of /-nucleophiles (e.g. 
2.73) to 2.64 under phase-transfer catalysis conditions. Preliminary experiments to test 
the reactivity of 2.73 with 2.64 under these conditions were performed in presence of 
solid K2CO3 (5.0 eq.) and TV-benzyl cinchonidinium bromide 2.78 (5 mol%) in toluene 
(0.05 M) at room temperature. After 24 h 2.74 was produced in 25% and 15% ee 
(Scheme 21, determined by CSP-HPLC).
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Scheme 21. S y n th e s is  o f  2.74 ca ta ly se d  b y  2.78
NOs 2.73 (5.0 eq.) 
K2C03 (5.0 eq.) 
2.78 (5 mol%)
N 0 2
toluene (0.05 M) 
r.t., 24 h
2.64 2.74
25% yield 
15% ee
The reaction between 2.64 and l/-benzotriazole 2.73 was chosen as a model for the 
reaction conditions development, screning of catalysts (quaternary ammonium salts 
derived from cinchona alkaloids), bases and suitable organic solvents. The four 
catalysts chosen for the first screning were the thre commercially available N-benzyl 
cinchonidinium bromide 2.78, 7V-benzyl quininium chloride 2.68 and /-benzyl 
cinchoninium chloride 2.79 whereas N-benzyl quinidinium bromide 2.80 was 
synthesised in our laboratory (Figure 8).
A screning study of reaction conditions for the reaction of 2.64 with 2,73 (5 eq.) was 
performed. Each of the four phase-transfer catalysts was tested with a range of nine 
inorganic bases (5.0 eq.) in both CH2CI2 and toluene (0.03 M), while the reaction in 
Et2 0 led to inconsistent and non reproducible results due to its volatile nature.
Figure 8 . Quaternary ammonium salts derived from cinchona alkaloids
2.78 2.68
OCH3
2.79 2.80
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Table 18. Evaluation of a range of bases in the adition of lH-benzotriazole 2.73 to
2.64 catalysed by 2.78 in CH2CI2
2.73 (5.0 eq.) 
2.78 (5 mol%)
base (5.0 eq.) 
CH2C)2 (0.03 M) 
r.t., 48 h
2.64 2.74
entry base conversion (%) ee (%)a,c ee (%)b,c
1 K2CO3 27 0 0
2 K2CO3 50% w/v 36 6 0
3 K3PO4 - - -
4 K3PO4 50% w/v 23 0 6
5 NaOH - - -
6 NaOH 50% w/v - - -
7 Cs2C03 - - -
8 CS2CO3 50% w/v 41 4 4
9 NaHC03 12 7 10
a ee refers to 2.74.b ee refers to 2.75.c Determined by CSP-HPLC.
1 0 0
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Al the reactions shown in Table 18 were performed in CH2CI2 with the employment of 
a range of inorganic bases and 2.78 as cinchona alkaloid catalyst. When K2CO3 solid 
was used, the desired products were yielded in low conversion (27%) and no 
enantiomeric exces was observed (Table 18, entry 1). The employment of K2CO3 and 
K3PO4 both 50% w/v led to the product in low yields and ee values (Table 18, entries 2 
and 4). The best conversion was obtained when CS2CO3 50% w/v was used but 
unfortunately stil low ee values were observed (Table 18, entry 8). The employment of 
NaOH both solid and 50% w/v, K3PO4 solid and Cs2C03 solid did not result in the 
product formation since only the starting material was recovered (Table 18, entries 3, 4- 
6).
Next, a screning study was caried out with the employment of 2.68 as catalyst in 
CH2CI2 (Table 19).
Table 19. Evaluation of a range of bases in the adition of l/-benzotriazole 2.73 to
2.64 catalysed by 2.68 in CH2Cl2
2.73 (5.0 eq.) 
2.68 (5 mol%)
base (5.0 eq.) 
CH2CI2 (0.03 M) 
r.t., 48 h
2.64 2.74
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entry base cron version (%) ee (%)a’c ee (%)b’c
1 K2CO3 - - -
2 K2CO3 50% w/v 31 0 4
3 K3PO4 - - -
4 K3P0 4 50% w/v 18 10 8
5 NaOH 21 6 8
6 NaOH 50% w/v - - -
7 CS2CO3 - - -
8 Cs2C03 50% w/v 38 8 8
9
a __
NaHC03 
b_~ mi­ 45C ■ 11 Tim ^ 8 6a ee refers to 2.74.b ee refers to 2.75.c Determined by CSP-HPLC.
As it is reported in Table 19, even though beter conversions than Table 18 were 
observed (Table 19, entry 9), stil low ee values were obtained. Beter results were 
achieved when K3PO4 50% w/v was employed. However the products obtained were 
characterised by low ee values (Table 19, entry 4).
Further reactions were then tested in presence of cinchona alkaloid catalyst 2.79 in 
CH2CI2 (Table 2 0).
Table 20. Evaluation of a range of bases in the adition of l/-benzotriazole 2.73 to
2.64 catalysed by 2.79 in CH2CI2
2.73 (5.0 eq.) 
2.79 (5 mol%)
base (5.0 eq.) 
CH2CI2 (0.03 M) 
r.t., 48 h
2.64 2.74
1 0 2
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entry base conversion (%) ee  (%)a’c ee (%)b’c
1 k2co3 15 6 5
2 K2CO3 50% w /v 21 1 0
3 K3PO4 - - -
4 K3P04 50% w /v 14 4 4
5 NaOH - -  . -
6 NaOH 50% w /v - - -
7 Cs2C03 - - -
8 Cs2C03 50% w /v 2 0 6 3
9
a r
NaHC03 19
C 1-^  . 11 y-in-n T TP.T jr~.
. 0 2
a ee refers to 2 .7 4 .b ee refers to 2 .7 5 .c Determined by CSP-HPLC.
The employment of the commercially available 2.79 did not lead to more encouraging 
results since low conversion and ee values were observed (Table 20, entries 1-2, 4, 8-9). 
The employment of NaOH both solid and 50% w/v, K3PO4 solid and CS2CO3 solid did 
not result in the product formation since only the starting material was recovered (Table 
20, entries 3, 5-7).
The best results was achieved when K2CO3 was used even though stil discouraging 
(Table 20, entry 1).
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Next, cinchona alkaloid catalyst 2.80 was synthesised in order to evaluate the 
posibility to act as a suitable catalyst in the adition of l/-benzotriazole 2.73 to 2.64 
(Table 21).
Table 21. Evaluation of a range of bases in the adition of 1/i-benzotriazole 2.73 to
2.64 catalysed by 2.80 in CH2CI2
2.73 (5.0 eq.) 
2.80 (5 mol%)
base (5.0 eq.) 
CH2CI2 (0.03 M) 
r.t., 48 h
2.64
entry base conversion (%) ee (%)a,c ee (%)b,c
1 K2CO3 - - -
2 K2CO3 50% w/v , 19 4 5
3 K3PO4 - - -
4 K3PO4 50% w/v - - -
5 NaOH 13 4 0
6 NaOH 50% w/v - - -
7 Cs2C03 - -
8 CS2CO3 50% w/v 18 3 4
9 NaHC03 13 5 0
a ee refers to 2.74.b ee refers to 2.75.c Determined by CSP-HPLC.
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Unfortunately, the employment of 2.80 did not result in beter conversion or ee values. 
When K2CO3 was used as inorganic base the reaction did not aford the desired product 
since the styrylisoxazole 2.64 was recovered as the only product (Table 21, entry 1). 
Even the employment of K3PO4 (solid and 50% w/v) did not lead to 2:74 or 2.75 since 
the starting material was recovered unreacted (Table 21, entries 3 and 4). While the use 
of NaOH solid aforded the target products even if in low conversion and no 
enantiomeric exces (Table 21, entry 5), the employment of NaOH 50% w/v did not 
yield the desired products (Table 21, entry 6). Even the use of CS2CO3 solid did not 
result in the product formation since only the starting material was recovered (Table 21, 
entries 7).
In presence of NaOH solid and NaHC0 3 both 2.74 and 2.75 were obtained with low ee 
values for 2.74 and no enantiomeric exces for 2.75 (Table 21, entries 5 and 9).
Next, in order to test the ability of l/-benzotriazole 2.73 to react with 2.64 in an 
enantioselective manner, a diferent solvent such as toluene was used (Tables 2-25).
Table 22. Evaluation of a range of bases in the adition of l/-benzotriazole 2.73 to
2.64 catalysed by 2.78 in toluene
2.73 (5.0 eq.) 
2.78 (5 mol%)
base (5.0 eq.) 
toluene (0.03 M) 
r.t., 48 h
2.64 2.74
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entry base conversion (%) ee (%)a’c ee (%)b’c
1 K2CO3 12d 24 -
2 K2CO3 50% w /v 40d,e 29 -
3 K3PO4 ld 18 -
4 K3PO4 50% w /v 12d 10 -
5 NaOH 14d 15 -
6 NaOH 50% w /v - - -
‘7 Cs2C03 - - -
8 Cs2C03 50% w /v - - -
9
a . n___
NaHC03
_  ~ b __ .
30
C T v 1 1 i . m  ^
0
d ^ ~ ~ * ■ , , ,
0
e • 1 * . /-ia ee refers to 2.74. b ee refers to 2.75.c Determ ined by CSP-HPLC. d Only 2.74 y ie ld ed .e Carried out at 0 
°C, 170 h.
Interesting results were obtained when the reaction was performed in presence of 
K2CO3 (solid and 50% w/v) or K3PO4 (solid and 50% w/v) as bases, toluene as solvent 
and 2.78 as catalyst, where inded only one isomer (2.74) was formed (Table 2, entries
1-5).
When K2CO3 50% w/v was used the reaction aforded 2.74 in 40% conversion even 
though it was caried out at 0 °C (Table 2, entry 2).
The employment of NaOH (solid and 50% w/v) and Cs2C0 3 (solid and 50% w/v) did 
not result in the products formation (Table 2, entries 6-8). When NaHC03 was used as 
base, low conversion and no enantiomeric exces were observed (Table 2, entry 9).
Next, the commercially available cinchona alkaloid catalyst 2.68 in toluene in presence 
of a range of inorganic bases was used (Table 23).
1 0 6
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Table 23. Evaluation of a range of bases in the adition of l/-benzotriazole 2.73 to
2.64 catalysed by 2.68 in toluene
2.73 (5.0 eq.) 
2.68 (5 mol%)
base (5.0 eq.) 
toluene (0.03 M) 
r.t., 48 h
2.64 2.74
entry base conversion (%) ee.(%)a,c ee (%)b,c
1 k2co3 - - -
2 K2C03 50% w/v 21 0 0
3 K3PO4 - - -
4 K3PO4 50% w/v 15 1 0
5 NaOH - - -
6 NaOH 50% w/v - - -
7 CS2CO3 - - -
8 Cs2C03 50% w/v 17 1 1
9 NaHC03 17 11 3
ee refersTto 2 .7 4 .b ee refers to 2 .7 5 .c Determ ined by CSP-HPLC.
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The employment of 2.68 as cinchona alkaloid catalyst did not lead to encouraging 
results since the products were recovered in low conversion and ee values. When K2CO3 
50% w/v was used the reaction aforded the product in 21% of conversion but no 
enantiomeric exces was obtained (Table 23, entry 2). In presence of K3PO4 50% w/v, 
CS2CO3 50% w/v or NaHC03 as inorganic bases, low product conversion and no ee 
values were yielded (Table 23, entries-4, 8-9).
When K2CO3 solid, K3PO4 solid, NaOH (solid and 50% w/v) and CS2CO3 solid were 
used, the reaction did not aford the desired product as the starting material was 
recovered unreacted (Table 23, entries 1, 3, 5-7).
Next, the employment of the cinchona alkaloid catalyst 2.79 in toluene was evaluated in 
the adition of ltf-benzotriazole 2.73 to 2.64 (Table 24).
Table 24. Evaluation of a range of bases in the adition of l/-benzotriazole 2.73 to
2.64 catalysed by 2.79 in toluene
no2
base (5.0 eq.) 
toluene (0.03 M) 
r.t., 48 h
2.73 (5.0 eq.) 
2.79 (5 mol%)
2.64 2.74 2.75
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entry base conversion (%) ee (%)a’c ee (%)b’c
1 K2CO3 - - -
2 K2CO3 50% w/v 13d 5 -
3 K3PO4 ~ - -
4 K3PO4 50% w/v lld 6 -
5 NaOH - - -
6 NaOH 50% w/v - - -
7 Cs2C 0 3 - - -
8 Cs2C0 3  50% w/v 10d 15 -
9
a r
NaHC03
~ ~ * b r- < * re­
13
C T 'v  ______* ______1 l ___ i ^ n r i  T T H T  y n
13
d  ~  1 ~  __! J  _ j
5
a ee refers to 2.74. b ee refers to 2.75.c Determined by CSP-HPLC. d Only 2.74 yielded.
The same interesting result of Table 22 was yielded when K2CO3 50% w/v, K3PO4 50% 
w/v and CS2CO3 50% w/v where only 2.74 was formed (Table 24, entries 2, 4 and 8). 
With the employment of NaHCC>3 the reaction aforded the desired product even though 
with discouraging results since low conversion (13%) and ee values (13% 2.74 and 3% 
2.75) were observed (Table 24, entry 9).
When K2C0 3 solid, K3P0 4 solid, NaOH (solid and 50% w/v) and CS2CO3 solid were 
used, the reaction did not aford the desired product as the starting material was 
recovered unreacted (Table 24, entries 1, 3, 5-7).
In order to test more reaction conditions, cinchona alkaloid catalyst 2.80 in toluene was 
employed. Once again, a range of inorganic bases was tested (Table 25).
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Table 25. Evaluation of a range of bases in the adition of l/-benzotriazole 2.73 to
2.64 catalysed by 2.80 in toluene
2.73 (5.0 eq.) 
2.80 (5 mol%)
base (5.0 eq.) 
toluene (0.03 M) 
r.t., 48 h
2.64 2.74 2.75
entry base conversion (% ) ee (%)a,c ee (%)b,c
1 k2co3 - - -
2 K2C03 50% w/v 14 6 2
3 K3PO4 - - -
4 K3PO4 50% w/v 12 5 4
5 NaOH - • -
6 NaOH 50% w/v - -
7 CS2CO3 15 0 0
8 Cs2C03 50% w/v 10 5 2
9 NaHC03 15 6 5
a ee refers to 2.74.b ee refers to 2.75.c Determined by CSP-HPLC.
110
C h a p t e r  2
As shown in Table 21, when cinchona alkaloid catalyst was employed, the reaction did 
not lead to sucesful results.
When K2C 0 3 solid, K3PO4 solid and NaOH (solid and 50% w/v) were used, the reaction 
did not aford the desired product as the starting material was recovered unreacted 
(Table 25, entries 1, 3, 5-6).
When the reaction was caried out in presence of K2CO3 50% w/v, K3PO4 50% w/v, 
CS2CO3 (solid and 50% w/v) or NaHCCh, the desired products 2.74 and 2.75 were 
obtained even though in low conversion and ee values (Table 25, entries 2, 4, 7-9).
Throughout the reaction conditions screning, a general low conversion of 2.64 was 
observed. Higher conversions of 2.64 to 2.74 were detected when CH2CI2 was used as 
solvent (Table 18, entry 8, and Table 19, entries 8 and 9). However the products 
obtained were characterised by a low enantiomeric exces. The best result was aforded 
when the reaction was performed in presence of K2C0 3 solid and 2.78 in toluene at 
room temperature (12% conversion and 24% ee) (Table 2, entry 1).
Having identified K2CO3, 2.78 and toluene as the most suitable combination of base, 
catalyst and solvent, we performed the same reaction lowering the temperature to 0 °C. 
After 170 hours the reaction exhibited a 40% conversion with a slight increase in ee 
(29%) for 2.74 (Table 2, entry 2).
2.8.1 Quaternary ammonium salts
The role of the quaternary ammonium salt instaled on the quinuclidine ring has been 
extensively investigated by Palomo and co-workers. 170 In the computational study, in 
order to optimise computational times, the bulky catalyst N-benzyl quininium chloride 
2 .6 8  was replaced by the hydroxyethyl trimethyl ammonium cation 2.81 while 
nitromethane 2.82 (and its deprotonated form 2.83) and /V-methoxycarbonyl imine 2.84 
were employed as the nitro source (Figure 9).
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Figure 9. H y d ro g e n  b o n d in g  so u rces
/—\ ,M e
CH3n0 2 + P= N \ 'OHO N+ Me Me OMe
2.81 2.82 2.83 2.84
The preliminary study served to identify the interactions between 2.83 and 2.84 and two 
sites with H-bonding donor capability in 2.68 and 2.81: OH and N+ (Figure 10) . 171
Figure 10. Hydrogen bonding complexes 2.81:2.82, 2.81:2.83 and 2.81:2.84
Calculations revealed a hydrogen bonding stabilisation energy of 5.0 kcal/mol for the 
complex 2.81:2.82, 10.0 kcal/mol for 2.81:2.83, 6 .8 kcal/mol for 2.84 (nitrogen 
atom):2.81 and 4.4 kcal/mol for 2.84 (oxygen atom):2.81. From these data it is 
reasonable to propose that the deprotonation of nitromethane in presence of a fre 
hydroxyl group on the catalyst is favoured as a stronger hydrogen bonding interaction is 
formed with 2.83 (10.0 kcal/mol). The distance between 2.81 and 2.83 (or 2.84) was 
found to be crucial to maximise the interaction. The O-H O2N length is 1.9 A in the 
case of 2.81:2.82, and 1.7 A in the case of 2.81:2.83, and the N+ "0 2N distances 
between 2.81:2.83 are shorter than in 2.81:2.82.
Bearing al these data in mind, several cinchona alkaloid-derived quaternary ammonium 
salt catalysts were employed in the conversion of 2.64 to 2.74. Fre and protected C-9 
catalysts of the cinchonidine and quinidine series were evaluated (Figure 1).
1.9,
2.81:2.82 2.81:2.83 2.81:2.84
1 1 2
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Figure 11. C i n c h o n a  a lk a lo id -d e r iv e d  q u ate rn a ry  a m m o n iu m  sa lt ca ta lysts .
While 2.85172 and 2.66152 were available in our laboratory and 2.87 is a commercially 
available product, 2.86 and 2.88 were prepared (Scheme 22 and Scheme 25, 
respectively).
Scheme 22. Synthesis of 2.86
Br THF
60 °C, 48 h
2.16 2.89 2.86
99% yield
2-methoxybenzyl bromide 2.89 was already available in our laboratory. 2.89 was 
reacted with the commercially available cinchonidine 2.16. The synthesis of 2.86 
proceeded smoothly and after 48 hours the reaction aforded the desired product in 99% 
yield.
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Since the use of phase-transfer catalysts possessing benzylic groups on the C-9 has been 
shown to be an efficient methodology to promote enantioselective reactions, 173 we 
decided to functionalise quinidine 2.53 at the C-9 position with a benzyl group to yield 
2.90 (Scheme 23).174 175
The reaction was carried out simply reacting benzyl chloride (1.1 eq.) with quinidine 
2.53. The reaction afforded the desired product after 24 hours at room temperature.
Scheme 23. Benzylation of C-9 OH of quinidine 2.53
2.53 2.90
48% yield
Since it seemed reasonable to expect an interaction between a phenol (pKa = 9.8) and 
l//-benzotriazole (pKa = 8 .2 ) due to a similar acidity, we wondered if a hydrogen bond 
donor (i.e., a hydroxyl group on the aromatic ring) at the C-6 ’ position could be helpful 
to increase the reaction enantioselectivity. The déméthylation of 2.90 was carried by 
using an excess of NaSEt in dry DMF at 110 °C, 1 h affording 2.91 in 33% yield 
(Scheme 24).174'176
Scheme 24. Déméthylation of 2.90
2.90 2.91
33% yield
To create a hydrogen bond network capable of catalysing the reaction between 2.64 and 
2.73 we decided to alkylate the nitrogen atom on the quinuclidine ring with a benzyl 
group (Scheme 25).
114
C h a p t e r  2
Scheme 25. S y n th e s is  o f  2.88 b y  q u a te m isa tio n  o f  q u in u c lid in e  2.91
OH OH
BnBr (1.3 eq.)
THF
60 °C, 12 h
The reaction was caried out in presence of benzyl bromide in THF afording after 12 
hours the title compound 2.88 as a yelow solid in 67% yield. Catalysts 2.85-2.88 were 
tested in the conversion of 2.64 to 2.73 in the presence of lH-benzotriazole and K2CO3 
in toluene (Table 26).
Table 26. Identification of suitable of cinchona-d&nved catalysts in Michael reaction 
between 2.64 and 2.73
2.73 (5.0 eq.) 
catalyst (5 mol%)
K2C03 (5.0 eq.) 
toluene (0.03 M) 
0 °C, 48 h
2.64 2.74
entry catalyst conversion(%) ee (%)a,c ee (%)b,c
1 2.85 - - ' -
2 2 .6 6 - - -
3 2 .8 6 43 0 0
4 2.87 25d 1 0 -
5a_r*_
2 .8 8
 ^b 'TV' ^
21c r'* ^_■_1 0r mi ^ i 0
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The advantage of testing catalysts with a free hydroxyl group at C-9 (2.85, 2.66 and 
2.86) well as catalysts with a protected OH group (2.87 and 2.88) was envisaged as a 
key point to understand the role of the OH group during the catalysis. The use of 
catalysts 2.85 and 2.66, incorporating a free hydroxyl moiety (Table 26, entries 1 and 
2), did not result in the formation of Michael adduct, despite the efficiency 
demonstrated by 2.66 in the asymmetric addition of nitroalkanes to 4-nitro-5- 
styrylisoxazoles. 152 In contrast catalyst 2.86 afforded a moderate conversion (Table 26, 
entry 3) of 2.64. Unfortunately the isolated product 2.74 was recovered as racemate 
(Table 26, entry 3).
The use of 2.87 resulted in the formation of only one diastereoisomer but still in low 
conversion and ee values (Table 26, entry 4) The employment of catalyst 2.88 led to 
low conversion and no enantiomeric excess (Table 26, entry 5).
Overall, the results were discouraging since the highest enantioselectivity was afforded 
in the reaction of 2.64 in presence of 2.87 which catalysed the formation of 2.74 in 10% 
ee (Table 26, entry 4).
The reaction of l//-benzotriazole with 2.64 resulted unsuccessful leading to low 
conversion and low levels of enantioselectivity.
Still intrigued by the potential applications of 2.64 as a Michael acceptor for the 
construction of a variety of products, we envisaged that a change in the structure of 
nucleophilic portion could be beneficial to enhance the reactivity. Thus, 1H- 
benzotriazole was replaced by l//-l,2,3-triazole 2.92 in the reaction with 2.64 in the 
presence of catalyst 2.78 under optimised conditions (Scheme 26).
Scheme 26. Michael reaction between 2.64 and 2.92
K2C03 (5.0 eq.) 
toluene (0.03 M)
0 °C, 170 h
2.92 (5.0 eq.) 
2.78 (5 mol%) No
reaction
2.64 2.93
116
Unfortunately the reaction did not afford the desired product since after 170 hours the 
starting material was recovered unreacted.
Still on the search for a suitable Michael donor for the enantioselective addition to 2.64, 
we decided to test indoline (2.76) as a nucleophile. Indoline proved successful when
♦  169employed in Michael addition reactions by previous member of our group. Indoline 
was therefore tested in the enantioselective addition to 2.64 (Table 27).
Table 27. Identification of suitable of cinchona-derived catalysts in.Michael reaction 
between 2.64 and 2.76
C h a p t e r  2
2.95
entry catalyst conversion (% ) ee (%)
1 2.78 40 0
2 2 .8 8 71 0
3 2.95 33 4
4 2 .8 8 43 0 a
5 2.95 1 0 T
a Carried out at 0 °C
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A screening study was performed with the employment of 2.78, 2.88 and 2.95 as 
enantioselective catalysts. Unfortunately, despite the moderate conversion levels, no 
product ee was observed (Table 27, entries 1 and 2), even in the case of 2.95, a catalyst 
capable of catalysing a wide variety of asymmetric transformations (Table 23, entry
^  173,177-179
When the reaction was performed at 0 °C with the employment of catalysts 2.88 and 
2.95, lower conversion was observed and no change in the ee values was detected 
(Table 23, entries 4 and 5).
One last nucleophile for the enantioselective addition to 2.64 was identified in tert-butyl 
alkylidinecarbazate 2.96 (Figure 12).
Figure 1 2 . tert-bntyl alkylidinecarbazate 2.96
"'Vyo 1
2.96
2.96 was prepared according to the reported procedure, 180-181 refluxing a solution of 
benzaldehyde 2.97 with tert-butyl carbazate 2.98 for 20 minutes. The reaction went 
smoothly and after 20 minutes 2.96 was recovered as a white solid in 93% yield 
(Scheme 27).
Scheme 27. Synthesis of 2.96
o
U H Hh2n'nyY hexane , N'VVo 1 ..... s o 1
reflux, 20 minutes
2.97 2.98 2.96
93% yield
2.96 was tested in the reaction with 2.64 in the presence of 2.78 K2C03 as inorganic 
base in toluene (Scheme 28).
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Scheme 28. M ic h a e l re a ctio n  b etw een  2.64 and 2.96
2.96 (5.0 eq.) 
2.78 (5 mol%)
K2C03 (5.0 eq.) 
toluene (0.03 M) 
r.t., 72 h
No
reaction
2.64 2.99
Unfortunately, no product formation was detected after 72 hours as the starting material 
was recovered unreacted. The reaction was carried out even at 40 °C but no product was 
observed.
2.8.2 Michael addition of C-nucleophiles
As the phase transfer catalysed conjugate addition of TV-nucleophiles to 2.64 failed to 
afford products characterised by high levels of enantioselectivity, we turned our 
attention to the employment of C-nucleophiles. Previous members of our group reported 
the highly enantioselective reaction of nitromethane in the reaction with 2.64 in the 
presence of a cinchona alkaloid-derived phase transfer catalysts (see section 2 .5 ) . 152
Prompted by these results, in order to further investigate the potential of the asymmetric 
phase transfer catalysed Michael addition to isoxazole derivatives, we decided to extend 
the reaction scope to a different substrate. Previous member of our group already 
optimised the reaction conditions for the formation of 2.103 from 3,5-dimethyl-4- 
nitroisoxazole 2.100 and isovaleraldehyde 2.101 (Scheme 29).182
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Scheme 29. S y n th e s is  o f  2.103 startin g  fro m  3 ,5 -d im e th y l-4 -n itro is o x a z o le  2.100
no2
2.100
NaOH (1.0eq.) 
2.101 (1.2 eq.)
H20/Et0H 9:1 
r.t., 96 h
MsCI (1.2 eq.) 
Et3N (2.0 eq.)
CH2CI2 
0 C  —  r.t.
N02
2.102
40% conversion
2.103
40% yield
2.102 was prepared starting from 2.100 in presence of NaOH and the reaction afforded 
the alcohol 2.102. The crude of the reaction was used for the next step without further 
purification. 2.102 was finally treated with methane sulphonyl chloride and Et3N 
leading to the desired isoxazole 2.103.
2.103 was then subjected to a screening study as the Michael acceptor in the reaction 
with nitromethane. 2.103 was chosen as the substrate not only because of its ability to 
act as a Michael acceptor, but also because its reaction with nitromethane leads to a 
useful intermediate in the synthesis of (S)-pregabalin, an anticonvulsive drug 
commercialised by Pfizer as Lyrica® (Scheme 30).
Scheme 30. Synthesis of (S')-pregabalin
2.103 2.104 (S)-pregabalin
A screening of cinchona-derived phase transfer catalysts was then performed in the 
reaction of 2.103 with nitromethane in toluene in presence of K2CO3 as inorganic base. 
While 2.78 is commercially available and 2.80 was prepared, catalysts 2.105-2.110 were 
available in our laboratory. All the reactions were carried out at 0 °C for 90 hours 
(Table 28).
1 2 0
C h a p t e r  2
Table 28. Evaluation of a range of cinchona catalysts in the Michael addition of 
nitromethane to 2.103
catalyst (x mol%) 
CH3N02 (5.0 eq.)
K2C03 (5.0 eq.) 
toluene 
90 h, 0 °C
2.103
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entry catalyst loading (mol %)
toluene
(M)
conversion
(%)a yield (%)b ee (%)c
1 2.78 1 0 0.05 60 58 760R)
2 2.78 1 0 0.03 59 50 76(7?)
3 2.78 5 0 .1 1 0 0 55 7Q(R'f
4 2.78 5 . 0.05 60 54 75CR)
5 2.78 3 0 .1 65 60 72(A)
6 2.78 1 0 .1 67 '55 71(A)
7 2.78 1 0.05 60 50 73(A)
8 2.78 1 0 .0 1 61 52 82(A)
9 2.80 5 0 .0 1 1 0 0 75 65(5)
1 0 2.105 5 0 .0 1 60 58 60(5)
11 2.106 5 0 .0 1 60 55 76(S)e
12 2.107 5 0 .0 1 69 57 43(5)
13 2.108 5 0 .0 1 65 62 67(5)
14 2.109 5 0 .0 1 65 60 52(5)e
15 2 .1 1 0 5 0 .0 1 58 49 65(5)
16 2.80 5 0 .0 1 55 43 59(5)f
17
a r v - i___ :
2.106
. . . . .  1 . . .  I . T
5 0 .0 1 44 37 70(5)f
a Determ ined by ‘H NM R spectroscopic analysis o f the crude 2.104 b Calculated after column 
chromatography on silica gel. c Determ ined by HPLC analysis using a Chiralpak AD column (n- 
hexane//PrOH 99:1, flow rate 0.75 mL/min). d A fter 24 h o u rs .e After 16 h o u rs .f Carried out at -37 °C.
Initial optimisation experiments were performed in toluene using 2.78 as a catalyst.
With 10 mol% of catalyst loading at 0.05 and 0.03 M concentrations, the reaction 
afforded the product in good conversion and good enantiomeric excess (Table 28, 
entries 1 and 2). Interestingly, lowering the catalyst loading to 5 mol% and increasing 
the concentration, 2.104 was obtained in 70% ee (Table 28. entry 3).
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With still 5 mol% of loading reducing the concentration, higher level of 
enantioselectivity was achieved (Table 28, entry 4).
The catalytic loading was lowered to 1 mol% and the reactions were performed at 
concentrations of 0.1, 0.05 and 0.01 M (Table 28, entries 6 -8 ). The highest product ee 
was detected at 0.01 M concentration in the presence of only 1 mol% catalyst loading 
(Table 28, entry 8 ). However, the product obtained with the employment of 2.78 was 
found to be the opposite enantiomer of the (^-pregabalin precursor.
In order to obtain the enantiomer necessary for the synthesis of (S)-pregabalin, of range 
of differently substituted quinidinium catalysts was then evaluated (2.80, 2.105-2.110) 
in the optimised reaction conditions (5 mol% of catalytic loading at 0.01 M 
concentration) and all of them resulted in the formation of the correct enantiomer of 
2.104. The employment of 2.80 resulted in the formation of the desired product in full 
conversion and 65% ee (Table 28, entry 9) whereas when 2.105 was used, a decrease in 
the conversion and enantiomeric excess was observed (Table 28, entry 10). 
Unsatisfactory results in the ee values were achieved when 2.107 and 2.109 were 
utilised (Table 28, entries 12 and 14). The employment of 2.108 led to good results both 
in conversion and ee values (Table 28, entry 13). The best achievement was obtained in 
presence of 2.106 affording 2.104 in 76% ee. Given the good results obtained when 
2.80 and 2.106 were used (Table 28, entry 9), the reactions were repeated at -37 °C but 
surprisingly a decrease in the ee values was yielded (Table 28, entries 16 and 17).
2.9 Conclusions
In conclusion we have reported the development of a Michael addition reaction protocol 
of N- and C-nucleophiles to 3-methyl-4-nitro-5-styrylisoxazole derivatives with the 
employment of a range of cinchona alkaloid derived catalysts under phase-transfer 
catalysis conditions.
The reaction between 3-methyl-4-nitro-5-styrylisoxazole and benzotriazole was chosen 
as model to develop the reaction conditions for the Michael addition of N-nucleophiles, 
since benzotriazole containing molecules have been shown to have antiemetic and 
gastroprokinetic features. 164 For this purpose, several reaction conditions were 
evaluated. In doing so, a wide range of cinchona alkaloid derived catalysts was tested.
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Free and protected C-9 catalysts of the cinchonidine and quinidine series were screened, 
but unfortunately the reactions afforded the desired Michael adducts in low yields and 
ee values. That said, more cinchona alkaloid derived catalysts, W-nucleophiles and 
reaction conditions (solvents, temperature, bases) will be needed to be studied to 
improve upon these results.
Next, we focused to the Michael addition of C-nucleophiles. In the case of the addition 
of nitromethane to 2.103, the reaction afforded the desired product in good ee values. 
2.103 was chosen as a valid candidate as its reaction with nitromethane affords an 
interesting intermediate for the synthesis of (S)-Pregabalin, an anticonvulsive drug 
developed by Pfizer. This screening study led to the formation of both (/?)- and (5)- 
enantiomers (depending on the cinchona alkaloid derived catalyst employed) affording 
the desired product in good yields and high ee values. However only the (S)-enantiomer 
is required for the synthesis of (5)-Pregabalin, therefore, in order to increase the ee 
values, further developments in the addition of nitromethane to 2.103 need to be 
evaluated.
This screening study has however set the basis for further developments of the 
asymmetric 1,4-conjugate addition reaction to isoxazoles derivatives for the 
construction of a wide variety of products with the employment of a variety of N- and 
C- nucleophiles.
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Chapter 3 
1H NMR Titration Experiments
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The last decade has witnessed terrific development in the field of organocatalysis. 
Hydrogen bonding-mediate organocatalysis is considered an interesting and appealing 
approach and this was demonstrated by the vast number of hydrogen bond directed 
transformations reported in this contest. The search for new chiral catalyst capable of 
promoting enantioselective transformations became a matter of great relevance in the 
whole field. It is not surprising that a variety of investigations involving the role of 
hydrogen bond donors and acceptors has been reported. Crystal structures of C-H ‘ O 
interactions have been analysed183"188 and in 1963, Allerhand and Schleyer189 concluded 
that the ability of a C-H group to donate hydrogen bonds depends on the hybridisation 
of the carbon. They determined that the hydrogen-bond donation increased with the 
greater “s” character (sp <sp <sp). Sanders and co-workers isolated a new receptor for 
tetraalkylammonium salts. The cyclic tripeptide 3.1 binds selectively to N- 
methylquinuclidinium 3.2 salts and acetylcholine 3.3 trough a hydrogen bond 
interaction between 3.2 or 3.3 and the amide moieties of the receptor (Figure l ) . 190 
When dealing with quantitative measures of intermolecular hydrogen bond two 
approaches are available: a) direct measure via [H NMR titration, b) X-ray analysis of 
donor-acceptor complexes. Importantly the *H NMR titration experiment allows to 
determine the exact binding constant and the bond strength through C-H shift.
Figure 1. Binding between 3.1 and 3.2 and 3.3
3.0 Introduction
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3.1 Asymmetric Michael addition
3.1.1 Bifunctional asymmetric (thio)urea-based organocatalysis
The employment of bifunctional (thio)urea catalysts represents a very useful approach 
in enantioselective C-C bond forming reactions. 173' 177' 179,191' 218 The idea behind the use 
of bifunctional catalysts comes straight from natural enzymatic systems,219 where a 
simultaneous activation of the electrophilic and the nucleophilic components occurs. 
This approach is therefore appealing for the design of chiral catalysts for the promotion 
of stereoselective transformations. Enantioselective Michael addition reactions, in 
particular the addition to nitroolefins represents one of the most investigated (thiourea- 
catalysed reactions. In 2003, Takemoto and co-workers developed a bifunctional 
organocatalyst 3.5 which incorporates an electron-withdrawing aryl substituent and a 
chiral tertiary amine group on a (thio)urea-based structure. 193,195 This catalyst was found 
to be an excellent promoter of the enantioselective Michael addition of 1,3-dicarbonyl 
compounds to nitroolefins (Scheme 1).
Scheme 1. Enantioselective Michael addition to 3.4 catalysed by 3.5
OOH, OCH,
NO;
H3CV V OCH3 <2°  eq'J H3COOC-X-COOCH.o o 3-6
3.5 (10 mol%)
toluene, r.t.
3.4 3.7
89% yield 
94% ee
3.1.L1 Proposed mechanism for the enantioselective Michael addition
In order to explain the reaction mechanism Takemoto and co-workers evaluated the 
effect of the solvent: the employment of nonpolar solvents resulted in the formation of
3.7 in moderate yield and high enantioselectivity, whereas the use of methanol resulted 
in lower product yield and ee. It was proposed that a solvation by methanol was 
disturbing the hydrogen bond interaction between the catalyst and the substrate.
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Takemoto and co-workers proposed that the two substrates involved in the reaction
were activated simultaneously by 3.5 and, since ureas and (thio)ureas are known to form
220 222hydrogen bonds with nitro compounds, ' an interaction between nitrolefins and the 
(thio)urea moiety of 3.5 via multiple hydrogen bonds was ocuring where the two N-H 
bonds of (thio)urea and the amino group are oriented in the same direction. The tertiary 
amine group of the catalyst was proposed to be responsible for the deprotonation of the 
1,3-dicarbonyls and the generation of a highly nucleophilic enolate ion would atack 
only a single face of the activated nitrolefin electrophile (TSi, Figure 2 ) .195
An alternative mechanism was proposed by Soos and co-workers223 in which the key 
intermediate of the reaction is the catalyst-nucleophile complex characterised by 
multiple hydrogen bonds between the N-H groups of the (thio)urea and the carbonyl 
groups of the deprotonated 1,3-dicarbonyl compound. Activation of the nitrolefin is 
then achieved via interaction with the protonated tertiary amino group of the catalyst 
rather than with the (thio)urea moiety (TS2, Figure 2).
Figure 2. Bifunctional activation mode by 3.5 proposed by Takemoto and Soos
Both mechanisms proposed by Takemoto195 and Soos223 lead to product 
enantioselectivity and this feature is controled by the hydrogen-bonding network 
provided by thre acidic N-H groups of the protonated catalyst, which determines the 
preferential relative orientation of the substrate inducing stereoselectivity.
The utility of catalyst 3.5 is not limited to the reaction ilustrated in Scheme 4 and a 
range of 1,3-dicarbonyl pronucleophiles were also found to be compatible with the 
Michael adition reaction to nitrolefins. 195,224 Moreover, 3.5 has been sucesfuly 
employed by the same group in the enantioselective adition of malononitrile to a,p- 
unsaturated imides225 and in the asymmetric aza-Henry reaction. 194,199
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3 . 1 2 ( T h i o ) u r e a - s u b s t i t u t e d  c i n c h o n a  a l k a l o i d s
Substitution of the C-9 hydroxy group on the natural cmc/iona-alkaloids backbone (see 
section 2 .2 .1) for an aryl(thio)urea functionality increases the rigidity and hydrogen- 
bond donating capacity of the parent alkaloids and allows this capacity to be easily 
modulated by selecting the appropriate substitution pattern on the (thio)urea moiety
X = O or S
Soos et a l investigated the use of these catalysts in the asymmetric addition of
of quinine with natural stereochemistry at C-9, exhibited no activity. However, when 
employed at 10 mol% loading, both e/?/-(thio)urea catalyst 3.9 and its /^ewdtfenantiomer
3.10 could promote the Michael addition reaction of nitromethane to 3.12 to afford 3.13 
in good to excellent results (Table 1).
Table 1. Asymmetric Michael addition catalysed by (thio)urea moieties
(Figure 3) . 192'226
Figure 3. Cmc/zona-alkaloids backbone
nitromethane to chalcones. 177 Surprisingly, organocatalyst 3.8, the (thio)urea derivative
toluene, r.t., 99 h
3.12 3.13
3.8 3.9 3.10 3.11
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entry catalyst yield (%) ee (%)
1 3.8 0 -
2 3.9 71 95(A)
3 3.10 59 86(5)
4 3.11 93 96(A)
Connon and co-workers reported an asymmetric Michael addition of dimethyl malonate 
to nitroolefins with the employment of 3.11 as catalyst. It was found that 3.11 could 
promote the facile conversion of 3.14 to 3.15 at very low catalyst loading (0.5 mol%) 
under optimised conditions (Scheme 2) . 178
Scheme 2. Enantioselective Michael addition of dimethyl
3.11
3.11(0.5 mol%)
. sv ^ N 0 2 CH2(C02Me)2 (2.0 eq.)
1 toluene, 0 °C, 46 h
3.14
3.2 Asymmetric aza-Henry reaction
The aza-Henry reaction is of prime importance for synthesis of nitrogen-containing 
molecules227"229 and important progresses have been made in the catalytic 
enantioselective aza-Henry reaction of aromatic azomethines based on 
organocatalysts. 194,199,209,230' 232
Palomo et a l focused their attention on the aza-Henry reaction involving oc-amido 
sulfones and nitromethane in presence of C s0H H 20  under phase-transfer conditions. 155 
At the same time, Herrera and Bemardi reported a similar aza-Henry reaction.233 
Palomo et a l carried out a study of several ammonium salt catalyst finding N-benzyl 
quininium chloride derivative 3.16 the most suitable one (Figure 4 ) . 170
malonate to 3.15 catalysed by 
Me02Cv^ C 0 2Me
3.15
92% yield, 94% ee
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Figure 4. N-benzyl quininium chloride cinchona-derivative 3.16
The initial screening of N-protected a-amido sulfones involving 3.16 as catalyst in 
presence of C s0H H 20  as base revealed that the amino sulfone 3.17 was the most 
suitable precursor for the aza-Henry reaction with nitroethane affording the desired 
target 3.18 in >95 conversion and 90% ee with syn:anti selectivity of dr 92:8 (Scheme 
3).
Scheme 3. Asymmetric aza-Henry reaction between nitroethane and 3.17 catalysed by 
3.16
CH3CH2N02 (5.0 eq)
NHBoc 3.16 (12 mol%) NHBoc
Ph SO2T0I-P CsOHh2o  ~ P h ^ Y N° 2
toluene, -40 °C, 44h ^H3
3.17 3.18
>95% conversion 
90% ee
A solvent screening was carried out and it was found that solvents with increased 
polarity such as THF produced diminished enantiomeric excesses of the targets whereas 
the best conditions were found when toluene was employed.
With these optimised conditions in hands, Palomo and co-workers explored the aza- 
Henry reaction of nitroethane using a range of different N -Boc protected a-amido 
sulfones and in general, reactions with alkyl amido sulfones produced syn adducts in 
higher enantiomeric excess (90-99% ee) compared to those employing aryl amido 
sulfones (80-95% ee).m
3.2.1 Proposed mechanism for the enantioselective aza-Henry reaction
It was observed that the reaction proceeds either in presence of 3.17 (Scheme 7, A) or 
the corresponding N-acyl imine 3.20 (Scheme 7, B), therefore the formation of 3.20
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from the respective 3.17 takes place in an independent event that preceded the aza- 
Henry reaction (Scheme 4).
Scheme 4. Enantioselective aza-Henry reaction between nitromethane and (A) a-amido 
sulfone 3.17 and (B) preformed N -acyl imine 3.20
CH3N02 (5.0 eq) 
^NHBoc 3.16(12 mol%)
Ph SO2T0l-p CsOH H20  (130 mol%)
toluene, -50 °C, 44 h
3.17
NHBocA^ no2
Ph
3.19 79% yield 
91% ee
B
Ph
NBocJ
CH3N02 (5.0 eq) 
3.16 (12 mol%)
CsOH-HgO (12 mol%) 
toluene, -40 °C, 44 h
NHBocA^.no2
3.20
Ph
3.19 75% yield 
80% ee
Second, the reaction in the presence of 3.17 was monitored by ]H NMR spectroscopy 
and the signals associated with the imine species (3.20) were not detected. This 
indicates that the base-promoted generation of imine proceeds slower than the imine 
consumption via aza-Henry reaction.
A third experiment suggested that the OH" anions present in the reaction are not 
responsible of imine formation from a-amido sulfone precursors. Thus the originated 
nitronate anion is the base that promotes elimination of sulfinic acid from a-amido 
sulfone to yield N-acyl imines. Both nitroalkane and catalyst 3.16 are required for imine 
generation, since neither treatment of 3.17 with CsOH in presence of 3.16, nor reaction 
of 3.17 with nitroethane and CsOH in absence of 3.16 afforded 3.19.170
3.2.2 Model studies of coordination of the reactants with the catalyst
Palomo and co-workers examined the interaction of catalyst, imine and nitroalkanes via 
computational studies. 170 In this study, in order to optimise computational times, the 
bulky catalyst 3.16 was replaced by the hydroxyethyl trimethyl ammonium cation 3.21 
while nitromethane 3.22 (and its deprotonated form 3.23) and N-methoxycarbonyl 
imine 3.24 were employed as the nitro source (Figure 5).
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Figure 5. H y d ro g e n  b o n d in g  c o m p le x e s  b etw een  3.21 and  d iffe re n t substrates
From a preliminary analysis, it was found that both catalyst 3.16 and its model 3.21 
possess two hydrogen bonding donating moiety, an OH and a N+-C-H site171 and that 
nitroalkanes and their conjugate bases bear coordinating N-O' groups. Moreover, 3.24, 
which can exist in either s-cis or s-trans conformations, can act as Lewis bases through 
the N  and carbonylic O atoms (Figure 6 ).
Figure 6. s-trans and s-cis form of 3.24
q \  ofc^yN^ Ph 
OMe
s-trans 3.24 s-cis 3.24
The complexation with a multiple hydrogen bond donor, for example 3.16 or 3.21 is 
better in the s-trans form which possess the O and N  atoms pointing toward the same 
site, whereas in the s-cis form they point towards opposite directions, making the 
coordination with a multiple hydrogen bond donor less effective the coordination to a 
multiple hydrogen bond donor site. Palomo and co-workers carried out calculations in 
order to estimate the relative binding energy of the catalyst OH to the reacting species. 
For 3.24 two complexes were analysed: one with N  and one with the carbonylic O as 
coordinating atoms. It was found that the hydrogen bonding stabilisation is maximal for 
the complex 3.21:3.23 (AG = -10.0 kcal/mol) (binding energy for 3.21:3.22 is AG = -5.0 
kcal/mol) and that the preferred binding site of 3.24 is the nitrogen atom (AG = -6 .8  
kcal/mol) over the oxygen atom (AG = 4.4 kcal/mol). These data are consistent with the 
following figure (Figure 7) where it is shown that in 3.21:3.22 the distance between OH 
and NO2 (1.9 A) is larger than in 3.21:3.23 (1.7 A). The bond distances measured in
0 !
MeO.TC7°^>
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3.21:3.24 (N) (1.8 A) are shorter that the complex 3.21:3.52 (1.9 A) but longer than 
3.21:3.23(1.7 A).
Figure 7. Hydrogen bonding complexes 3.21:3.22, 3.21:3.23 and 3.21:3.24
&r\ i
H \  y 2.7 A
”'jcV0"')
1 -9 A CH3 2.7 A 
3.21:3.22
rN~i
0 - H' h, 2.2 A
1.8 Â H', VP 
:n
Ph-
/ 2.6 A
OMe
3.21:3.243.21:3.23
Structures of the two transition states (between the catalyst-OH and the imine) lowest in 
energy, TSi-Si and TSi~/?e were reported by Palomo and co-workers (Figure 8 ).
Figure 8 . Two transition states lowest in energy for the aza-Henry reaction
H u
^0  ^_ N'^BuMe
,N, H
TS.RF-Si
The lowest transition state in energy presents five hydrogen bonding interactions and
othe shortest one (A, 1.6 A) appears between the OH and one of the oxygens of the nitro 
group.
A second major aspect revealed by Palomo et al. was the necessity of a free OH on 
catalyst 3.16 to obtain high enantiomeric excess. Indeed when derivatives of 3.16 were 
used possessing alkylated OH, the enantiomeric excesses were strongly affected. This 
result coupled with calculation explained above pointed out a bifunctional mode of 
action of catalyst 3.16 in which the OH forms hydrogen bonding with the “CH2NO2 and 
the N+-C-H forms a hydrogen bonding with the imine hydrogen bonding acceptor sites.
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We have recently described a highly enantioselective addition of nitromethane to 3-
i r-imethyl-4-nitro-5-styrylisoxazole 3.25, a new class of cinnamate equivalents. The 
reaction is catalysed by cinchona-based quaternary ammonium salts similar to those 
employed by Palomo. In addition- we have shown that alkylation of the phase-transfer 
catalysts OH lead to complete destruction of enantioselectivity.
Based on this finding and the similarities with Palomo’s work (same Michael donor and 
same catalyst) we wondered whether or not a hydrogen bonding couple could be 
proposed formed by NO2 of 3.25 and N+-C-Ha to explain the high enantiofacial 
discrimination of the reaction of 3.25 with nitromethane. In this regard, two transition 
states, involving styrylisoxazole 3.25, cinchona alkaloid catalyst and nitromethane, 
were proposed.
As it is shown in Figure 9, in the first transition state, three interactions are represented: 
1) between the hydroxyl group on the catalyst and the oxygen atom on the 
nitromethane; 2 ) between the benzylic proton of the catalyst and one of the oxygen 
atoms on the nitro group on the styrylisoxazole; 3) between the proton on C-9 and the 
second oxygen atom on the nitro moiety of 3.25.
In the first transition state, the hydroxyl group is placed on the backside of the molecule, 
which leads to the formation of the (S)-enantiomer (Figure 9, TSi).
In the second transition state, the same three interactions between the cinchona alkaloid 
catalyst and styryl isozaxole 3.25 are depicted (between the hydroxyl group of the 
catalyst and nitromethane and between the nitro group on the isoxazole and two protons 
of the cinchona alkaloid-derived) but the opposite situation is represented as the 
hydroxyl group is on the front side of the catalyst allowing the formation of the (fl)- 
enantiomer (Figure 9, TS2).
3.3 Results and discussion
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Figure 9. P ro p o se d  m o d e l fo r  h y d ro g e n  b o n d in g  b etw een  N O 2 o f  3.25 and N +- C - H a
TS,
i  L. "to o 2 n
TSs
3.25
In 2002, Houk et al. reported hydrogen-bonded complexes between
trimethylammonium cation and methyl acetate and dimethylformamide (Figure 10). 171
Figure 10. Interaction energies between trimethylammonium cation and methyl acetate 
and dimethylformamide
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The interaction between trimethylammonium cation and dimethylformamide is -9.4 
kcal/mol (Figure 10, A) and the interaction between methyl acetate and 
trimethylammonium cation is -40.9 kcal/mol in toluene whereas it is reduced in CHCI3 
to 22.2 kcal/mol (Figure 10; B).
We have corresponded with Prof. Houk who has kindly provided calculation involving 
(CH3)N+ and NO2 as a model.
As it is shown in Figure 11, the interaction energy between nitroethane and 
trimethylammonium cation is -8 .0  kcal/mol which is very close to the one between 
trimethylammonium cation and dimethylformamide (-9.4 kcal/mol, Figure 10, A).
This data showed a remarkable binding of nitro to N+-C-Ha pointing out a putative 
strong hydrogen bond.
Figure 11. Model for the hydrogen bonding interaction between nitroethane and 
trimethylammonium cation proposed by Houk
Based on these findings, a model for the hydrogen bonding interactions between 
styrylisoxazole 3.25, nitromethane and cmc/zona-alkaloid catalysts has been devised 
(Figure 12).
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Figure Ì 2 .  P ro p o se d  m o d e l fo r  the h y d ro g e n  b o n d in g  in te ra ctio n
As explained, hydrogen bonding is visible as a shift in !H NMR titration experiments. 
For this reason we set up to investigate the behaviour of catalyst 3.26 in solution of 
CDCI3 under sequential addition of aliquots of isoxazole 3.25.
3.3.1 Protons and carbons assignment
Styrylisoxazole 3.25 is an appealing substrate for a variety of transformations. This was 
demonstrated for example by its successful conversion to cyclopropane and 
cyclopentanone derivatives reported by our group.
The employment of 3.25 as a Michael acceptor was also successful in the 
enantioselective addition of nucleophile such as nitromethane, catalysed by cinchona-
1 S9alkaloids derivatives. When the Michael addition reaction of nitromethane with 3.25 
in the presence of N-benzyl cinchoninium chloride 3.26 was performed, good 
enantioselectivity was obtained for the product 3.27 (Scheme 5).
Scheme 5. Enantioselective Michael addition of nitromethane to 3.25 catalysed by 3.26
3.26 (5 mol%) 
CH3N02 (5.0 eq.)
K2C03 (5.0 eq.) 
toluene, 0°C
3.25
76% e e
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Catalyst 3.26 possesses a free hydroxyl group and a quaternary ammonium salt moiety. 
These structural features represent a situation that matches the requirement for a 
catalyst-substrate interaction, as postulated by Palomo. 170 In order to determine whether 
an efficient catalyst-substrate coordination and activation was taking place during the 
addition of nitromethane, !H NMR titration experiments were performed. The target of 
this investigation was represented by the identification of the formation of a catalyst- 
styryisoxazole complex by detecting the change in chemical shift of one or more 
protons.
3.3.2 Representative procedure for titration experiments of 3,25:3.26 solutions
Catalyst (3.26)-styrylisoxazole (3.25) complex was fully characterised and the signals 
associated with all the protons and carbons identified (see experimental section and 
appendix). Initially, 0.75 mL of a solution of 3.26 in CDCI3 (0.024 mmol, 0.031 M) 
was added to an oven-dried NMR tube. A spectrum was obtained for the catalyst 
solution in order to determine appropriate acquisition parameters. The tube was 
removed from the spectrometer and portions of 0.1 eq. of 3.25 were added until an 
equimolar solution of 3.25:3.26 was achieved (Figure 15) then subsequently, the 
solution was brought to a 2:1 ratio by adding 0.2 eq. portions of 3.25 (Figures 14 and 
15). The experiments were performed at room temperature.
Figure 13. Styrylisoxazole 3.25 and cinchona-derived catalyst 3.26
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Figure 14. H NMR t itra tio n  o f  a m ix tu re  3.25:3.26 in  CDCI3.
Figure 15. !H NMR (expansion) titration of a mixture 3.25:3.26 in CDCI3
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The ]H NMR titration experiments indicated that increasing the percentage of 
styrylisoxazole 3.25, in solution it was causing a gradual shift of the signals associated 
with the benzylic protons of the catalyst Ha and Hb (Figures 14 and 15, red arrows). 
We reasoned that this change in chemical shift could be attributed (presumably) to a 
catalytic-styryl binding event.
In order to prove these results, a different substrate (3.28) was evaluated in the 
formation of complex with catalyst 3.26.
As in the previous experiment, initially, 0.75 mL of a solution of 3.26 in CDC13 (0.0024 
mmol, 0.0031 M) was added to an oven-dried NMR tube.
A spectrum was obtained for the catalyst solution. The tube was removed from the 
spectrometer and portions of 0.1 eq. of 3.28 were added until a solution 0.7:1 ratio 
3.28:3.26 was achieved (Figure 16)
As in the case of 3.25, the ’H NMR titration experiments resulted in the change of the 
chemical shift the benzylic protons of catalyst 3.26 (Figure 16, red arrows).
Figure 16. NMR (expansion) titration of a mixture 3.28:3.26 in CDCI3
141
C h a p t e r  3
As a final titration experiment, the enantioenriched Michael adduct 3.27, derived by the
• ♦ 1 addition of nitromethane to 3.25 was employed. In this case the solution was brought
to a 1.4:1 ratio 3.27:3.26.
The experiment revealed a similar pattern, i.e. the benzylic protons in the lH NMR were 
shifted when compared to those in the non complexed catalyst. However, the change in 
chemical shift was smaller (about 0.5 ppm) than those observed in the previous 
experiments (Figures 17 and 18, red arrows).
Figure 17. !H NMR titration of a mixture 3.27:3.26 in CDC13.
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Figure 18. ]H NMR (expansion) titration of a mixture 3.27:3.26 in CDCI3.
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The employment of NOE/ROE bidimensional NMR experiments to detect the 
complex formed by the substrate and the catalyst was decided. Similar studies involving 
quaternary ammonium salts were previously reported by Pochapsky and co­
workers.77,234
Table 2 indicates the NOE contacts observed in the experiments. For example, as it is 
shown, interactions between the proton on C-9 (6.51 ppm) and protons on the aromatic 
ring at 7.58 ppm and on the benzylic position at 7.58 were observed.
Moreover, contacts between quinuclidine ring (2.72 and 3.96 ppm) and the benzylic 
moiety were noted.
Interactions between the quinoline ring and the aromatic ring on the quinuclidine 
moiety were present since NOE contacts were observed between the proton at 7.89 ppm 
(quinoline) and the proton at 7.58 (aromatic ring on the quinuclidine).
Intermolecular contacts between protons of styrylisoxazole 3.25 and protons of the 
catalyst 3.26 were not observed as only intramolecular contacts were detected (Table 2). 
Thus, unfortunately the employment of preliminary NOE experiments did not result in 
the detection of the substrate-catalyst complex.
Table 2. NOE/ROE through space connections
3 . 3 . 3  N O E  e x p e r i m e n t s
4.52, 3.31
3.25 3.26
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product peak (ppm)
3.26
3.25
6.51 7.58 8.31 6 .21 5.40 4.1
4.1 8.32 6.51 6 .2 2 3.96 1.70 0.71
2 .1 2 7.89 5.86 4.52 0.71
0.71 2 .1 2 1.78 1.70 4.1
1.78 0.72 2.72 5.86 4.1 3.96
1.70 - - - - - -
3.96
2.72 7.58 6 .2 2 4.1 2.72 1.70
2.28 3.31 5.19 5.86 2.72 1.70
5.19
5.23
5.86 - - - - -
4.52
3.31 2.72 2 .1 2 5.86 5.20 5.40 7.58
6 .2 2
5.40
6.51
3.31
7.58
4.52
8.31
6.51
5.40
6 .2 2
3.96
7.58 4.12
8.31 7.58 7.1 7.05 6.51 6 .2 2 4.1
7.89 8.82 2 .1 2 7.58
8.82 7.89
7.82 -
7.70 -
2.73
In order to understand whether a sp3 instead of a sp2 carbon on the styrylisoxazole 3.25 
could show intermolecular NOE contacts, the complex catalyst-substrate 3.27:3.26 was 
employed instead of 3.25:3.26 and the test are at the moment still under investigation by 
Dr. John O’Brien form the Chemistry Department at Trinity College of Dublin. .
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In conclusions, the aim of the investigation described in this chapter was represented by 
the identification of the formation of a catalyst-styryisoxazole complex by detecting the 
change in chemical shift of one or more protons. Based on previous findings reported by 
Palomo and co-workers, who proved via computational studies the presence of 
hydrogen bonding interactions between cinchona alkaloid catalysts and nitro group in 
the aza-Henry reaction, and by Houk, who provided calculation of the interaction 
energies between tetramethylammonium cation and nitroethane, we wondered if it was 
reasonable to explain the high enantiofacial discrimination of the reaction between 
styrylisoxazoles and nitromethane. In this regard it was plausible to devise a model in 
which styrylisoxazole, cinchona alkaloid catalyst and nitromethane reacted via 
hydrogen bonding interactions.
Inspired by the fact that in literature examples of hydrogen bonding visible by !H NMR 
were reported,235 we carried out NMR titration experiments in presence of 
quaternary ammonium cinchona-derived catalyst (3.26) and three different substrates. 
In each of these experiments, a change in chemical shift of the benzylic protons of the 
catalyst was observed. This could presumably be due to a catalyst-substrate binding 
event. In order to confirm this hypothesis, preliminary NOE/ROE bidimensional lH 
NMR experiments were employed, but unfortunately intramolecular contacts between 
protons of the styrylisoxazole and protons of the cinchona alkaloid catalyst were not 
observed. However, these experiments set the basis for further developments and 
additional ]H NMR titration experiments with the employment of different substrates 
and quaternary ammonium cinchona-derived catalysts, therefore further investigations 
by means of NOE/ROE experiments need to be performed.
3.4 Conclusions
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4.0 Experimental section
4.1 Experimental section chapter 1 
General experimental
Melting points were determined using a Stuart scientific melting point apparatus and are 
uncorrected. Infrared spectra (IR) were obtained in CCI4 using a Bruker Tensor27 FT- 
IR instrument. Absorption maximum (vmax) was reported in wave numbers (cm 1) and 
only selected peaks are reported. NMR experiments were performed on a Bruker 
Avance 400 instrument and samples were obtained in CDCI3 (referenced to 7.26 ppm 
for ’H and 77.0 for 13C) and in DMSO-d6  (referenced to 2.52 and 3.35 ppm for !H and
40.0 for 13C). Coupling constants (.J) are in Hz. Multiplicities are reported as follows: s, 
singlet, d, doublet, dd, doublets of doublets, t, triplet, q, quartet, m, multiplet, c, 
complex, and br, broad. High resolution mass spectra were obtained on a Waters Micro 
mass LCT and low resolution mass spectra were recorded on Waters Micro mass 
Quattro LCMS spectrometers at 70 eV. Reactions in the hydrogenator were performed 
in PARR® 5500 Series Compact Reactor. Optical rotations were measured on a Perkin- 
Elmer 241 polarimeter. The enantiomeric excess (ee) of the products was determined by 
chiral stationary phase HPLC (Daicel Chiralpak AD, Chiralcel OJ, Chiralcel OD, 
Chiralpak AS columns), using a UV detector operating at 254 nm. Tetrahydrofuran was 
freshly distilled over sodium benzophenone prior to use according to standard 
procedure. All other reagents and solvents were used. as purchased from Aldrich. 
Reactions were checked for completion by TLC (EM Science, silica gel 60 F254). Flash 
chromatography was performed using silica gel 60 (0.040-0.063 mm, 230-400 mesh). 
Retention factors (Rf) are reported to ± 0.05.
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P r e p a r a t i o n  o f  1.4049
°- och3HO'-p-
Hcf
To a stirred solution of 2-deoxy-D-ribose (20.0 g, 149.0 mmol) in methanol (240 mL), 
acetyl chloride (690 1^, 6.5 mol%) was added. The reaction mixture was stirred at room 
temperature for 1 h, then sodium bicarbonate (7.70 g) was added and the reaction stirred 
for further 10 min. The solid formed was filtered trough celite, and the filtrate was 
evaporated in vacuo to afford 1.40 as a mixture of two diastereoisomers as an orange oil 
(22.0 g, >99% yield). This product did not require any further purification.
(a  + (3 anomers): Rf = 0.53 (chloroform/methanol 8:2).
SH (400 MHz, CDC13): 5.19-4.95 (m, 2H), 4.39-4.32 (m, 1H), 4.11-4.08 (m, 1H),
3.99 (q, J = 4.4, 1H) 3.92 (q, J = 4.4, 1H), 3.70-3.55 (m, 
4H), 3.32 (s, 3H, -CH3), 3.30 (s, 3H, -CH3), 2.19-2.10 (m, 
2H), 2.06-2.00 (m, 1H), 1.92-1.88 (m, 1H).
5C (100.6 MHz, CDCI3): 105.60, 105.56, 87.7, 87.5, 72.9, 72.3, 63.6, 63.2, 55.5,
54.9,42.7,41.6.
HRMS (ESI): calculated for [M+Na]+, C6H120 4Na: 171.0633; found:
171.0638.
Preparation of 1.4149
O O H J
BnO \__ f
Bncf
The reaction was split in two round-bottom flasks. To a stirred solution of 1.40 (22.7 g, 
153.4 mmol) in THF (160 mL), powdered KOH (77.0 g, 1380.0 mmol, 9.0 eq.) and 
benzyl chloride (247.0 mL, 2148.0 mmol, 14.0 eq.) were added sequentially, and the 
reaction mixture was heated to reflux conditions for 24 h. The reaction mixture was 
allowed to cool to room temperature, then the solution was filtered and the solvent
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removed in vacuo. The residue was purified by flash chromatography on silica gel 
eluting the first time with petroleum ether to eliminate excess benzyl chloride, the
The reaction was split in two round-bottom flasks. A stirred solution of 1.41 (25.0 g,
76.0 mmol) in Ac0H/H20  80:20 (740 mL) was heated to 49 °C (external temperature) 
for 24 h. A solution of ACOH/H2O (80:20, 500 mL) was then added, and the reaction 
mixture was allowed to stir at the same temperature for another 24 h. The reaction was 
cooled to room temperature and the solvent was removed in vacuo. Heptane was added 
to the resulting crude mixture and then removed under reduced pressure to eliminate the 
residual acetic acid. The crude residue was then purified by column chromatography 
eluting with petroleum ether/ethyl acetate 9:1. The title compound 1.35 was obtained as 
yellow oil (19.9 g, 83% yield).
second time with petroleum ether/ethyl acetate 8:2 to afford the title compound 1.41 as 
a yellow oil (42.6 g, 85% yield)
(a  + p anomers): Rf = 0.39 and 0.57 (petroleum ether/ethyl acetate 8:2).
5h (400 MHz, CDCI3): 7.45-7.20 (m, 20H), 5.13-5.07 (m, 2H), 4.63-4.47 (m,
8 H), 4.29-4.21 (m, 2H), 4.16-4.12 (m, 1H), 4.00-3.92 (m, 
1H), 3.57-3.43 (m, 4H), 3.41 (s, 3H, -CH3), 3.31 (s, 3H, - 
CH3), 2.26-2.19 (m, 2H), 2.19-2.15 (m, 1H), 2.05-2.00 
(m, 1H).
5C (100.6 MHz, CDCI3): 138.3, 138.23, 138.20, 138.1, 128.5, 128.4, 127.9, 127.8,
127.7, 127.6, 105.5, 105.3, 82.9, 82.2, 80.0, 78.6, 73.5, 
73.4, 72.1, 71.7, 71.6, 70.2, 55.3, 55.0, 39.5, 39.0.
HRMS (ESI): calculated for [M +Naf, C2oH24Na04: 351.1572; found: 
351.1558.
Preparation of 1.3549
BnO'
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(a  + (3 anomers): Rf = 0.18 (petroleum ether/ethyl acetate 8:2).
3300, 3032, 2937, 1590, 1310, 1042, 870.
7.42-7.27 (m, 20H), 5.56-5.49 (m, 2H), 4.62-4.47 (m, 
11H), 4.29-4.22 (m, 2H), 4.13-4.10 (m, 1H), 3.67-3.62 
(m, 1H), 3.59-3.50 (m, 2H), 3.39-3.35 (m, 1H), 2.28-2.20 
(m, 2H), 2.17-2.10 (m, 2H).
138.1, 138.0, 137.9, 137.5, 137.3, 128.7, 128.6, 128.5, 
128.48, 128.46, 128.44, 128.3, 128.1, 128.0, 127.98, 
127.96, 99.4, 83.3, 82.7, 79.83, 79.8, 79.0, 78.8, 73.2, 
72.1,71.9,71.8,41.8, 39.2.
calculated for [M +Na]\ Ci9H22Na0 4: 337.1416; found: 
337.1421.
Preparation of 1.42a and 1.42b50,236
Bncf BnO"
1.42b 1.42a
To a stirred solution of 1.35 (3.44 g, 10.9 mmol) in dry THF (39.0 mL) at 0 °C, a 
solution of ethynyl magnesium bromide (0.5 M in THF, 45 mL, 21.8 mmol, 2.0 eq.) 
was added. The reaction mixture was then allowed to reach room temperature stirring 
for 46 h. The reaction mixture was then quenched with ammonium chloride saturated 
solution (20 mL), diluted with dichloromethane and washed with H20  (3 x 30 mL) and 
brine (3 x 30 mL). The organic layer was dried over Na2S0 4  and concentrated in vacuo. 
The residue was purified by flash chromatography on silica gel eluting with petroleum 
ether/ethyl acetate 2:1 to give the title compounds 1.42a and 1.42b as yellow oils (1.42a 
910 mg, 25% yield, 1.42b 1.37 g, 38% yield).
IR- vmax (neat) / cm"1:
5h (400 MHz, CDC13):
5C (100.6 MHz, CDCI3):
HRMS (ESI):
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Rf = 0.23 (petroleum ether/ethyl acetate 2:1).
§H (400 MHz, CDCI3): 7.39-7.28 (m, 1 0 H), 4.67-4.53 (m, 5H), 4.02-3.97 (m,
2H), 3.59 (d, J = 5.1, 2H), 3.12 (d, 7 = 7, 1H), 2.55 (bs,
1H), 2.48 (d, J = 2, 1H), 2.12-2.05 (m, 1H), 1.95-1.88 (m,
1H).
5C (100.6 MHz, CDCI3): 137.6, 137.5, 128.6, 128.5, 128.2, 128.1, 127.95, 127.91,
84.6, 73.5, 72.9, 72.7, 72.4, 71.4, 70.5, 59.8, 37.1.
HRMS (ESI): calculated for [M+Na]+, C2iH24Na04: 363.1572; found:
363.1607.
1.42b
[a]D27 = -6.4 (c = 0.96 in CHC13).
Rf = 0.13 (petroleum ether/ethyl acetate 2:1).
5h (400 MHz, CDC13): 7.38-7.26 (m, 10H), 4.67-4.62 (m, 1H), 4.60-4.53 (m,
4H), 3.99-3.94 (m, 1H), 3.83-3.78 (m, 1H), 3.62 (dd, 71 =
4 , h =  10, 1H), 3.57 (dd, Jx = 6 , h  = 10, 1H), 3.36 (d, 7 = 
5, 1H), 2.85 (d, 7 = 4, 1H), 2.48 (d, 7 = 2, 1H), 2.19-2.12 
(m, 1H), 2.05-1.98 (m, 1H)
8 C (100.6 MHz, CDCI3): 137.7, 137.6, 128.5, 128.4, 128.0, 127.98, 127.96, 127.92,
84.6, 77.2, 73.5, 73.1, 72.1, 71.7, 70.7, 59.8, 38.5.
1.42a
[a ] D29 = -19 .2  (c = 1.02 in CHCI3).
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HRMS (ESI): calculated for [M+Na]+, C2 iH24Na0 4: 363.1572; found: 
363.1566.
Preparation of 1 A3 f t 9
BnO
BnO'
To a stirred solution of 1.42b (968 mg, 2.84 mmol) in acetone (8 . 8  mL), toluene-p- 
sulphonyl chloride (580 g, 3.12 mmol, 1.1 eq.) and KOH (5 M in H20 , 1.5 mL, 7.38 
mmol, 2.6 eq.) were sequentially added. The reaction was stirred at room temperature 
for 52 h. The reaction mixture was then diluted with water and extracted with 
dichloromethane (3 x 10 mL). The organic layer was dried over Na2S0 4  and 
concentrated in vacuo. The crude material obtained was purified by column 
chromatography eluting with petroleum ether/ethyl acetate 9:1 to afford the title 
compounds 1.43P as pale yellow oil (483 mg, 53% yield).
[ot] D28 = +29.8 (c = 1.05 in CHCI3).
Rf = 0.8 (petroleum ether/ethyl acetate 4:1).
5H (400 MHz, CDCI3): 7.37-7.29 (m, 10H), 4.78-4.75 (m, 1H), 4.63-4.52 (m,
4H), 4.19-4.16 (m, 1H), 4.14-4.12 (m, 1H), 3.64 (dd, Jl =
10.0, J2 = 5.0, 1 H), 3.51 (dd, = 10.0, J2= 6.0, 1 H), 2.50 
(d, / =  2.0, 1H), 2.34-2.27 (m, 1H), 2.21-2.13 (m, 1H).
5c (100.6 MHz, CDCI3): 138.1, 137.8, 128.4, 128.3, 128.2, 127.7, 127.6, 127.6,
83.7, 82.5, 80.7, 74.1, 73.5, 73.4, 71.1, 70.6, 67.5, 39.4.
HRMS (ESI): calculated for [M+Na]+, C2 ,H22Na03: 345.1467; found: 
345.1437
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Preparation ofL44a/b
OH OH
The reaction was split in two round-bottom flasks. To a stirred solution of 1.35 (19.9 g, 
63.3 mmol) in dry THF (220 mL) at 0 °C a solution of vinyl magnesium bromide (1 M 
in THF, 190 mL, 190 mmol, 3.0 eq.) was added under controlled atmosphere. The 
reaction mixture was allowed to reach room temperature and stirred for further 24 h. 
The reaction mixture was cooled to 0 °C and quenched with ammonium chloride 
saturated solution (50 mL), then stirred for further 10 minutes at room temperature. The 
solvent was then evaporated under reduced pressure and the salts formed were filtered 
off; water (30 mL) was added and the product was extracted with EtOAc (3 x 100 mL). 
The organic extracts was dried over Na2S0 4  and concentrated in vacuo. The residue was 
purified by column chromatography on silica gel eluting with dichloromethane/ethyl 
acetate 8:2 to afford the mixture of two diastereoisomers 1.44a/b as a yellow oil (19.8 g, 
91% yield).
(a+P anomers): Rf = 0.30 and 0.46 (dichloromethane/ethyl acetate 8:2).
IR: vmax (neat) / cm 1: 3422, 3064, 3031, 2868, 1737, 1643, 1497, 1454, 1371,
1245, 1208, 1092, 923, 737, 699.
5H (400 MHz, CDC13): 7.45-7.23 (m, 20H), 5.93-5.84 (m, 2H), 5.30-5.20 (m,
2H), 5.12-5.08 (m, 2H), 4.67-4.54 (m, 8 H), 4.40-4.32 (m, 
2H), 4.05-3.95 (m, 2H), 3.81-3.70 (m, 2H), 3.62-3.55 (m, 
4H), 1.90-1.70 (m, 4H).
5c (100.6 MHz, CDCI3): 141.1, 140.8, 138.0, 137.9, 128.7, 128.6, 128.2, 128.1,
128.09, 128.06, 114.6, 114.2 78.4, 77.7, 77.4, 73.6, 72.6,
72.2, 71.8, 71.7, 71.0, 70.9, 70.6, 69.8, 37.2, 37.1.
HRMS (ESI): calculated for [M+Na]+, C2iH26Na04: 365.1729; found: 
365.1739.
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Preparation ofl36a/fi
BnO
Bn(3 Bn(5
1.36p 1.36a
To a stirred solution of 1.44a/b (9.00 g, 26.2 mmol) in acetone (250 mL), toluene-p- 
sulphonyl chloride (5.49 g, 28.8 mmol, 1.1 eq.) and KOH (5 M in H20 , 13 mL, 2.5 eq.) 
were sequentially added. The reaction was stirred for 52 h at 35 °C (external 
temperature). The reaction mixture was then diluted with water and extracted with ethyl 
acetate (3 x 100 mL). The combined organic extracts were dried over Na2SC>4 and 
concentrated in vacuo. The two diastereoisomers were separated by column 
chromatography eluting with petroleum ether/diethyl ether 85:15 to afford the title 
compounds 1.36a and 1.36P as pale yellow oils (1.36a 1.93 g, 23% yield; 1.36P 3.03 g, 
36% yield).
1.36P50
[a] D20 = +21.4 (c = 4.3 in CH2C12).
Rf = 0.56 (petroleum ether/ethyl acetate 8:2).
5H (400 MHz, CDCI3): 7.39-7.21 (m, 10H), 6.01-5.93 (m, 1H), 5.25-5.08 (m,
2H), 4.65-4.39 (m, 4H), 4.37-4.31 (m, 1H), 4.16-4.13 (m, 
1H), 4.04-4.02 (m, 1H), 3.86-3.82 (m, 1H), 3.77-3.73 (m, 
1H), 2.35-2.28 (m, 1H), 1.91-1.86 (m, 1H).
5C (100.6 MHz, CDCI3): 139.4, 138.5, 138.4, 128.5, 128.4, 127.9, 127.6, 127.5,
116.0, 81.5, 79.5, 79.3, 79.1, 73.6, 71.3, 69.3, 38.5.
HRMS (ESI): calculated for [M+H]+, C2 iH250 3: 325.1804; found:
325.1817.
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1.36a
[a ] D20 = +34.0 (c = 6.0 in CH2C12).
Rf =0.63 (petroleumether/ethyl acetate 8:2).
IR: vmax (neat) / cm'1: 2864, 1454, 1094, 925, 787, 697.
5h (400 MHz, CDCI3): 7.39-7.21 (m, 10H), 5.91-5.81 (m, 1H), 5.30-5.25 (m,
1H), 5.13-5.10 (m, 1H), 4.65-4.46 (m, 5H), 4.25-4.19 (m, 
2H), 3.79 (dd, J, = 10.0, J2 = 5.6, 1H), 3.72 (dd, JI = 9.6, 
J2 = 6.4, 1H), 2.32-2.26 (m, 1 H), 1.78-1.71 (m, 1 H).
8 c (100.6 MHz, CDCI3): 138.33, 138.29, 138.2 128.51, 128.46, 127.8, 127.74,
127.7, 116.6, 83.7, 81.5, 80.0, 77.5, 77.4, 73.5, 71.2, 38.8.
HRMS (ESI): calculated for [M+H]+, C2 iH250 3: 325.1804; found:
325.1817.
Preparation of 1.37/3
OH
BnCJ
To a solution of 1.360(1.00 g, 3.08 mmol) in THF/H20  (1:1, 80 mL), N- 
methylmorpholine-Af-oxide (540 mg, 4.60 mmol, 1.5 eq.) and OsC>4 (78 mg, 0.31 mmol, 
0.1 eq.) were added sequentially. After stirring at room temperature for 3 h, the reaction 
mixture was quenched with Na2S2 0 s/NaHS0 3  (765 mg, 1.3 eq.) and stirred 1 h at the 
same temperature. The reaction was then extracted with ethyl acetate (3 x 50 mL). The 
combined organic extracts were washed with 1 N HC1 (1 x 50 mL), followed by H20  (1 
x 50 mL) and brine (1 x 50 mL). The organic layer was dried over Na2S0 4  and 
concentrated in vacuo to afford 1.37(3 as a mixture of two diastereoisomers (dr 80:20) as 
a brown oil. This product did not require any further purification for the next step (1.10 
g, 99% yield).
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Rf = 0.24 (dichloromethane/methanol 9:1).
IR: vmax (neat) / cm'1: 3384, 2936, 1445, 1064.
5h (400 MHz, CDCI3): 7.42-7.22 (m, 20H), 4.69-4.51 (m, 6 H), 4.42-4.39 (m,
2H), 4.27-4.11 (m, 4H), 3.99-3.97 (m, 2H), 3.91-3.89 (m,
2H), 3.79-3.61 (m, 8 H), 2.29-2.20 (m, 2H), 2.14-2.08 (m,
2H).
Sc( 100.6 MHz, CDCI3): 138.1, 137.7, 128.6, 128.54, 128.52, 128.0, 127.93,
127.9, 127.8, 127.7, 81.5, 80.9, 79.5, 78.8, 78.73, 78.67,
78.5, 73.6, 73.1, 72.8, 71.5, 71.4, 68.9, 6 8 .8 , 64.9, 64.0,
33.7, 32.0.
HRMS (ESI): calculated for [M+Na]+, C2 iH26Na05: 381.1678; found: 
381.1691.
Preparation ofL38j3
To a stirred solution of 1.37p (1.30 g, 3.60 mmol) in CH2C12 (40 mL), acetic anhydride 
(6.2 mL, 65.0 mmol, 18.3 eq.), pyridine (3.1 mL, 38.5 mmol, 10.7 eq.) and a catalytic 
amount of MAf-dimethylaminopyridine (22 mg, 0.18 mmol, 0.05 eq.) were added 
sequentially. The reaction was stirred at room temperature for 2 h, then diluted with 
CH2C12 and washed with HC1 10% (2 x 30 mL), followed by NaHC03 saturated 
solution (2 x 30 mL). The organic phase was dried over Na2S 0 4 and then concentrated 
in vacuo. The reaction afforded a mixture of two diastereoisomers (dr 67:33) which 
were separated by column chromatography eluting with petroleum ether/diethyl ether 
8:2 to afford 1.38p-a and 1.38p-b as yellow oils (1.38p-a 0.96 g, 60% yield; 1.38p-b 
0.31 g, 20% yield).
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1.380-a
6 j - L / 0'
[a] D20 = +26.6 (c = 6.17 in CH2C12).
Rf = 0.76 (petroleum ether/ethyl acetate 6:4).
IR: vmax(neat) / cm"1: 1748, 1224, 793.
5h (400 MHz, CDC13): 7.36-7.28 (m, 10H, Ar), 5.18 (ddd, Jx = 6.4, J2 = 3.6, J3 =
2.8, 1H, H-8 ), 4.61-4.50 (m, 4H, H- 6  and H-7), 4.36 (d, J 
= 12, 1H, H-9), 4.18-4.01 (m, 4H, H-3, H-l, H-9’ and H-
4), 3.78 (dd, J! = 10, J2 = 4.8, 1H, H-5), 3.68 (dd, J} = 10,
J2= 6.4, 1H, H-5’), 2.20-2.04 (m, 2H, H-2 and H-2’), 2.07 
(s, 3H, H -ll), 2.05 (s, 3H, H-10).
8 C (100.6 MHz, CDCI3): 171.0, 170.4, 138.3, 138.1, 128.5, 127.9, 127.82, 127.8,
127.76, 127.72, 82.3, 78.3, 76.2, 73.6, 73.4, 71.3, 68.9,
63.0,33.7,21.2,21.0.
HRMS (ESI): calculated for [M+Na]\ C25H3oNa0 7: 465.1889; found:
465.1881.
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1.38|3-b
[a]D20 = +21.4 (c = 5.43 in CH2C12).
Rf = 0.68 (petroleum ether/ethyl acetate 6:4).
IR‘ Vmax (neat) / cm"1: 1748,1224,793. -
SH (400 MHz, CDC13): 7.34-7.27 (m, 10H, Ar), 5.24 (ddd, J} = 6.4, J2 = 3.6, J3 =
2.8, 1H, H-8 ), 4.62-4.52 (m, 4H, H- 6  and H-7), 4.42 (m,
1H, H-9), 4.37-4.33 (m, 1H, H-3), 4.18-4.10 (m, 2H, H-l
and H-9’), 4.04-4.00 (m, 1H, H-4), 3.80 (dd, Jj = 10, J2 =
4.8, 1H, H-5), 3.70 (dd, J} = 10, J2 = 6.4, 1H, H-5’), 2.20-
2.14 (m, 1H, H-2), 2.04 (s, 3H, H -ll), 2.02 (s, 3H, H-10),
1.94-1.89 (m, 1H, H-2’).
8 C (100.6 MHz, CDCI3): 171.3, 170.8, 128.54, 128.5, 127.9, 127.8, 127.74 127.7,
127.52, 127.5, 81.6, 78.4, 76.3, 73.6, 72.5, 71.6, 69.0,
63.6, 33.7,21.2, 20.9.
HRMS (ESI): calculated for [M+Na]+, Cas^oNaO?: 465.1889; found:
465.1881.
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Preparation of 1.57fra
OAc
,0 ,
l_IO \ / >— OAc
HC)
To a stirred solution of 1.38P-a (300 mg, 0.678 mmol) in methanol/formic acid 9:1 (24 
mL), Pd/C 10% (144 mg, 1.36 mmol, 2.0 eq.) was added. The reaction mixture was 
vigorously stirred at room temperature under atmospheric hydrogen pressure (balloon) 
for 16 h. The solution was then filtered on celite and the solvent evaporate under 
reduced pressure to afford a colourless oil. This product did not require any further 
purification for the next step. (163 mg, 92% yield).
[a] D25 = +53.3 (c = 0.3 in CH2C12).
Rf = 0.2 (dichloromethane/methanol 9:1).
IR: vmax (neat) / cm'1: 3584, 2946, 1740.
5h (400 MHz, CDC13): 5.26-5.23 (m, 1H), 4.53-4.48 (m, 2H), 4.17-4.10 (m, 2H),
4.00-3.91 (m, 2H), 3.88-3.85 (m, 1H), 2.37-2.30 (m, 1H), 
2 . 1 1  (s, 3H, -OCH3), 2.07 (s, 3H, -OCH3), 1.97-1.95 (m, 
1H).
5C (100.6 MHz, CDCI3): 170.9, 170.4, 77.3, 76.4, 73.5, 72.6, 62.5, 61.8, 37.2, 21.1,
2 1 .0 .
HRMS (ESI): calculated for [M+Na]+, CnHi8Na07: 285.0950; found:
285.0954.
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Preparation of 1.58fra
To a stirred solution of 1.57|3-a (163 mg g, 0.621 mmol) in dry pyridine (3.3 mL), 4,4'- 
dimethoxytrityl chloride (274 mg, 0.810 mmol, 1.3 eq.) was added under an inert 
atmosphere. The reaction was stirred at room temperature for 16 hours, then quenched 
with a solution of chloroform/methanol 9:1 ( 8  mL), diluted with CH2CI2 (5 mL) and 
washed with H20  (1 x 10 mL). The organic phase was dried over MgSC>4 , concentrated 
in vacuo and purified by column chromatography on silica gel eluting with petroleum 
ether/ethyl acetate 7:3 containing 3% of Et3N to afford 1.58p-a as a yellow oil (210 mg, 
60% yield).
[oc] D25 = + 1 . 8  (c = 21.0 in CH2CI2).
Rf = 0.86 (petroleum ether/ethyl acetate 1:1).
IR: vmax (neat) / cm* : 3584, 3029, 2946,1740.
5h (400 MHz, CDCI3): 7.39-7.28 (m, 4H), 7.45-7.21 (m, 5H), 6.90-6.79 (m, 4H),
5.26-5.23 (m, 1H), 4.53-4.46 (m, 2H), 4.21-4.10 (m, 1H),
3.95-3.91 (m, 1H), 3.79 (s, 6 H, ArOCH3), 3.39-3.37 (m, 
2H), 2.66-2.65 (m, 1H), 2.33-2.25 (m, 1H), 2.10 (s, 3H, - 
OCH3), 2.04 (s, 3H, -OCH3), 1.97-1.91 (m, 1H).
8 C (100.6 MHz, CDCI3): 170.9, 170.3, 158.7, 144.7, 135.8, 130.1, 128.08, 128.04,
127.0, 113.4, 8 6 .8 , 81.7, 76.1, 73.0, 72.7, 62.9, 62.6, 55.4,
37.1.21.2.21.0.
HRMS (ESI): calculated for [M+Naf, C32H36Na0 9: 587.2257; found:
587.2266.
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Preparation of 1.39fi-a
CN
To a stirred solution of 1.58p-a (235 mg, 0.416 mmol) in dry CH2CI2 (10 mL), N,N- 
diisopropylethylamine (181 jxL, 1.04 mmol, 2.5 eq.) and 2-cyanoethyl N,N- 
diisopropylchlorophosphoramidite (204 jllL, 0.915 mmol, 2.2 eq.) were added 
sequentially under an inert atmosphere. The reaction was stirred at room temperature 
overnight, then poured into ice-cold water (15 mL) and extracted with CH2CI2 (3 x 15
mL). The combined organic extracts were washed with water (1 x 10 mL), dried over
MgSC>4 , and evaporated under reduced pressure. The crude residue was purified by 
silica gel column chromatography (petroleum ether/ethyl acetate 8:2 containing 3% 
Et3N) to afford a diastereoisomeric mixture of 1.39p-a (dr 85:15) as a yellow oil (303 
mg, 95% yield).
Dfc vmax (neat) / cm'1: 3029, 2946,1740; 1380.
8 h (400 MHz, CDC13): 7.49-7.57 (m, 2H), 7.38-7.19 (m, 7H), 6.91-6.77 (m, 4H),
5.11-5.07 (m, 1H), 4.61-4.53 (m, 1H), 4.47-4.05 (m, 4H),
3.79 (s, 3H), 3.78 (s, 3H), 3!65-3.12 (m, 5H), 2.58-2.51 
(m, 1H), 2.45-2.20 (m, 2H), 2.15-2.12 (m, 1H), 2.08 (s, 
3H), 2.06 (s, 3H), 1.97-1.91 (m, 1H), 1.21-0.90 (m, 12H).
8 C (100.6 MHz, CDCI3): 171.0, 170.9, 170.3, 170.1, 158.47, 158.45, 145.13, 145.1,
136.47, 136.46, 136.24, 136.21, 130.31, 130.25, 128.5,
128.4, 127.8, 126.8, 126.7, 117.9, 117.7, 113.09, 113.06, 
86.23, 86.21, 83.2, 83.1, 76.01, 76.0, 73.3, 73.1, 64.3,
64.0, 62.9, 62.7, 58.7, 58.5, 58.1, 58.0, 55.33, 55.29, 43.4,
43.3, 43.2, 43.1, 36.7, 36.5, 24.74, 24.67, 24.63, 24.60,
24.55.24.4.24.3.21.2.21.1.21.0.20.97.
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HRMS (ESI): calculated for [M+Na]+, C4 iH53N2NaOioP: 787.3336; 
found: 787.3344.
Preparation of 1.57fi-b
OAc
HO OAc
To a stirred solution of 1.38p-b (200 mg, 0.452 mmol) in methanol/formic acid 9:1 (19 
mL), Pd/C 10% (96 mg, 0.90 mmol, 2.0 eq.) was added. The reaction mixture was 
vigorously stirred at room temperature under atmospheric hydrogen pressure (balloon) 
for 16 h. The solution was then filtered on celite and the solvent evaporate under 
reduced pressure to afford a colourless oil. This product did not require any further 
purification for the next step. (51 mg, 43% yield).
[a] D25 = +40.0 (c = 0.6 in CH2C12).
Rf = 0.2 (dichloromethane/methanol 9:1).
IR: vmax (neat) / cm"1: 3584, 2946, 1740.
8 h (400 MHz, CDCI3): 5.27-5.23 (m, 1H), 4.47-4.44 (m, 1H), 4.29-4.26 (m, 1H),
4.17-4.10 (m, 2H), 3.93-3.79 (m, 3H), 2.30-2.26 (m, 1H), 
2.10 (s, 3H), 2.03 (s, 3H), 1.85-1.80 (m, 1H).
5C (100.6 MHz, CDCI3): 171.7, 171.2, 81.5, 77.4, 73.8, 73.7, 63.3, 62.0, 38.3, 21.4,
2 1 .0 .
calculated for [M+Na]+, CnHigNaOy: 285.0950; found:
285.0954.
HRMS (ESI):
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Preparation of 1.58 j3-b
OAc
0 N\
To a stirred solution of 1.57p-b (46 mg g, 0.175 mmol) in dry pyridine (1.0 mL), 4,4'- 
dimethoxytrityl chloride (83 mg, 0.25 mmol, 1.4 eq.) was added under an inert 
atmosphere. The reaction was stirred at room temperature for 16 hours, then quenched 
with a solution of chloroform/methanol 9:1 (2 mL), diluted with CH2CI2 (5 mL) and 
washed with H2O ( 1 x 5  mL). The organic phase was dried over MgS(>4 , concentrated 
in vacuo and purified by column chromatography on silica gel eluting with petroleum 
ether/ethyl acetate 7:3 containing 3% of Et3N to afford 1.58P-b as a yellow oil (42 mg, 
43% yield).
[<x] D25 = +2.0 (c = 2.0 in-CH2Cl2).
Rf = 0.86 (petroleum ether/ethyl acetate 1:1).
IR: vmax(neat) / cm'1: 3584, 3029, 2946, 1740.
5h (400 MHz, CDCI3): 7.47-7.21 (m, 9H), 6.84 (d, J = 8 .8 , 4H), 5.26-5.24 (m,
1H), 4.42-4.38 (m, 2H), 4.26-4.15 (m, 2H), 3.89-3.88 (m, 
1H), 3.79 (s, 6 H), 3.42 (dd, Jj .= 10, J2 = 5.2, 1H), 3.32 
(dd, J} = 10, J2 = 4.8, 1H), 2.87-2.85 (m, 1H), 2.36-2.29 
(m, 1H), 2.05 (s, 3H), 2.04 (s, 3H), 1.87-1.75 (m, 1H).
§c (100.6 MHz, CDCI3): 170.84, 170.82, 158.7, 144.8, 135.9, 135.8, 130.1, 128.2,
128.1, 113.4, 8 6 .8 , 81.3, 75.9, 72.7, 72.3, 63.5, 62.7, 55.4,
37.4, 21.1., 21.0.
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HRMS (ESI): 
Preparation of 1.39/3-b
calculated for [M+Na]+, C32H36Na09: 587.2257; found:
587.2266.
CN
To a stirred solution of 1.58P-b (27 mg, 0.048 mmol) in dry CH2Cl2 (1.2 mL), NfN- 
diisopropylethylamine (20 [XL, 0.12 mmol, 2.5 eq.) and 2-cyanoethyl N,N- 
diisopropylchlorophosphoramidite (24 (iL, 0.449 mmol, 2.2 eq.) were added 
sequentially. The reaction was stirred at room temperature overnight under argon 
atmosphere, then poured into ice-cold water (5 mL) and extracted with CH2C12 ( 3 x 5  
mL). The combined organic extracts were washed with water, dried over MgS0 4 , and 
evaporated under reduced pressure. The crude residue was purified by silica gel column 
chromatography (petroleum ether/ethyl acetate 8:2 containing 3% EtsN) to afford a 
diastereoisomeric mixture of 1.390-b as a yellow oil (15 mg, 41% yield).
IR' vmax (neat) / cm" : 
5h (400 MHz, CbCl3):
3029, 2946, 1740; 1380.
7.29-7.20 (m, 18H), 6.76-6.74 (m, 8 H), 5.27-5.22 (m, 2H) 
4.45-3.98 (m, 8 H), 3.71 (s, 6 H), 3.70 (s, 6 H), 3.65-3.12 
(m, 10H), 2.54-2.50 (m, 2H), 2.78-2.55 (m, 6 H), 2.39- 
2.32 (m, 2H), 2.09 (s, 6 H), 2.01 (s, 6 H), 1.92-1.81 (m, 
2H), 1.25-0.79 (m, 24H).
5C (100.6 MHz, CDCI3): 170.84, 170.76, 170.5, 158.43, 158.4, 145.1, 136.6, 136.3, 
132.5, 131.0, 130.4, 130.31, 130.28, 130.22, 128.9, 128.5,
128.4, 127.8, 126.8, 126.7, 117.8, 116.7, 113.1, 86.2,
82.1, 76.3, 76.0, 73.3, 72.7, 63.8, 63.6, 63.4, 58.2, 58.2, 
55.31, 55.27, 45.42, 45.4/43.2, 43.1, 35.9, 24.84, 24.63,
24.6, 24.59, 24.55, 24.4, 24.3, 21.2, 21.1, 21.0, 20.97.
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HRMS (ESI): calculated for [M+Na]+, C^IfeNzNaOioP: 787.3336;
found: 787.3346.
Preparation of 1.56J3
BnCf
To a stirred solution of 1.37P (67 mg, 0.19 mmol) in CH3CN (1.7 mL), anthraldehyde 
dimethyl acetal59 (59 mg, 0.23 mmol, 1.25 eq.) and /?-toluensulfonic acid (0.8 mg, 2 
mol%) were added. The reaction was stirred at room temperature 48 h, then it was 
neutralised with Et3N and the solvent was evaporated. The crude material was purified 
by column chromatography on silica gel eluting with petroleum ether/ethyl acetate 9:1 
to afford the title compound 1.56P (mixture of two diastereoisomers dr 78:22) as a 
yellow oil (18 mg, 18%).
Major diastereoisomer
[a] D25 = +8 . 6  (c = 1 .4 in CH2C12).
Rf = 0.44 (petroleum ether/ethyl acetate 8:2).
TR: vmax (neat) / cm'1: 3012, 1592, 1220, 780.
5h (400 MHz, CDC13): 8.59-8.52 (m, 2H), 8.44 (s, 1H), 7.97-7.92 (m, 2 H), 7.60-
7.36 (m, 5H), 7.32-7.11 (m, 9H), 7.05 (s, 1H), 4.61-4.50
(m, 4H), 4.42-4.32 (m, 3H), 4.32-4.23 (m, 1H), 4.23-4.11
(m, 2H), 3.84-3.70 (m, 2H), 2.20-2.15 (m, 2H).
8 c (100.6 MHz, CDCI3): 138.4, 138.3, 131.6, 131.1, 130.6, 129.2, 128.5, 128.0,
127.8, 127.6, 126.3, 125.0, 124.7, 101.8, 82.3, 79.34,
79.28,79.0,73.7,71.3, 69.2,68.5, 35.1 .
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HRMS (ESI): calculated for [M+H]+, G36H35O5 : 547.2484; found:
547.2503.
Minor diastereoisomer
[oc] D 25 = -2 0 . 0  (c = 0.4 in CH2C12).
Rf = 0.36 (petroleum ether/ethyl acetate 8:2).
IR: vmax (neat) / cm'1: 3012, 1592, 1 2 2 0 , 780.
5h (400 MHz, CDCI3): 8.53-8.40 (m, 3H), 8.10-7.91 (m, 2H), 7.52-7.40 (m, 4H),
7.40-7.17 (m, 10H), 7.15 (s, 1H), 4.73-4.50 (m, 4H), 4.42-
4.17 (m, 4H), 4.20-4.10 (m, 2H), 3.90-3.71 (m, 2H), 2.29-
2.15 (m,2H).
8 C (100.6 MHz, CDCI3): 138.4, 138.2, 131.6, 131.0, 130.5, 129.3, 128.6, 128.0,
127.8, 127.79, 127.7, 127.6, 126.4, 125.1, 124.9, 124.4
101.4, 82.3, 79.5, 79.0, 78.3, 73.7, 71.3, 70.0, 69.3, 35.1.
HRMS (ESI): calculated for [M+H]+, C36H35O5 : 547.2484; found:
547.2500.
Preparation of 1.60CC and 1.60/5
B nC > + B n O
BnO* BnC)
1.60a 1.600
A stirred solution of 1.41 (2.5 g, 7.6 mmol) in dry CH2CI2 (48 mL) was cooled to 0 °C 
under an inert atmosphere. Trimethylsilyl cyanide (1.3 mL, 10.6 mmol, 1.4 eq.) was 
added followed by boron trifluoride etherate (3.4 mL, 27.4 mmol, 3.6 eq.). The reaction 
was stirred at 0 °C for 2 h. After this time, NaHCC>3 saturated solution (50 mL) was
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slowly added and the reaction mixture stirred until evolution of CO2 was complete. The 
product was extracted with CH2CI2 (3 x 40 mL), the combined organic extracts were 
dried over Na2S0 4 , concentrated in vacuo and purified by column chromatography on 
silica gel eluting with petroleum ether/diethyl ether 8 : 2  to afford the title compounds 
1.60a and 1.60P as yellow oils (1.60a 1 . 2 1  g, 49% yield; 1.60P 1 . 0  g, 41% yield).
1.60a
[a ] D25 = +10.5 (c = 1.9 in CH2C12).
IR: vmax (neat) / cm’1: 2994, 2232, 1103.
5H (400 MHz, CDCI3): 7.35-7.27 (m, 1 0 H), 4.89-4.87 (m, 1 H), 4.61-4.48 (m,
4H), 4.40-4.37 (m, 1H), 4.18-4.15 (m, 1H), 3.52 (d, J = 4, 
2H), 2.42-2.39 (m, 2H);
5C (100.6 MHz, CDCI3): 137.8, 137.6, 128.63, 128.61, 128.2, 128.0, 127.8, 127.7,
119.1, 85.0, 79.5, 73.7, 71.5, 70.0, 66.3, 37.3.
HRMS (ESI): calculated for [M+H]+, C20H22NO3: 324.1600; found:
324.1594.
1.60p
[a] D25 = +14.0 (c = 2 . 0  in CH2C12).
IR: vmax (neat) / cm*1: 2994, 2232, 1103.
5h (400 MHz, CDC13): 7.38-7.27 (m, 10H), 4.80-4.76 (m, 1H), 4.61-4.50 (m,
4H), 4.26-4.23 (m, 1H), 4.22-4.19 (m, 1H), 3.58 (dd, J1 =
10.4, J2 = 4.4, 1H), 3.50 (dd, J2 = 10.4, J2 = 5.2, 1H), 
2.43-2.40 (m, 2H).
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5c (100.6 MHz, CDCI3): 137.9, 137.5, 128.7, 128.6, 128.2, 128.0, 127.89, 127.87,
118.9, 84.9, 80.2, 73.8, 71.6, 70.3, 65.9, 37.8.
HRMS (ESI): calculated for [M+H]+, C20H22NO3 : 324.1600; found:
324.1596.
Preparation of 1.61 a
0
BnO \ ___/  H
BnC?
A stirred solution of 1.60a (0.20 g, 0.62 mmol) in dry toluene (10 mL) was cooled to - 
78 °C. DIBAL-H (1 M in toluene, 0.74 mL, 0.74 mmol, 1.2 eq.) was added via syringe. 
The reaction was allowed to warm to room temperature. After 45 minutes the reaction 
was quenched with CH3OH (5 mL) and Rochelle salt saturated solution (25 mL) was 
added. The resulting sospension was stirred for 4 h at room temperature, diluted with 
water and extracted with ethyl acetate (3 x 30 mL). The combined organic extracts were 
washed with H2O and brine, then dried over Na2SC>4 and concentrated in vacuo. The 
crude material obtained was purified by column chromatography on silica gel eluting 
with petroleum ether/ethyl acetate 85:15 to afford 1.61a as a yellow oil (74 mg, 37%).
[a ] D25 =+40.0 (c = 1.3 in CH2CI2).
LR: vmax(neat)/cm'':
8 h (400 MHz, CDCI3):
8 c (100.6 MHz, CDCI3):
2971, 2748, 1719.
9.75 (d, J = 1.2 1H), 7.37-7.24 (m, 10H), 4.55-4.38 (m, 
6 H), 4.11-4.09 (m, 1H), 3.52 (dd, J = 10.4, 4.4, 1H), 3.46 
(dd, J = 10.4,5.2,1H), 2.32-2.30 (m, 2H).
205.0, 138.0, 137.6, 128.6, 127.9, 127.9, 127.8, 127.74, 
127.7, 84.5, 83.0,79.6,73.6,70.8,70.7, 34.6.
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HRMS (ESI): calculated for [M+H]+, C20H23O4 : 327.1596; found:
327.1612.
Preparation of 1.65a
O H
^ - n ° 2
BnO'
To a stirred solution of 1.61a (36 mg, 0.11 mmol) in dry CH2CI2 (1 mL), CH3NO2 (0.1 
mL, 1.70 mmol, 15.0 eq.) and Et3N (3.2 jo,L, 0.022 mmol, 0.2 eq.) were added. The 
reaction was stirred at room temperature for 16 h, then the solvent was evaporated and 
the crude material was purified by column chromatography on silica gel eluting with
petroleum ether/ethyl acetate 7:3 to afford the title compound 1.65a as a mixture of two
diastereoisomers (dr 70:30) as a yellow oil (29 mg, 6 8 %).
IR: vmax (neat) / cm"1: 3644, 3010, 1573, 1361.
SH (400 MHz, CDC13): 7.38-7.28 (m, 20H), 4.69-4.26 (m, 16H), 4.13-4.08 (m,
4H), 3.48-3.40 (m, 4H), 3.01-2.62 (br s, 2H), 2.29-2.12 
(m, 4H).
5C (100.6 MHz, CDCI3): 138.0, 137.6, 128.7, 128.7, 128.6, 128.6, 128.2, 128.0,
128.0, 127.9, 127.9, 127.9, 127.7, 127.7, 83.8, 83.6, 80.5,
80.4, 79.4, 79.1, 78.9, 78.4, 73.6, 71.5, 71.5, 70.8, 70.8,
70.7, 34.0, 33.5.
HRMS (ESI): calculated for [M+H]+, C2 |H26N 06: 388.1760; found:
388.1775.
Preparation of 1.62 a
O H
B n Ö
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To a stirred solution of the diastereoisomeric mixture of 1.65a (0.017 g, 0.044 mmol) in 
CH3OH (1 mL), Pd/C 10% (0.004 g, 0.044 mmol, 1 eq.) and HCOONH4 (0.028 mg, 
0.44 mmol, 10 eq.) were added. The reaction was inserted into the cavity of a Biotage
Microwave apparatus and heated for 15 minutes at 40 °C by microwave irradiation. The
mixture was then filtered on celite and purified by column chromatography on silica gel 
eluting with dichloromethane/methanol 98:2 to afford the title compound 1.62a as 
mixture of two diastereoi somers (dr 70:30) a yellow oil (100 mg, 64%).
3652, 3413, 2998, 1498, 1097.
7.34-7.24 (m, 20H), 4.52-4.37 (m, 8 H), 4.16-3.86 (m, 
10H), 3.44-3.37 (m, 4H), 3.10-2.75 (m, 4H), 2.22-2.16 
(m, 2H), 2.04-1.99 (m, 2H).
137.9, 137.8, 128.5, 127.9, 127.8, 127.8, 83.5, 82.9, 80.3
80.2, 79.8, 73.4, 71.4, 70.6, 69.6, 42.3, 33.9.
calculated for [M+H]+, C2 iH28N04: 358.2018; found: 
358.2025.
Preparation of 1.61/3
O
BnCj
A stirred solution of 1.60(3 (300 mg, 0.930 mmol) in dry toluene (15 mL) was cooled to 
-78 °C and DIBAL-H (1 M in toluene, 1.2 mL, 1.12 mmol, 1.2 eq.), was added. The 
reaction was allowed to warm to room temperature. After 45 the reaction minutes was 
quenched with CH3OH (5 mL) and Rochelle salt saturated solution (25 mL) was added. 
The mixture was stirred 4 h at room temperature, diluted with water and extracted with 
ethyl acetate (3 x 30 mL). The combined organic extracts were washed with H20  and 
brine, then dried oyer Na2S0 4  and concentrated in vacuo. The crude material obtained
IR: vmax(neat)/cm'1:
SH (400 MHz, CDCI3):
8 C (100.6 MHz, CDCI3): 
HRMS (ESI):
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was purified by column chromatography on silica gel eluting with petroleum ether/ethyl 
acetate 85:15 to afford the title compound 1.61P as yellow oil (184 mg, 61%).
[a ] D25 = +29.3 (c = 1 .5 in CH2C12).
2971,2748,1719.
9.67 (d, J = 2.0, 1H), 7.35-7.29 (m, 10H), 4.57-4.30 (m, 
6 H), 4.15-4.10 (m, 1H), 3.55-3.42 (m, 2H), 2.13-2.08 (m, 
2H).
205.0, 138.0, 137.6, 128.6, 127.9, 127.9, 127.86, 127.85,
127.7, 84.5, 83.0,79.6, 73.6,70.8,70.7, 34.7.
calculated for [M+H]+, C20H23O4 : 327.1596; found: 
327.1602.
O H
BnQy ^  N ° 2
B nO '
To a stirred solution of 1.610 (180 mg, 0.54 mmol) in dry CH2C12 (1 mL), CH3NO2 (0.4 
mL, 8.0 mmol, 15 eq.) and Et3N (15 ul-, 0.107 mmol, 0.2 eq.) were added. The reaction 
was stirred at room temperature for 16 h, then the solvent was evaporated. The crude 
material obtained was purified by column chromatography on silica gel eluting with 
petroleum ether/ethyl acetate 7:3 to afford the title compound 1.650 (a mixture of two 
diastereoisomers, dr 70:30) as a colourless oil (112 mg, 54%).
IR: vmax (neat) / cm'1: 3639, 3008,1570,1355.
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IR: vmax (neat) / cm"1:
5h (400 MHz, CDC13):
5c (100.6 MHz, CDCI3): 
HRMS (ESI): 
Preparation of 1.65f}
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8h (400 M Hz, CDC13):
5C (100.6 MHz, CDC13):
HRMS (ESI):
7.37-7.28 (m, 20H), 4.57-4.36 (m, 14H), 4.22-4.11 (m, 
6H), 3.56-3.45 (m, 4H), 2.18-2.06 (m, 4H).
137.9, 137.5, 137.0, 129.8, 128.71, 128.7, 128.6, 128.3,
128.2, 128.1, 128.0, 127.89, 127.8, 127.13, 83.8, 83.7,
80.8, 80.5, 79.5, 79.0, 77.9, 76.2, 73.9, 73.7, 73.6, 71.7,
71.5, 70.8, 70.6, 70.5, 70.4, 33.2, 32.1:
calculated for [M+H]+, C21H26NO6: 388.1760; found: 
388.1771.
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General procedure A for the organocatalytic and enantioselective Michael addition of 
lH-benzotriazole 2.73 to 3 - methyl-4-nitro-5-sty rylisoxazo le 2.64 (Section 2.8, Tables 
18-25).
To a solution of 2.64 (10 mg, 0.04 mmol, 1.0 eq.) in the relevant solvent (1.4 mL) and. 
cinchona-derived catalyst (5 moI%) were added, followed by l//-benzotriazole 2.73 (26 
mg, 0.22 mmol, 5.0 eq.). The resulting mixture was stirred at the stated temperature for
5 minutes, then the relevant base (0.22 mmol, 5.0 eq.) was added. After the stated 
reaction time, the reaction was then quenched with aqueous NH4CI (2 mL, saturated 
solution), and extracted with toluene ( 3 x 2  mL). The combined organic extracts were 
dried over Na2S0 4 and the solvent evaporated under reduced pressure. The crude 
material was purified by a column chromatography (petroleum ether/ethyl acetate) 
affording 2.74 and 2.75 as a pale yellow oils.
Preparation of2.74162
4.2 Experimental section chapter 2
Prepared according to general procedure A. Rf = 0.29 (petroleum ether/ethyl acetate 
85:15).
[a] D25 = -5.7 (c = 0.7 in CH2C12).
5H (400 MHz, CDCI3): 8.05 (d, J = 8.4, 1H), 7.43-7.31 (m, 8 H), 6.44-6.40 (m,
1H), 4.77 (dd, J, = 15.6, J2 = 9.2, 1H), 4.36 (dd, J, = 15.6, 
J2 = 6 .4 ,1H), 2.50 (s, 3H).
5C (100.6 MHz, CDC13): 170.4, 155.8, 146.5, 137.1, 132.8, 129.53, 129.48, 127.9,
126.7,124.5, 120.4,109.7, 59.9, 34.0, 11.7.
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HRMS (ESI):
Preparation of 2.75 162
calculated for [M+Na]+, CigHisNsOsNa: 372.1073; 
found: 372.1074.
Prepared according to general procedure A. Rf = 0.61 (petroleum ether/ethyl acetate 
85:15).
[a ] D25 = -4.0 (c = 1 in CH2C12). 
5h (400 MHz, CDC13): 7.85-7.83 (m, 2H), 7.50-7.48 (m, 2H), 7.39-7.35 (m, 5H), 
6.60-6.56 (m, 1H), 4.68 (dd, J} = 15.6, J2 = 9.6, 1H), 4.30 
(dd, Jj = 15.6, J2 = 6.0, 1H), 2.49 (s, 3H).
5C (100.6 MHz, CDCI3): 170.3, 144.5, 137.1, 129.5, 129.3, 127.0, 126.9, 118.4,
67.1,34.1, 11.7.
HRMS (ESI): calculated for [M+Na]+, CigH^C^Na: 372.1073;
found: 372.1076.
Preparation of 2.74 (Section 2.8, Table 22, entry 2)
Prepared according to general procedure A using l//-benzotriazole 2.73, catalyst 2.78 (1 
mg, 0.21 mmol, 5.0 mol%) and K2CC>3 (30 mg, 0.22 mmol, 5.0 eq.) in toluene (1.4 mL) 
for 96 h at 0 °C, affording 2.74 as the only product in 40% yield as a yellow oil. The ee 
of the product was determined by CSP-HPLC using a Chiralpak AD column (n- 
hexane/z'PrOH 80:20, flow rate 1 mL/min, tm¡n = 22.6 min, imaj = 31.2 min, 29% ee). 
Spectral data were identical to compound 2.74 described in general procedure.
174
Experimental section chapter 2
Preparation of catalyst 2.80
To a suspension of quinidine (650 mg, 2.0 mmol, 1.0 eq.) in THF (12.0 mL) benzyl 
bromide (0.31 mL, 2.6 mmol, 1.3 eq.) was added. The resulting mixture was heated at 
60 °C for 16 h. The reaction was diluted with CH2CI2 (10 mL) and washed with H2O (3
x 15 mL). The organic phase was dried over Na2SC>4 and the solvent evaporated under
reduced pressure. The crude material was purified by column chromatography 
(chloroform/methanol 95:5) affording 2.80 as a purple solid (512 mg, 52% yield).
Rf = 0.39 (chloroform/methanol 90:10).
[a ] D 25 = +1.7 (c = 1 in CH3OH)
3621,2991, 1673, 1270, 1230.
8.60 (d, J = 4.4, 1H), 7.95 (d, J = 9.2, 1H), 7.81 (d, J =
4.4, 1H), 7.72-7.70 (m, 2H), 7.36 (d, J = 2.8, 1H), 7.35-
7.18 (m, 4H), 6.73-6.71 (m, 1H), 6.57-6.56 (m, 1H), 6.02-
5.89 (m, 2H), 5.25-5.19 (m, 3H), 4.67-4.55 (m, 1H), 3.95-
3.90 (m, 2H), 3.85 (s, 3H), 3.44-3.41 (m, 1H), 2.98-2.95 
(m, 1H), 2.45-2.35 (m, 2H), 1.90-1.80 (m, 3H), 1.09-1.01 
(m, 1H).
158.1, 147.6, 144.4, 142.8, 135.6, 134.1, 132.1, 130.6,
129.3, 127.1, 120.8, 120.4, 118.4, 102.9, 6 8 .6 , 66.3, 56.9, 
56.2, 54.0,38.3,27.3,24.2,21.8.
HRMS (ESI): calculated for [M]+, C27H3 iN20 2: 415.2386; found:
415.2378.
IR: Vmax(neat) / cm'1: 
5h (400 MHz, CDCI3):
5C (100.6 MHz, CDCI3):
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m.p.: 198-202 °C
Preparation of catalyst 2.86
To a stirred suspension of cinchonidine (926 mg, 3.2 mmol, 1.0 eq.) in THF (13.0 mL) 
2-methoxybenzyl bromide237 (823 mg, 4.1 mmol, 1.3 eq.) was added. The resulting 
mixture was heated at 60 °C for 48 h. The solvent was evaporated under reduced 
pressure and the crude material was purified by column chromatography 
(chloroform/methanol 95:5) affording 2.86 as a pink solid (1.55 g, 99% yield).
Rf = 0.33 (chloroform/methanol 90:10).
[a] D25 = -1.1 (c = 1 in CH3OH)
3610, 2987, 1655,1237.
8.93 (d, J = 4.4, 1H), 8.13-8.03 (m, 3H), 7.88 (d, J = 4.4, 
1H), 7.62-7.59 (m, 1H), 7.55-7.53 (m, 1H), 7.45-7.41 (m, 
1H), 7.08-7.04 (m, 1H), 6.92-6.89 (m, 1H), 6.82-6.80 (m, 
1H), 6.58-6.57 (m, 1H), 6.04 (d, J = 12, 1H), 5.54-5.48 
(m, 1H), 5.11-4.92 (m, 4H), 3.87 (s, 3H), 3.75-3.73 (m, 
1H), 3.30-3.10 (m, 3H), 2.51-2.49 (m, 1H), 2.39-2.19 (m, 
2H), 2.00-1.99 (m, 1H), 1.71-1.68 (m, 1H), 1.33-1.32 (m, 
1H).
158.7, 150.3, 148.0, 145.2, 136.7, 136.4, 132.6, 130.7,
129.1, 127.5, 124.6, 122,4, 121.7, 120.6, 117.9, 115.6,
111.3, 70.2, 63.7, 60.8, 58.4, 56.0, 51.0, 38.2, 26.5, 25.1, 
2 1 .6 .
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5h (400 MHz, CDCI3):
8 C ( 1 0 0 .6  MHz, CDCI3):
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HRMS (ESI): calculated for [M]+, C27H31N2O2: 415.2386; found: 
415.2372.
m.p.: 99-101 °C
Preparation of2.90ll4A15
OCH3
To a solution of quinidine (1.0 g, 3.1 mmol) in dry DMF (10.0 mL), NaH (74 mg, 3.1 
mmol) and benzyl chloride (390 juL, 3.39 mmol, 1.1 eq.) were added. The resulting 
mixture was stirred overnight at room temperature under an argon atmosphere. The 
reaction was quenched with brine (10 mL) and extracted with ethyl acetate ( 3x15 mL). 
The combined organic phases were dried over Na2SC>4 and evaporated under reduced 
pressure. The crude material was purified by column chromatography 
(chloroform/methanol 95:5 containing 1 % Et3N) affording 2.90 as a yellow oil (617 mg, 
48%).
[a] D25 = +137.4 (c = 0.86 in CHC13)
5h (400 MHz, CDCI3): 8.70 (d, J = 4.4, 1H), 7.98 (d, J = 9.2, 1H), 7.41 (d, J = 4.4
Hz, 1H), 7.40-7.31 (m, 7H), 6.00-5.83 (m, 1H), 5.15 (br, 
1H), 5.02-5.00 (m, 1H), 4.90 (s, 1H), 4.40 (d, J =11.2,  
1H), 4.31 (d, J = 11.2, 1H), 3.90 (s, 3H), 3.30-3.18 (m, 
1H), 3.13-3.05 (m, 1H), 2.93-2.71 (m, 3H), 2.26-2.22 (m, 
1H), 2.11-2.05 (m, 1H), 1.68 (br, 1H), 1.51-1.43 (m, 2H),
1.29-1.24 (m, 1H).
HRMS (ESI): calculated for [M+H]+, C27H31N2O2 : 415.2386; found: 
415.2370.
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OH
Preparation of2.91llA~V5
A solution of 2.90 (617 mg, 1.49 mmol) in dry DMF (5 mL), was added dropwise to a 
suspension of CH3CH2S (1.0 g, 12 mmol, 8  eq.) in dry DMF (5 mL). The resulting 
mixture was stirred overnight at 110 °C under an argon atmosphere. The reaction was 
quenched with NH4CI saturated solution (10 mL) until pH = 7 and extracted with ethyl 
acetate ( 3x15  mL) and washed with water (3 x 15 mL). The combined organic phases 
were dried over Na2SC>4 and evaporated under reduced pressure. The crude material was 
purified by column chromatography (dichloromethane/methanol 95:5) affording 2.91 as 
a yellow oil (194 mg, 33%).
[a ] D25 = +154.7 (c = 1.05 in CHC13)
§ h  (400 MHz, CDCI3): 10.40 (br, 1H), 8.72 (d, J = 4.4, 1H), 8.07(d, J = 9.2, 1H),
7.81 (s, 1H), 7.49 (br, 1H), 7.47-7.28 (m, 6 H), 6.04-5.89 
(m, 1H), 5.52 (br, 1H), 5.05-4.96 (m, 2H), 4.41-4.31 (m, 
2H), 3.56 (br, 1H), 3.05-3.03 (m, 2H), 2.87-2.78 (m, 2H),
2.26-2.24 (m, 2H), 1.79 (br, 1H), 1.52-1.39 (m, 2H), 1.18 
(br, 1H)
HRMS (ESI): calculated for [M+H]+, C26H28N20 2: 401.2229; found:
401.2228.
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Preparation of 2.88
To a solution of 2.91 (84 mg, 0.21 mmol) in THF (4.0 mL) benzyl bromide (32 DL, 
0.27 mmol, 1.3 eq.) was added. The resulting mixture was heated at 60 °C for 16 h. The 
reaction was diluted with CH2CI2 (5 mL) and washed with water (3 x 10 mL). The 
organic phase was dried over Na2SC>4 and then evaporated under reduced pressure. The 
crude material was purified by column chromatography (chloroform/methanol 90:10) 
affording 2 . 8 8  as a yellow solid (80 mg, 67%).
Rf = 0.2 (dichloromethane/methanol 90:10).
[a] D25 = +0.04 (c = 2.2 in CH3OH)
IR: vmM (neat) / cm"1:
5h (400 MHz, CDCI3):
5c (100.6 MHz, CDCI3):
HRMS (ESI): calculated for [M]+, C33H35N20 2 : 491.2699; found:
491.2687.
3617, 3008.
8.79 (d, J = 4.4, 1H), 8.28 (d, J = 2.4, 1H), 8.02 (d, J = 
9.2, 1H), 7.60-7.54 (m, 3H), 7.47-7.37 (m, 9H), 6.06-6.00 
(m, 2H), 5.85-5.79 (m, 1H), 5.24 (d, J = 10.4, 1H), 5.08 
(d, J = 17.2, 1H), 4.94-4.91 (m, 2H), 4.44-4.37 (m, 2H), 
4.05-3.98 (m, 2H), 3.49-3.35 (m, 1H), 2.82-2.79 (m, 1H), 
2.41-2.30 (m, 2H), 1.94-1.71 (m, 3H), 1.23-1.10 (m, 1H).
157.6, 146.3, 137.9, 135.9, 135.4, 134.2, 131.9, 129.6, 
129.5, 129.3, 129.2, 129.0, 128.9, 128.6, 126.8, 124.1, 
118.8, 118.2, 105.1, 74.3, 72.1, 68.1, 65.9, 60.5, 37.8, 
33.7, 31.1,27.3, 25.8, 23.7, 22.0, 21.2.
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m.p.: 213 °C
Preparation of2.96m
H
A solution of benzaldehyde 2.97 (0.5 mL, 5.0 mmol, 1.0 eq.) and tert-butyl carbazate 
2.98 (660 mg, 5 mmol, 1.0 eq.) in hexane (6.0 mL), was heated under reflux conditions 
for 20 minutes. The solution was allowed to cool to room temperature. The precipitate 
formed was filtered by gravity filtration, then washed with hexane to remove the 
impurities, affording 2.96 as a white solid (1.03 g, 93% yield).
5H (400 MHz, CDC13): 7.87 (s, 1H), 7.83 (s, 1 H), 7.69-7.67 (m, 2H), 7.40-7.35
(m, 3H), 1.54 (s,9H).
5C (100.6 MHz, CDCI3): 155.6, 144.2, 132.1, 130.7, 129.4, 126.9, 82.2, 29.1.
HRMS (ESI): calculated for [M+Na]+, Ci2H16N20 2Na: 243.1109; 
found: 243.1102.
m.p. 213 °C
Preparation of 2.102182
To a solution of 3,5-dimethyl-4-nitroisoxazole (1.00 g, 7.09 mmol, 1.0 eq.) in 
H20/ethanol 9:1 (4 mL), NaOH (284 mg, 7.10 mmol, 1.0 eq.) was added and the
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solution was stirred at room temperature 30 minutes followed by the addition of 
isovaleraldehyde 2.101 (913 jiL, 8.52 mmol, 1.2 eq.). The reaction was allowed to stir at 
room temperature 96 h, quenched with NH4CI saturated solution and extracted with 
CH2CI2 (3 x 10 mL). The collected organic phases were dried over Na2SC>4 and then 
evaporated under reduced pressure affording 2.102 as a yellow oil (conversion 40%). 
The crude was used for the next step without further purification.
5h (400 MHz, CDCI3): 4.23-4.20 (1H, m), 3.36 (1H, dd, Ji = 15.0, J2 = 4.0), 3.29
(1H, dd, Jj = 15.0, J2 = 7.0), 2.55 (3H, s), 1.87-1.76 (1H, 
m), 1.58-1.53 (1H, m), 1.40-1.34 (1H, m), 0.95 (3H, d, 7 = 
7.0), 0.93 (3H, d, 7 = 7.0).
5C (100.6 MHz, CDCI3): 172.9, 155.8, 130.9, 6 8 .0 , 46.8, 36.1, 24.8, 23.3, 2 2 .0 ,
11.8
HRMS (ESI): calculated for [M]+, Ci0H16N2O4: 228.1110; found:
228.1215.
Preparation of 2.103 X*2
To a solution of 2.102 (7.09 mmol, 1.0 eq) in CH2C12 (40 mL), methane sulfonyl 
chloride. (658 |iL, 8.51 mmol, 1.2 eq.) was added at 0 °C followed by addition of Et3N 
(1.98 mL, 14.2 mmol, 2.0 eq.) at room temperature. After 50 minutes, complete 
consumption of 2.102 was observed. The reaction was diluted with H2O and extracted 
with CH2CI2. The collected organic phases were dried over Na2S0 4 and then evaporated 
under reduced pressure. The crude residue was then purified by column chromatography 
eluting with petroleum ether/ethyl acetate 9:1. The title compound 2.103 was obtained 
as a yellow oil (597 mg, 40% yield).
181
Experimental section chapter 2
5h (400 MHz, CDCI3): 7.11-7.00 (m, 2H), 2.53 (s, 3H, N=C-CH3), 2.30-2.22 (m,
2H), 1.89-1.79 (m, 1H), 0.95 (d, 6 H 7 = 7.0, CH(CH3)2)
5C (100.6 MHz, CDC13): 170.1, 158.2, 133.0, 127.0, 103.2, 42.1, 24.4, 23.9, 22.3,
12.5.
HRMS (ESI): calculated for [M]+, Ci0H14N2O3: 210.1004; found:
210.1008.
General procedure for the organocatalytic and enantioselective Michael addition of 
nitromethane to 2.103 (Section 2.8.2, Table 28)ni
To a solution of 2.103 (10 mg, 0.048 mmol, 1.0 eq.) in toluene, cinchona-derived 
catalyst (5 mol%) was added, followed by nitromethane (13 jiL, 0.24 mmol, 5.0 eq.). 
The resulting mixture was stirred at the stated temperature for 5 minutes, then K2C03 
(33 mg, 0.24 mmol, 5.0 eq.) was added. After the stated reaction time, the reaction was 
then quenched with aqueous NH 4CI (2 mL, saturated solution), and extracted with 
toluene ( 3 x 5  mL). The combined organic extracts were dried over Na2S0 4 and the 
solvent evaporated under reduced pressure. The crude material was purified by a 
column chromatography (petroleum ether/ethyl acetate 9:1) affording 2.104 as pale 
yellow oil.
The ees of the product were determined by CSP-HPLO using a Chiralpak AD column 
(n-hexane/i'PrOH 99:1, flow rate 0.75 mL/min, tj = 37.4, t2 = 41.7).
(5)-2.104 [a] D25 = + 8 . 0  (c = 1 in CH2C12)
(7?)-2.104 [a] D 25 = - 6 . 8  (c = 0.6 in CH2C12)
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5h (400 M Hz, CDC13):
5c (100.6 MHz, CDC13):
HRMS (ESI):
4.38 (d, J = 6.0, 2H), 3.38-3.25 (m, 2H), 2.91-2.80 (m, 
1H), 2.56 (s, 3H), 1.74-1.63 (m, 1H), 1.36-1.23 (m, 2H), 
0.92 (d, J = 4.0, 3H), 0.90 (d, J = 4.0, 3H),
172.1, 155.9, 78.5, 40.9, 33.9, 30.0, 29.7 25.1, 22.4, 22.3,
11.7.
calculated for [M]+, CnHnNsOs: 271.1168; found: 
271.1160.
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General experimental
NMR experiments were performed on a Bruker Avance II 600 instrument and samples 
were obtained in CDC13 (referenced to 7.28 ppm for !H and 77.0 for 13C). Coupling 
constants (7) are in Hz. Multiplicities are reported as follows: s, singlet, d, doublet, dd, 
doublets of doublets, t, triplet, q, quartet, m, multiplet, c, complex, and br, broad.
Representative procedure for titration experiments of 3.25:3.26 solution
0.15 mL of a solution of 3.26 in CDCI3 (0.0024 mmol, 0.0031 M) was added to an 
oven-dried NMR tube. A spectrum was obtained for the catalyst solution in order to 
determine appropriate acquisition parameters. The tube was removed from the 
spectrometer and portions of 0.1 eq. of 3.25 were added until an equimolar solution of 
3.25:3.26 was achieved then subsequently, the solution was brought to a 2:1 ratio by 
adding 0.2 eq. portions of 3.25. The experiments were performed at room temperature.
N-benzyl cinchoninium chloride 3.26 (1.0 eq.) and 3-methyl-4-nitro-5-styrylisoxazole
3.25 (1.0 eq.)protons assignment
4.3 Experimental section chapter 3
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5h (600 MHz, CDCI3): 8.80 (d, J = 4.8, 1H, H-l), 8.28 (d, J = 8.4, 1H, H-4), 7.86
(d, J = 4.2, 1H, H-2), 7.80 (d, J = 16.2, 1H, H-2’) 7.69- 
7.65 (m, 3H, H -l’, H-3’ and H-8 5), 7.56-7.45 (m, 6 H, H- 
3, H-22, H -l8 , H-4’, H-5’ and H-6 ’), 7.20-7.01 (m, 5H, 
H-5, H-6 , H -l9, H-20 and H-21), 6.54-6.52 (m, 1H, H-9), 
6.20 (d, J = 12, 1H, H-17), 5.83-5.80 (m, 1H, H-13), 5.38 
(d, J = 12, 1H, H-17’), 5.22-5.15 (m, 2H, H-14 and H- 
14’), 4.57-4.50 (m, 1H, H-15), 4.11-4.08 (m, 1H, H-8 ), 
3.97-3.90 (m, 1H, H-10), 3.31-3.27 (m, 1H, H-15’), 2.77- 
2.70 (m, 1H, H-10’), 2.60 (s, 3H, H-9’), 2.26-2.24 (m, 1H, 
H -l2), 2.15-2.10 (m, 1H, H-7), 1.75-1.64 (m, 3H, H-16, 
H -ll and H-l T), 0.77-0.68 (m, 1H, H-75).
N-benzyl cinchoninium chloride 3.26 (1.0 eq.) and 3-methyl-4-nitro-5-styrylisoxazole
3.25 (1.0 eq.) carbons assignment
3.26 3.25
5C (150 MHz, CDCI3): 167.2 (C-10’), 156.1 (C-12’), 149.4 (C-l), 147.0 (C-25),
144.7 (C-24), 143.1 (C-25), 135.3 (C-13), 134.3 (C-13’), 
134.0 (C-l8  and C-22), 131.11 (C-5’), 129.8 (C-20), 
129.4 (C-3), 129.2 (C-4’ and C-6 ’), 128.7 (C-l9 and C- 
21), 128.4 (C-3’ and C-8 ’), 128.3 (C-5 and C - ll’), 127.2 
(C-26), 127.11 (C-6 ), 123.6 (C-23), 123.0 (C-4), 119.8 
(C-2), 118.0 (C-14), 111.0 (C-l’), 67.2 (C-8 ), 65.7 (C-9),
61.7 (C-17), 56.4 (C-10), 54.5 (C-15), 38.1 (C-12), 27.2 
(C-16), 23.9 (C-ll), 21.8 (C-7), 11.8 (C-95).
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Compound 1.41
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Compound 1.35
■4 o> yr <h rvci co cn• 05 Tf co (7> C\ cn^ cti oo cr> co n '^ .^  cd co co.cm t> oo o\ mm H.m in oarv ro cvim cn h. , '■*—<-o  <ri un co cn o  cnrr^ - m cN i-< *-ro go vjo cd.cd’^ -vo.cm oo o  vo in ^  m r- vD <r ro cM ih o;cvr"* vo rin rvcM cmn n  f^ .rn n ’csj in «r.vo ^cm in in in ui.in:tn ^  ^  cm cm cm cm t-<;ih h h . h  \£> vo •x) vom in in in in in uvm-m p in  cm cm .cm
-rr -t>- T' in'/in-N* x? ^  ^  '«J1 ^  ^  cn m ro'rrrp nrrp W'Vp.rVrn.Jro’ro^^rp cm cm cm
d o\ r-H.rni  o r^ . >j.rh □ i-h ^  oo r> t ■.;r^ .• cm f ; cv   cm  r-r o m' cnj * H- — •- i rp CMCM .CM (M (N H H r-l
I CM CM CM CM (N
BnO'
i-HOo>cr»ti3o5ci>r^ r'f-ikLim TOn,i'nr'yDm'iiHinor'r-fCi'i'r^co(viaonor-r^u^i• .............................................................* ♦............... * ► * ' * ■■«'riMO0si^i'tnf-'C^r>Gc0iiii?'C0r^<iCDiDron-r*r^mixJC>tDma>«ii©(neor-r-r'r*r^f^r‘ P^ rfcr^r-r'0(TiVf-imoj ♦ » * . . « .*: » ■ i . *. ■ * ■ - < ■tnnr^rinMtNCNif f^NrsrcrgcsjfNiNcscNfvLf i^NCMcMfNoJNiMiMr^oCiOOOcrtnf^r^fNOicNfSp-iooiJiC i^DCDoo- u n r tn d ^ N i
\
199
Appendix chapter 1
Compound 1.44a/b
CO AO in 03 0 :f0 .0 IO oV rH IO ^  W CD HO O iH,.nmn ro fo n 1 . COQO CD. rM CM CN CN CN
r* t>  m -in, to m  in.mm m>m in:mm in in in in in 10m  i n ^
_ VD H.O O Cì r^ .iniQS.CO U) o  rocn cn r-i:*-ti»h;*h o;o o.om_mm m co m rr-'vD vo in in:tn in co oo co acco rr1
.rs « ‘ « I <4. ^  ^  .ro  ro  —-* —*'—i ^  —*••
OHOH 
Bntf \ / ^
BnO’
w ^ r  \
r - r 'r 'n r 'r ' f ^ r ' i . i j
v
200
K>O
o  -
■ Bl.-14■ 79:4J - 7S.23■ 73.60 • 71.26 ■69.26
n01o
<*>ON■co
Appendix chapter 1
202
120.5120.46127.70 127.74327.70
- 03.65
-01.45
73,5-171,15
ä~
TJ■o
14.09
no
3oc3
C l
ON
P
5.33
1 .04
2.2942.2762.272
Appendix chapter 1
Appendix chapter 1
Compound 1.370
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Compound 1.38p-a
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Compound 1.38P-b
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Compound 1.56p major diastereoisomer
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Compound 1.560 minor diastereoisomer
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Compound 1.570-a
0ij}r^^cncrt^in,<j’c30^cTttTìaD^^in^in^nfSHHoocoM^^^min
r-inintnLnLDin^
HOOOOOOOOO^ WtDcOCO(s Ms (nMNNCNCN^ OOOOQOOO'^^^v^^^^^^nnnnnnmnc^cNWCNJCMMoJcgojoJCNcNrNirgH
r- m vd o  m ro
r- vd in in ^  cc00 CO CO 00 00 i—f
OAc
HO' OAc
HO
A-. jLj UjL
7.5 7.0 6.5
I
6.0
■ i ■ 
5.5 5.0 3.0 2.5
n---- - 1 i ■ ■ ■ 1 i
2.0 1.5 ppm |
V
208

no
3o
c3a-
i noo“CO
0.95/ 
1.11'
0.98;s^ t:
2.88\2.7121.33/ L
c
7 .4 4 7  
7 .4 4 3  
7 .4 3 8  
7 .4 2 5  
7 .3 3 7  
7 .3 3 2  
7 .3 1 5  
7 .3 0 8  
7 .2 9 0  
7 .2 7 1  
7 .2 5 9  
7 .2 2 9  
7 .2 2 6  
7 .2 0 8  
6 .8 4 5
6 .8 4 1
6 .8 2 3
5 .2 9 8
5 .2 4 7
5 .2 3 9
4 .4 9 7
4 .4 8 9
4 . 4 66
4 . 459
4 .2 0 2
4 .1 8 8
4 .1 7 2
4 . 157
4 . 127
4 .1 1 0
4 .1 0 5
4 .0 9 1
3 . 9 34
3 .3 8 6
3 .3 7 4
2 .6 6 0
2 . 081
2 .  078
2 . 0 35
2 .0 2 7
1 .9 6 7 Appendix chapter 1
Appendix chapter 1
Compound 1.390-a
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Compound 1.60P
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Compound 1.65p
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Compound 2.74
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H P L C  spectra for compound 2.74 (Section 2.11, Table 23, entry 2)
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H P L C  spectra for compound 2.104 (Section 2.11.2, Table 29, entry 9)
Paga 1 of 1
Software Version 
Operator 
Sample Number 
Auto Sampler 
Instnjmenl Name 
Instrument Serial # 
Delay Time 
Sampling Rate 
Sample Volume 
Sample Amount 
Dais Acquisition Time
6.3.1.0504
manager
SER200 Periun Elmer LC 
None 
0.00 mln 
2.2727 pts/s
1.000000 ul
1.0000
17/10/2011 10:15:00
Date
Sample Name 
Study 
Rack/Vi at 
Channel..
A/D mV Range 
End Time
Area Reject 
Dilution Factor 
Cycle
01/11/2011 11:48:17 
GB568
1000
59.99 min
0.000000
1.00
1
Raw Data Fite : C:\TOTALCHROM DATA\Rasulls\Gea\GB568GB568.ad.81%.0.75ml.9.001.raw 
Result File: C:\TOTALCHROM DATA\Results\Gea results\GS5G8GB568.Bd.B1%.0.75ml.B.001.rst |Editing In Progress) 
Inst Method : C:\TOTALCHROM DATA\Methods\B1 %-0.75mL-60min from C:\TOTALCHROM 
D AT A\ Resu It s\Gea\GB568GS568.sd.B 1 % .0.75 ml. B. 0 01. ra w
Proc Method : C:\TDTALCHROM DATA\Meihods\B1%-0.75ml-60min trom C:\TOTALCHROM DAT A\Re su I ls\Gea 
resu!falGB558GB568.ad .01 %. 0.75ml. B. 001. rsj {Editing Iri PropressJ
Calib Method : C:\TOTALCHROM DATA\Melhods\B1%-0.75mL-60min from C:\TOTALCHROM DATA\Resu ItsVGea 
results\GB568GBS6a.acl.B1%.0.75ml.B.001.rsl [Editing in Progress)
Report Format File: C:\PenExe\TcWSWer6.3.1\Conflg\U6ertmanager\DelauIt.rpl 
Sequence Fils': C:VTOTALCHROM DATA\Sequances\GB568-.a<j.B1%.0.75ml.-..seq
D E F A U L T  R E P O R T
Peak Component Time Area Height Area Norm. Area Cat. Volt BL Raw Adjust«!
#■ Name [mln] [uV’sec] [uV) [%J [%] Range Range Amount Amount .
1 41.250 7155147.49 98837.77 17.55 17.55 *MM 7.1551 7.1551
2 44.B73 33619330,57 277048.67 B2.45 .82.45 "MM 33.6193 33.6193:
40774476.06 3758B0.44 100.00 100.00 40,7745 40,7745'
Missing Component Report
Componsnt Expected Retention (Calibration File)
AH components were found
«minó Nam« : G8SS3 ,. Swnpteff: Page 1 o! 1teNem* : CMOTALCHROto OATAiResailtVis^aB563GBSSa.ed S )%.£). 75m!£.CQl.,iHY ialB:0l/tV2Dll 11:40:20 , , ,
Whod Time of (nj«c)rai: 17/10Í2D11 10:15:00 . .. . ,X>rtTtm*::34.G4 uh; EnaThie : 56.63 min Low Point : -4,83 mAU Hion Peint ‘ 208 04 mAU WOIIs«u-4,fl3mAU Plot scoto: Z93.8 .mAU
"ITiTi ! ¡Tl nI 11nT* inymi ¡iTTi'i 11 ¡ ; | \(\z\ n n i ¡ ? iT]'rnrmTiTniTyrn-[ [Tintttt njr, îtî'"itîTjttttttiiTrrrnrr
56; 38 - 40 42 44 .46  ' ■ 4B>. - SO ’ 52 54 • -.66".
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Appendix chapter 2
H P L C  spectra for compound 2.104 (Section 2.11.2, Table 29, entry 11)
Software Version 
Operator 
Sample Number 
AutoSampler 
Instrument Name 
Instrument Serial # 
Delay Time 
Sampling Rale 
Sample Volume 
Sample Amount 
Data Acquisition Time
SER200 PerKinElmer LC 
None 
0.00 mtn1 
2.2727 pista
1.000000 ul
1.0000
18/10/2011 10:35:02
Dale
Sample Name
Sludy
RacK/Vlal
Channel
A/D mV Range
End Time
01/11/2011 11:22:30 
CH570'
1000
59.99 min
Area Reject 
Dilulic 
Cycle
Factor : 1.00 
1
Raw Data File : C:\TOTALCHROM DATA\Results\Gea\GB570GB570.ad.B1%.0.75ml B.001 .raw
Result File : C:\TOTALCHROM DATA'Resulis\Gea resulis\GB570GB570 ad.B1%.0.75ml.B.001.rsl [Editing in Progress]
Inst Method : CATOTAICHROM DATA\Methods\B1 %-0,75ml-50m In Tram C:\TOTALCHROM.
D ATAVRes ul ts\Gea\G B570GB570.ad. B1 %. 0.7 5m I, B. 001. raw
Proc Method : C:\TOTALCHROM DATA\Me1hods\B1%-0.75mL-60mln Irom C:\TOTALCHROM DATA\Resutls\Gea 
resulls\GB570GB570.ad.B1%.0,75ml.B.001.rsl [Editing in Progress]
Calih Method : C:\TOTALCHROM DATA\Methods1B1%-0.75mL-60mln from C:\TOTALCHROM DATAVResolls\Gea 
resulLsiGB570GB570.ad.B1%.0.75ml.B.OOI fEl [Editing in Progress]
Report Format Tile: C:\PenExe\TcWSWer6.3.1\Config\User\manager\Default.rpl 
Sequence File : C:\TOTALCHROM DATA\Sequences\GB570-.ad.B1%.0.75ml.-:.seq
D E F A U L T  R E P O R T
Peak Component Time
# Name [min}
Area
[uVsec]
Height. 
W
Area Norm. Area Cal. Volt 
[%) [%] Range Range
Raw Adjusted 
Amount Amount-
43.032 3293686.55 44183.37 12.04
46.391 24071398.91 201794 A3 ‘ 67.96
12.04
87.96
27365006.46 245963.19 100.00
■MM 3.2937 3.2937
*MM 24.0714 24.0714
27.3651 27.3651-
Missing Component Report
Component Expected Retention (Calibration Rie).
All components were found
SwnpliNafni :GBW0. Snmplcrt: .. Pape t rt 1
‘ :CATOT«.CHROMDATAiRo5ulls\G«iyiGBi70QB57t)j<i.S1S.0.r5mlB.001Jsw: 01/11/2011 11:22:46 ’ ’ ' ,os : ' ... Tim» a! InjKilcm: 1& 10/201110:3502 Wgh Point : 211.10 mAU
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Appendix chapter 3
S p e c tra l d a ta  fo r  N -b e n z y l c in c h o n in iu m  c h lo r id e  3 .2 6  (1 .0  e q .) a n d  3 -m e th y l-4 -  
n itro -5 -s ty ry lis o x a z o le  3 .2 5  (1 .0  e q .)
/ / ! i I  11 I I I  I I I I  a
9.5 9.0 8.S
A M M  M
i ¡ m m m m m m  « 3 ! $  * m  i
\ i l w y  i i i i i  i iii \
' 't....  i ....I.......I.......'I...... I...... I ...... i " ..... i.......i....  T”" ■ ■ ■ ■ i...... i.......i.......i■ • ■
170 1 60 1 50 140 1 30 1 20 110, 100 90 BO 70 60 50 4 0 30 20 1 0 ppm
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